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ABSTRACT 
 
Salmonella enterica serovar Typhimurium (S. Typhimurium) causes a 
systemic disease in susceptible mouse strains that is widely used as a model 
of human typhoid fever. I developed a reporter system based on fluorescence 
dilution that measures bacterial replication directly at both the population and 
single cell level. To understand how S. Typhimurium colonises host tissues 
during disease, I applied fluorescence dilution to study S. Typhimurium 
replication during acute murine typhoid, following oral inoculation. Bacteria 
that had not replicated were found in the Peyer’s patches (PP), mesenteric 
lymph nodes (MLN) and spleen. Hence, replication is not a prerequisite for S. 
Typhimurium to traverse the intestinal wall and reach deeper tissues. 
Furthermore, non-replicating bacteria were found to persist for long periods of 
time within the intestine and, to a smaller extent, in the spleen, suggesting 
that these bacteria may represent dormant reservoirs that cause chronic 
infections. Bacteria replicated rapidly upon invasion of the PP, while the MLN 
represented a more restrictive niche for bacterial replication. In addition, the 
spleen was seeded preferentially by bacteria that had already replicated 
elsewhere. Further analysis of bacterial replication in the spleen provided 
insights into the contribution of the Salmonella-encoded pathogenicity island-2 
type III secretion system to replication in this organ. Experiments also showed 
that S. Typhimurium preferentially colonised and replicated within 
macrophages within the spleen. Therefore, the use of fluorescence dilution 
has provided detailed insights into the relationship between the replication of 
S. Typhimurium and its colonisation of host tissues, and has revealed the 
existence and localisation of non-replicating bacteria that could persist during 
chronic infections.  
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1. INTRODUCTION 
 
1.1. Classification and evolution of Salmonella  
 
Salmonella is a genus of Gram-negative, facultative anaerobic bacilli that 
belongs to the family of Enterobacteriaceae. These bacilli were first isolated 
by Gaffkey in 1884 and later named after Daniel Salmon. The nomenclature 
used to define this genus was previously very complex, however multilocus 
enzyme electrophoresis and genomic deoxyribonucleic acid (DNA)-DNA 
hybridisation have since been used to provide a more accurate and 
universally acceptable classification. Salmonella is now known to consist of 
three species: Salmonella bongori (Reeves et al., 1989, Boyd et al., 1996), 
Salmonella enterica (Crosa et al., 1973, Le Minor and Popoff, 1987) and 
Salmonella subterranean (Shelobolina et al., 2004) (Fig. 1.1).  
 
Analysing the phylogenetic distribution of Salmonella genes has revealed 
much information about the evolution of this genus and the development of S. 
enterica pathogenicity. Approximately 120-160 million years ago, Salmonella 
diverged from the genus Escherichia and soon after, acquired products that 
enabled enteropathogenicity. These include factors that enable attachment to 
the intestinal epithelium, such as: type I fimbriae and long polar fimbriae, 
encoded within the fim and lpf are operons, respectively, and factors that 
mediate invasion of the intestinal epithelium (Mills et al., 1995, Li et al., 1995, 
Baumler et al., 1997a). The latter consists of genes contained within 
Salmonella-pathogenicity island-1 (SPI-1), which encodes the machinery and 
secreted proteins of a type three secretion system (T3SS) (Galan and Curtiss, 
1989). As a result, Salmonella was able to access a more favourable niche 
within the intestinal epithelium and subepithelial layer, where there was 
presumably less competition for nutrients and colonisation sites compared to 
the commensal-rich environment of the gut lumen. 
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The next evolutionary transition resulted in the divergence of Salmonella 
enterica from Salmonella bongori. This correlates with the acquisition of a 
second T3SS, encoded by genes within SPI-2, which promotes intracellular 
replication (Shea et al., 1996, Ochman et al., 1996, Hensel et al., 1997). 
Using this virulence system, Salmonella enterica was able to better colonise 
host tissues and disseminate from the gastrointestinal tract to systemic sites, 
by exploiting a relatively protected niche within host cells. 
 
Salmonella enterica underwent further diversification, through multifactorial 
acquisition and loss of genetic elements, which gave rise to an expansion of 
the host range. As a result, this species has been classified into six 
subspecies: I (enterica), II (salamae), IIIa (arizonnae), IIIb (diarizonae), IV 
(houtenae), VI (indica) and VII (not yet named) (Boyd et al., 1996, Crosa et 
al., 1973). Before being recognised as a separate species, Salmonella 
bongori was classified as subspecies V. All subspecies, apart from group I, 
typically inhabit cold-blooded vertebrates and the environment. However, 
group I or Salmonella enterica subspecies enterica (S. enterica) gained the 
ability to colonise warm-blooded vertebrates. S. enterica has been further 
divided into over 2400 serovars that can be serologically identified using the 
Kaufmann and White classification scheme. This involves grouping isolates 
according to their expression of three highly variable surface antigens: 
lipopolysaccharide (LPS) ‘O’ antigen, flagellar ‘H’ antigen and virulence ‘Vi’ 
polysaccharide capsular antigen. 
 
Serovars of S. enterica display varying degrees of host specificity, resulting in 
a wide spectrum of gastrointestinal to systemic diseases (Table 1.1). Clinical 
manifestation of disease depends on both the serovar and the host. S. 
enterica Typhi (S. Typhi) and S. Paratyphi A, B and C are host-restricted and 
only infect humans and higher primates, where they cause an acute systemic 
illness known as typhoid and paratyphoid fever, respectively. Host-adapted 
serovars include S. Dublin, S. Choleraesuis and S. Gallinarum. These can 
infect several hosts, however they cause the majority of Salmonella-
associated disease in cattle (S. Dublin), pigs (S. Choleraesuis) and chickens 
(S. Gallinarum), suggesting a greater adaptation to these hosts (Kingsley and 
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Bäumler, 2000). Other serovars are generalists, such as S. Typhimurium, 
which can infect a broad host range including humans, cattle, pigs, poultry, 
horses and rodents.  
 
 
  
Table 1.1. Spectrum of diseases caused by serovars of S. enterica.  
S. enterica serovar Human disease Disease in other hosts 
Typhi Typhoid Higher primates (typhoid) 
Paratyphi Paratyphoid Higher primates (paratyphoid) 
Typhimurium Colitis 
Mice (murine typhoid) 
Wide range e.g. Cattle, Pigs (enteritis) 
Enteriditis Colitis Wide range e.g. Cattle, Pigs (enteritis) 
Dublin Invasive bacteraemia Cattle (bovine typhoid) 
Choleraesuis Invasive bacteraemia Pigs (swine typhoid) 
Gallinarum (Rare) Chickens (fowl typhoid) 
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1.2. Human diseases caused by S. enterica 
 
In humans, S. enterica is responsible for the vast majority (>99%) of 
Salmonella-associated infections (Baumler, 1997), with only 12 serovars 
causing approximately 70% of reported cases (Anjum et al., 2005). The major 
clinical syndromes in immunocompetent humans that result from infection with 
S. enterica are enteric (typhoid and paratyphoid) fever and colitis (Table 1.2). 
However, in certain risk groups, including young, elderly and 
immunocompromised individuals, bacteriaemia and other focal infections also 
occur.  
 
1.2.1. Nontyphoidal salmonellosis 
 
1.2.1.1. Diarrhoeal disease (Colitis) 
 
S. enterica-induced diarrhoeal disease or colitis in humans represents a 
significant disease burden and gives rise to approximately 3% (93.8 million 
cases) of diarrhoeal diseases worldwide each year, with 155 000 fatalities 
Diarrhoeal disease Typhoid fever 
Incubation period Short (12-72 h) Long (8-14 days) 
Symptom duration Short (3-7 days) Long (2-3 weeks untreated) 
Intestinal pathology 
Colitis 
PMN infiltrate 
Enteritis (mild) 
Mononuclear infiltrate 
Extraintestinal 
pathology  
MLN 
MLN,  
Liver,  
Spleen,  
Bone marrow 
Complications Bacteraemia 
Haemorrhage (10-20%)  
Intestinal perforation (1-3%) 
Outcome Typically self-limiting 
Mortality (<1% if treated) 
Chronic carriage (1-5%)  
Relapse (5-10%) 
Table 1.2. Common features of NTS and typhoid fever in humans. 
PMN (polymorphonuclear leukocyte); MLN (mesenteric lymph nodes) 
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(Majowicz et al., 2010). Many nontyphoidal S. enterica serovars can cause 
human colitis. The most prevalent isolates in the US and parts of Europe are 
S. Enteriditis and S. Typhimurium (Olsen et al., 2001, Cogan and Humphrey, 
2003). These bacteria can colonise the intestines of most farm animals and 
therefore, can be acquired from multiple animal reservoirs. Transmission is 
usually by consumption of food, such as eggs, meat and dairy products from 
infected animals or via food or water that has become contaminated with 
animal waste.  
 
In healthy adults, nontyphoidal salmonellosis (NTS) is usually self-limiting 
(Table 1.2). Symptoms typically manifest after a short incubation period of 12 
to 72 h and these consist of nausea, vomiting, diarrhoea and abdominal 
cramps (Pegues and Miller, 2010). Acute diffuse colitis with crypt abscess 
formation and occasionally distal ileal involvement is typically observed by 
post-mortem or biopsy (Day et al., 1978, McGovern and Slavutin, 1979, Boyd, 
1985). This acute inflammation is also characterised by mucosal oedema and 
a large polymorphonuclear leukocyte (PMN) infiltrate. The majority of cases 
resolve without treatment within 3 to 7 days, however some patients can 
become chronic fecal carriers (Buchwald and Blaser, 1984). 
 
1.2.1.2. Extraintestinal infections 
 
Infants, elderly and immunocompromised individuals with NTS are often 
unable to contain the infection to the gastrointestinal tract and in these cases 
a potentially life-threatening invasive disease can occur. This syndrome is 
particularly prevalent in human immunodeficiency virus (HIV)-infected 
individuals in sub-Saharan Africa, where mortality rates can reach 
approximately 50% and many patients experience recurrent infections 
(Gordon et al., 2002). Invasive NTS bacteraemia is frequently associated with 
a non-specific fever and hepato- and splenomegaly, in the absence of 
gastrointestinal symptoms (Gordon, 2008). Approximately 5-10% of invasive 
NTS infections develop metastatic focal infections (Mandal and Brennand, 
1988), with increased incidence rates observed in immunosuppressed 
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individuals. Vascular infections are the most common, however disease can 
manifest in almost all organ systems.  
 
1.2.2. Typhoid fever 
 
S. Typhi and S. Paratyphi are the causative agents of the enteric fevers 
known as typhoid and paratyphoid fever, respectively. Typhoid is a more 
severe disease then paratyphoid and is responsible for the vast majority 
(approximately 90%) of enteric fever (Parry, 2006). In 2000 alone, typhoid is 
estimated to have caused approximately 21 million cases and 200 000 deaths 
worldwide (Crump et al., 2004). However, this is likely to represent an 
underestimation of disease rates, as endemic areas often lack the facilities to 
provide a definitive diagnosis. Infections result from ingestion of food or water 
contaminated with human waste. Therefore, typhoid is more predominant in 
developing countries, which lack the infrastructure to provide adequate 
sanitation and access to clean drinking water. The greatest burden of typhoid 
is within regions of south-central and southeastern Asia and southern Africa 
(Crump et al., 2004).  
 
The infectious dose of S. Typhi in healthy human volunteers is between 103 to 
109 organisms (Hornick et al., 1970). Gastric acid provides the initial barrier to 
infection and an increased susceptibility to typhoid commonly occurs in 
patients with achlorhydria, due to ageing, previous gastrectomy, treatments 
affecting gastric acid production or infection with Helicobacter pylori (H. pylori) 
(Bhan et al., 2002). A broad range of symptoms has been reported in typhoid 
patients. These differ in severity and normally develop following a longer 
incubation period of 8 to 14 days, compared to NTS infections (Table 1.2). 
Early symptoms include diarrhoea, common in young children and adults with 
HIV infection, and fever (Parry, 2006). Constipation is also common in about 
one third of patients (Pegues and Miller, 2010). Other common symptoms 
include abdominal pain, malaise, flu-like symptoms and headache. Intestinal 
biopsies reveal enteritis and mucosal thickening characterised by 
mononuclear-rich infiltrates (Sprinz et al., 1966, Kraus et al., 1999). Most 
patients develop a low-grade bacteraemia, thought to facilitate the 
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dissemination of S. Typhi to systemic sites after invasion of the Peyer’s 
patches (PP) (Hornick et al., 1970). Enlargement of the mesenteric lymph 
nodes (MLN), liver and spleen is often observed and is associated with the 
formation of granulomatous lesions. Bacteria are also found in the bone 
marrow and gallbladder. Importantly, re-seeding of S. Typhi from an infected 
gallbladder back into the intestine can lead to re-invasion of the PP (Bos and 
Willemsen, 2002). This can cause serious complications, namely: capillary 
thrombosis of the terminal ileal PP, resulting in haemorrhage (10-20%), 
necrosis, ulceration and eventually intestinal perforation (1-3%) (Pegues and 
Miller, 2010). Untreated typhoid usually resolves in approximately 3 weeks, 
however relapse occurs in 5-10% of cases (Parry, 2006). With good 
management, that is: eradication of the infection with antibiotics, rehydration, 
restoration of nutrition and treatment of complications, typhoid fatality rates 
can be as low as 1% (Pegues and Miller, 2010). However, antibiotic treatment 
is becoming gradually more challenging, with the increasing incidence of drug 
and multi-drug resistant (MDR) serovars (Crump and Mintz, 2010). 
 
Following acute typhoid fever, approximately 1-5% of patients develop chronic 
asymptomatic infection characterised by persistent shedding of S. Typhi in 
urine or stools (Bhan et al., 2005). Approximately 25% of chronic carriers 
arise from subclinical infections of S. Typhi (Mohan et al., 2006). Persistent 
reservoirs of bacteria are thought to be located within the liver (Nath et al., 
2010) and gallbladder (Sinnott and Teall, 1987). Adequate surveillance for 
such individuals is important, as they can contribute significantly to the spread 
of infection. In addition, long-term carriage of S. enterica has been suggested 
to increase the risk of gallbladder, pancreas and large bowel carcinoma 
(Caygill et al., 1994).  
 
1.2.3. Disease prevention 
 
Given that S. Typhi can only survive within human hosts and is transmitted 
between hosts via contaminated food and water, it would be possible to 
eradicate typhoid. Indeed, this has almost been achieved in developed 
countries, where the majority of typhoid cases only occur in returning 
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travellers (Clark et al., 2010). However, the worldwide eradication of typhoid is 
not currently feasible, as this disease is endemic in many countries that still 
lack the means to provide safe drinking water and basic sanitation. Therefore, 
one measure to control the incidence of typhoid fever has been the 
development of vaccines against S. Typhi. Two vaccines are currently 
licensed against typhoid fever: Ty21a, a live attenuated oral vaccine, which 
must be adminstered as 3 to 4 doses and a parenteral Vi capsular 
polysaccharide (Vi CPS), consisting of a purified polysaccharide from the 
bacterial capsule. Neither vaccine exhibits 100% efficacy (Fraser et al., 2007), 
nor can they be given to very young children, an age-group with high 
incidence rates of typhoid fever in endemic countries (Sinha et al., 1999). A Vi 
polysaccharide-protein conjugate, a conjugate of Vi CPS with non-toxic 
recombinant Pseudomonas aeruginosa endotoxin, represents a promising 
new vaccine with improved efficacy in children (Lin et al., 2001). Other 
candidates in clinical trials include attenuated S. Typhi strains with 
combinations of several mutations or deletions in genes required for 
biosynthetic pathways and/or virulence systems, such as the M01ZH09 S. 
Typhi vaccine strain that harbours an aroC and ssaV deletion, which are 
required for aromatic amino acid biosynthesis and SPI-2 T3SS-associated 
effector secretion, respectively (Kirkpatrick et al., 2006, Hien et al., 2010), with 
the aim of creating a vaccine that is effective after a single oral dose. No 
vaccine is currently available against S. Paratyphi or nontyphoidal serovars. 
 
In summary, S. enterica places a major burden on public health services and 
economy worldwide. Case-fatality rates can be high and disease 
management can be difficult, particularly with regard to the global increase of 
MDR isolates and the persistence of chronic carriers. Furthermore, an ideal 
vaccine is yet to be found. Together, this highlights the need for a better 
understanding of S. enterica pathogenesis, so that more efficient control and 
treatment regimens can be developed.  
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1.3. Animal models of human S. enterica infections 
 
Use of appropriate animal models represents a fundamental part of S. 
enterica research. Although a wealth of knowledge can be gained from tissue 
culture models, the relevance of these findings must be tested in more 
physiological contexts. Furthermore, certain aspects of pathogenesis, such as 
systemic dissemination and tissue colonisation, can only be properly studied 
within the living host. 
 
1.3.1. Models of S. enterica-induced colitis 
 
Most studies of NTS in man have focused on experimental infection of calves 
with S. Typhimurium, as this produces a pathology in the intestine that is 
similar to human colitis (Santos et al., 2001). In particular, the bovine ligated 
intestinal loop model has provided insights into the early dynamics of 
intestinal pathology and the contribution of S. enterica virulence factors to the 
development of intestinal disease, for example the requirement of the  SPI-1 
T3SS for invasion and fluid secretion (Layton and Galyov, 2007). However, to 
overcome the out-bred nature, high cost and lack of tools that limit analyses 
using bovine models, a murine model has been developed (Barthel et al., 
2003). Although S. Typhimurium produces a systemic disease with minimal 
intestinal involvement in murine hosts, pre-treatment with the antibiotic 
streptomycin eliminates the gut microflora and renders the intestine 
susceptible to colonisation. These mice subsequently develop acute diffuse 
inflammation of the caecum and colon, accompanied by a PMN-rich infiltrate. 
In susceptible mouse strains, this intestinal pathology occurs in parallel with 
systemic typhoid, which limits studies to early time-points. However, this has 
been somewhat overcome by using genetically-resistant mice (Stecher et al., 
2006, Woo et al., 2008). Streptomycin pre-treated mice have since been used 
to study the role of S. enterica effectors and host immune responses in colitis 
pathogenesis (Hapfelmeier et al., 2004, Coburn et al., 2005, Hapfelmeier et 
al., 2008, Valdez et al., 2009). 
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1.3.2. Murine model of typhoid fever 
 
The pathogenesis of typhoid fever has been difficult to study, owing to the 
host restriction of S. Typhi. Some of the first typhoid fever studies were 
conducted in chimpanzees, which are susceptible to infection with S. Typhi 
(Edsall et al., 1960). Although these primates display a milder form of typhoid, 
the clinical course of infection and pathological tissue changes are very typical 
of the human disease (Edsall et al., 1960, Gaines et al., 1968). 
 
However, over the last 20 years, research has largely focused on the closely 
related strain S. Typhimurium, in a murine model of systemic salmonellosis. 
S. Typhimurium is a natural pathogen of mice and certain genetically 
susceptible, inbred mouse strains develop a systemic pathology that closely 
resembles human infection with S. Typhi. Using mice is more cost efficient 
than large animal models. In addition, the genetics of mouse strains is well 
developed. Therefore, murine infection with S. Typhimurium has been widely 
adopted as a surrogate pathogen and host model to study the bacterial 
virulence and host resistance mechanisms that occur during human typhoid 
fever.  
 
Experimental infection of BALB/c and C57BL/6 natural resistance-associated 
macrophage protein-1 (now known as solute carrier 11a1 [Slc11a1])-deficient 
mouse strains are used to model acute typhoid fever. These mice carry a 
mutation that inactivates Slc11a1 (Lissner et al., 1983, Vidal et al., 1993), 
rendering them highly susceptible to S. Typhimurium infection. Acute S. 
Typhimurium infections in Slc11a1-susceptible mice have been well 
characterised. Oral infection of these mice with 104 to 105 colony forming units 
(CFU) of S. Typhimurium results in a fatal systemic disease (Scherer and 
Miller, 2001). Considerably less bacteria (<10 CFU) are required to cause 
death in 50% of infected mice (lethal dose, LD50) when administered 
intravaneously or intraperitoneally. Most orally ingested bacteria (>99%) are 
killed in the stomach or passed out of the gut. However, some survive in the 
intestine, from where they can traverse the intestinal epithelium (Carter and 
Collins, 1974). Several features of murine intestinal pathology are similar to 
	   24	  
that observed in typhoid patients: notably diffuse enteritis, enlarged PP and 
thickening of the ileal mucosa, accompanied by a characteristic mononuclear 
leukocyte infiltrate (Santos et al., 2001). This is followed by dissemination to 
and colonisation of the MLN, liver and spleen, mirroring the tissue distribution 
of bacteria in human typhoid. S. Typhimurium predominantly replicates in the 
liver and spleen, within host phagocytes (Richter-Dahlfors et al., 1997, 
Salcedo et al., 2001), and this is associated with the development of 
hepatosplenomegaly. Microscopic examination of infected organs reveals 
granulomatous lesions formed initially of PMNs and later mononuclear cells, 
with central areas of necrosis (Nakoneczna and Hsu, 1980, Nakoneczna and 
Hsu, 1983). Similar lesions have also been described in chimpanzees (Edsall 
et al., 1960) and humans (Mert et al., 2004). 
 
In addition to causing acute infections, S. Typhi is also able to chronically 
persist within infected individuals for long periods of time. This syndrome 
cannot be appropriately studied in Slc11a1-deficient mice, due to their 
exquisite susceptibility to infection with S. Typhimurium. However, Slc11a1-
resistant mice routinely develop sublethal infections when infected with 
virulent S. Typhimurium and can harbour persistent reservoirs of these 
bacteria within infected tissues for up to one year (Monack et al., 2004a). 
Therefore, this adapted model has since been used to study the mechanisms 
underlying chronic S. Typhi carriage. 
 
Recently, two groups have developed humanised mouse models, in which S. 
Typhi is capable of causing a systemic disease. Immunodeficient alymphoid 
recombination-activating gene-2−/− interleukin (IL)-2 receptor gamma subunit 
(rγ)−/− (Song et al., 2010) and nonobese diabetic-severe combined 
immunodeficient IL-2rγ−/− mice (Libby et al., 2010) are partly humanised by 
engraftment with human hematopoietic stem cells. As a result, mice develop 
human-derived phagocytic cells that can then serve as a niche for S. Typhi 
infection. At present, these models are unlikely to be used for routine 
laboratory studies as the humanised mice display varying infection outcomes 
and are labour intensive to generate. However, these animals could prove 
useful for pre-clinical testing of vaccine candidates. 
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1.3.3. Limitations of animal models 
 
The murine typhoid model has been used for decades to provide very detailed 
information on bacterial virulence and host defence mechanisms that are 
directly relevant to human typhoid fever. However, it is important to bear in 
mind that findings in the murine model do not necessarily directly translate to 
human infection. This is highlighted by a clear difference in the cause of death 
between murine and human typhoid. In humans, late stages of disease are 
characterised by re-seeding of bacteria from an infected gallbladder into the 
intestine, perforation of the gut and peritonitis (Bos and Willemsen, 2002). 
Although S. Typhimurium does colonise the gallbladder of mice (Monack et 
al., 2004a, Menendez et al., 2009), lethal infection of mice typically occurs as 
a result of large bacterial loads in the liver and spleen, leading to tissue 
damage, multi-organ failure and bacteraemia. In addition, mice infected with 
S. Typhimurium do not develop diarrhoea (Santos et al., 2001), which is a 
common feature of human typhoid (Parry, 2006). 
 
Discrepencies between the pathology of murine and human typhoid are likely 
to partly result from genetic differences in the development, activation and 
activity of immune cells between mice and man (Mestas and Hughes, 2004). 
In addition, significant differences exist between the genomes of S. Typhi and 
S. Typhimurium that also contribute to the altered disease outcomes in the 
two mammalian species. A greater understanding of this was made possible 
through the availability of the genome sequences of S. Typhi CT18 (Parkhill et 
al., 2001) and S. Typhimurium LT2 (McClelland et al., 2001). At least 204 
genes present on the S. Typhimurium chromosome are absent from or 
functionally altered in S. Typhi (Parkhill et al., 2001). Of these pseudogenes, 
145 represent intact genes in S. Typhimurium and up to 46 genes may 
contribute significantly to systemic virulence in the mouse model, including: 
fimbrial genes (Townsend et al., 2001), effector genes of the T3SSs such as 
sopD2 (Brumell et al., 2003, Jiang et al., 2004) and sopE2 (Bakshi et al., 
2000) and the Salmonella plasmid virulence (spv) genes contained in the 
Salmonella virulence plasmid (pSLT) that is not carried by S. Typhi (Gulig et 
al., 1992). Indeed, this genetic degradation is thought to explain the severe 
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host restriction of S. Typhi. Furthermore, the murine model cannot account for 
the function of the 601 genes that are unique to S. Typhi (Parkhill et al., 2001) 
and which may contribute to its human tropism. These include genes located 
within SPI-7 that are important for virulence in typhoid fever, such as: genes 
encoding a type IVB pilus required for adhesion to and invasion of human 
monocytes and epithelial cells (Zhang et al., 2000, Pan et al., 2005) and the 
viaB locus that is responsible for the biosynthesis, translocation and 
regulation of the Vi exopoylsaccharide antigen or capsule (Virlogeux et al., 
1995). Interestingly, the Vi capsule has been shown to downregulate toll-like 
receptor (TLR)-4-mediated activation of macrophages, potentially by masking 
LPS (Wilson et al., 2008). In addition, the tviA operon contained within the 
viaB locus has been reported to reduce flagellin secretion and so, 
downregulate TLR-5-mediated release of IL-8 by intestinal epithelial cells 
(Winter et al., 2008). Collectively, these responses act to reduce inflammation 
and PMN accumulation within the intestine. The Vi capsule has also recently 
been suggested to confer resistance to complement-mediated phagocytosis 
and killing (Wilson et al., 2011). Therefore, it is thought that functions 
conferred by this capsule might also underly the different disease outcomes 
produced in man by infection with S. Typhi and S. Typhimurium. The 
presence of the capsule in S. Typhi might promote colonisation of systemic 
sites through evasion of immune detection, however without this advantage, 
large pro-inflammatory responses are initiated by S. Typhimurium in the 
human gut, which restricts bacteria to gastrointestinal tissues.  
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1.4. Mechanisms of host resistance to S. enterica infection 
 
Most understanding of the immunology of S. enterica infections has been 
obtained by studying host responses during sublethal infections of mice. In 
this model, the immunological response to S. Typhimurium can be divided into 
four distinct phases (Fig. 1.2) (Mastroeni, 2002). These involve innate immune 
effector mechanisms to moderate and soon after, suppress bacterial growth 
and antigen-specific adaptive immune responses, to eventually clear the 
infection and establish protection against a secondary infection. 
 
1.4.1. Innate immunity to S. enterica 
 
The gut provides the primary defense against S. enterica and controls the 
numbers of viable bacteria that are able to establish an invasive infection. 
After oral ingestion, S. enterica must contend with the extreme acidity of 
gastric acid, peristalsis of the intestinal tract and a diverse range of 
antimicrobial molecules, including: defensins, cathelicidin antimicrobial 
peptide (AMP) and bactericidal/permeability-inducing protein (Salzman et al., 
2003, Dann and Eckmann, 2007). Resident gut microbial flora, namely 
members of the genus Bacteroides, may also provide a barrier to S. enterica, 
through the production of volatile fatty acids (Bohnhoff et al., 1964). Indeed, 
mice pre-treated with streptomycin, which disrupts the intestinal microbiota, 
are more susceptible to infection (Bohnhoff and Miller, 1962). 
  
The damage caused through invasion of the intestinal mucosa and replication 
within host tissues undoubtedly exposes S. enterica to the bloodstream. 
Complement can subsequently opsonise, although not lyse, S. enterica 
(Joiner et al., 1982), which promotes uptake of bacteria by phagocytic cells 
present within host tissues. Importantly, mice deficient in the C1q complement 
component experience delayed kinetics of S. Typhimurium clearance from the 
blood and are more susceptible to infection (Warren et al., 2002).  
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Host phagocytes represent one of the most important components of innate 
immunity against S. enterica. Indeed, macrophages resident within host 
tissues are encountered by S. enterica soon after invasion. These are 
accompanied by the infiltration of PMNs within the first few days of infection 
and later, mononuclear cells (Nakoneczna and Hsu, 1980). Both 
macrophages and neutrophils have been implicated in the early control of S. 
enterica growth during infection (O'Brien et al., 1979, Conlan, 1996, Conlan, 
1997). Host phagocytes possess a diverse repertoire of pattern-recognition 
receptors (PRRs), which recognise conserved pathogen-associated microbial 
peptides, and can promote phagocytosis and upregulate phagocyte 
antimicrobial activities (Blander and Medzhitov, 2004). TLR-4 represents one 
well characterised PRR that plays an important role in the immunity against S. 
enterica. TLR-4 recognises LPS present in the outer membrane of S. enterica 
and this interaction induces macrophage activation by triggering signalling 
cascades that stimulate the release of nitric oxide and tumour-necrosis factor-
alpha (TNFα) (Royle et al., 2003). The importance of this function is 
highlighted by the finding that TLR-4-deficient mice rapidly succumb to 
infection with S. Typhimurium (O'Brien et al., 1980), most likely due to 
delayed chemokine expression, inadequate macrophage function and 
impaired adaptive immune responses (Vazquez-Torres et al., 2004, Weiss et 
al., 2004). 
 
The interaction of S. Typhimurium with host macrophages has been 
extensively studied. These immune cells employ several mechanisms to 
control the early growth of these bacteria. One key mediator is Slc11a1, which 
is present on the phagosome membrane in macrophages and localises to the 
Salmonella-containing vacuole (SCV) (Cuellar-Mata et al., 2002). This metal 
transporter has a pleiotropic effect on innate resistance to S. enterica, 
including: limiting the availability of divalent cations to intracellular bacteria 
(Cellier et al., 2007), promoting SCV fusion with degredative compartments 
(Cuellar-Mata et al., 2002) and increasing macrophage antimicrobial activity, 
such as nitric oxide production (Ables et al., 2001). Interestingly, recent 
evidence suggests that Slc11a1 also enhances host cell cytokine secretion 
and consequently, may influence the intensity of the inflammatory response 
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(Valdez et al., 2008, Valdez et al., 2009). The activity of Slc11a1 seems to be 
involved in suppressing the early intracellular replication of S. Typhimurium 
(Hormaeche, 1980, Benjamin et al., 1990) and it is well known that mice 
carrying a non-functional Slc11a1 protein are highly susceptible to S. 
Typhimurium infection (Vidal et al., 1995). However, despite the important 
functions of this protein, no association between human Slc11a1 
polymorphisms and typhoid fever has yet been found (Dunstan et al., 2001a).  
 
Macrophages also use a range of oxygen-dependent mechanisms to control 
S. enterica growth. Reactive oxygen species (ROS) are generated from the 
reduction of molecular oxygen by the multicomponent nicotinamide adenine 
dinucleotide phosphate-oxidase or phagocyte oxidase (Phox) (Vazquez-
Torres and Fang, 2001). These free radicals are highly toxic to S. 
Typhimurium, although their precise targets still remain elusive (Slauch, 
2011). Mice that lack a functional oxidative burst succumb to S. Typhimurium 
infection within the first few days of inoculation (De Groote et al., 1997, Shiloh 
et al., 1999, Mastroeni et al., 2000b), resulting from little or no bacterial killing 
and increased bacterial replication (Grant et al., 2008). Similarly, humans with 
chronic granulomatous disease, due to mutations in genes encoding Phox 
subunits, are predisposed to recurrent fungal and bacterial infections, 
including S. enterica (Mouy et al., 1989). Infected macrophages also produce 
reactive nitrogen species (RNS), primarily through the oxidation of L-arginine 
by inducible nitric oxide synthase (iNOS) (Vazquez-Torres and Fang, 2001). 
In contrast to Phox-mediated killing, RNS are predominantly bacteriostatic 
and exert their function at later stages of the infection (Mastroeni et al., 
2000b). Mice deficient in iNOS are able to control the initial replication of S. 
Typhimurium, but develop fatal bacterial loads during the second and third 
weeks of infection (Shiloh et al., 1999, Mastroeni et al., 2000b). Additional 
mediators of phagocytic host resistance to S. enterica include hydrolytic 
enzymes and AMPs, such as cathelicidin-related AMP (Groisman et al., 1992, 
Rosenberger et al., 2004), although less is known about their functions.  
 
As the infection progresses, multicellular focal lesions or granulomas, 
containing host phagocytes, gradually develop around infected cells. Immune 
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cell recruitment to and function within infection foci is directed by the release 
of cytokines, in particular: TNFα, IL-12 and interferon-gamma (IFNγ). Mice 
that lack these cytokines, due to gene deletions or antibody targeting, 
experience exacerbated infections with S. Typhimurium, particularly following 
the first week of infection (Muotiala and Makela, 1990, Mastroeni et al., 1991, 
Mastroeni et al., 1995, Everest et al., 1998, Mastroeni et al., 1998). 
Furthermore, humans with genetic or acquired deficiencies in the production 
of these cytokines are more susceptible to S. enterica infection (van de Vosse 
et al., 2004). Therefore, appropriate granuloma formation and function is 
essential to control S. enterica growth. 
 
Dendritic cells (DCs) play a crucial role in integrating innate and adaptive 
immune responses against S. enterica. Immature DCs are positioned within 
peripheral and lymphoid tissues and represent some of the first immune cells 
encountered by S. enterica within the host (Niess et al., 2005). During murine 
typhoid, DCs rapidly undergo maturation within lymphoid tissues (Salazar-
Gonzalez et al., 2006). At these sites, mature DCs present bacterial antigens 
to adaptive immune cells, which can subsequently generate an antigen-
specific response against the pathogen. Indeed, studies have demonstrated 
that DCs isolated from the spleen and liver can produce clonal expansion of 
S. enterica-specific cluster of differentiation factor (CD)4+ and CD8+ T cells ex 
vivo (Yrlid and Wick, 2002, Johansson and Wick, 2004). Furthermore, 
conditional DC ablation in transgenic mice abolished clonal expansion of S. 
Typhimurium-specific CD4+ T-cells (Salazar-Gonzalez et al., 2006). 
 
1.4.2. Adaptive immunity to S. enterica 
 
Although CD4+ and CD8+ T-cell depleted mice are able to control the early 
growth of S. enterica, these mice are unable to successfully eliminate bacteria 
or generate protective immunty against a subsequent infection (Hess et al., 
1996). This demonstrates the need for antigen-specific adaptive immunity. 
Importantly, human polymorphisms in major histocompatibility complex (MHC) 
class II genes have been linked to increased susceptibility to typhoid fever 
(Dunstan et al., 2001b). Furthermore, it is well documented that HIV-infected 
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individuals, that develop significant impairment of T-cell-mediated immunity, 
are at increased risk of S. enterica infection (Gordon, 2008).  
 
CD4+ T-cells with a T helper type (Th)1 phenotype lie at the heart of the 
adaptive immune response (Hess et al., 1996). The importance of Th1-
defined T-cell populations is demonstrated by the increased susceptibility of 
mice deficient in T-bet, a transcription factor required for Th1 differentiation, to 
infection with S. Typhimurium (Ravindran et al., 2005). Cross-presentation of 
S. enterica antigens on MHC class I can also induce CD8+ T-cell responses 
ex vivo (Yrlid and Wick, 2002, Johansson and Wick, 2004). Indeed, S. 
enterica-specific CD8+ T-cells have been isolated from humans immunised 
with attenuated S. Typhi vaccine strains (Sztein et al., 1995). However, 
compared to CD4+ T-cells, CD8+ T-cells seem to play a smaller role (Hess et 
al., 1996). The mechanisms used by T-cells to control S. enterica infection are 
still not well understood. It is likely that CD4+ T-cells upregulate the 
microbicidal activities of macrophages and enhance appropriate antibody 
responses (Dougan et al., 2011). In turn, innate immune cells also promote 
the development of efficient adaptive immunity, through the production of Th1-
like cytokines, such as IFNγ and TNFα (Kirby et al., 2002, Rydstrom and 
Wick, 2007). This creates a positive feedback loop that further amplifies both 
arms of the immune system, to effectively clear the infection. 
 
In addition to T-cells, infection with S. enterica in mice and humans also 
generates bacteria-specific antibodies (Mastroeni, 2002), which indicates that 
salmonellae must be transiently exposed to the extracellular space during 
infection. Although B-cells seem dispensable for clearance of a primary 
infection, they play an important role in the acquired immune resistance to S. 
enterica (Mastroeni et al., 2000a). Adoptive transfer experiments showed that 
full protection to virulent S. Typhimurium in previously susceptible mice is only 
conferred after the simultaneous administration of both immune serum and 
cells from vaccinated mice (Mastroeni et al., 1993). Antibody may contribute 
to killing of S. enterica by promoting phagocytosis of bacteria and 
upregulating oxidative responses within innate phagocytic cells (Uppington et 
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al., 2006). In addition, B-cells can influence the T-cell arm of the immune 
response, by presenting antigens to CD4+ T-cells. The importance of this 
pathway was demonstrated by the inability of B-cell-deficient mice to generate 
Th1 T-cell immunity needed to clear a secondary infection of S. Typhimurium 
(Mastroeni et al., 2000a). Indeed several human immunodeficiency 
syndromes, characterised by defects in both B- and T-cell-mediated 
responses, have been reported to increase the risk of salmonellosis (Dougan 
et al., 2011). This demonstrates that both cellular and humoral immune 
effector mechanisms are required to effectively protect against a secondary 
infection with S. enterica. However, it is important to bear in mind that even 
after a natural infection of humans with S. Typhi, a robust immune response is 
not always generated, since patients can relapse or become chronic carriers.  
 
In conclusion, complex mechanisms involving cross-talk between innate and 
adaptive immune cells and integration of T- and B-cell-mediated responses 
are required to establish an effective immunological response against S. 
enterica. The mouse model has proven invaluable for dissecting some of 
these responses, particularly the use of gene knockout mouse strains, and 
many findings in mice have correlated with similar observations in humans. 
However, further studies using this model, with an emphasis on translation to 
human typhoid, are needed to provide a more complete understanding of S. 
enterica immunity and this will no doubt facilitate the development of more 
efficient vaccines against typhoid fever. 
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1.5. S. enterica virulence factors 
 
1.5.1. The S. Typhimurium genome 
 
Salmonellae have evolved into very succesful pathogens as a result of 
horizontal gene transfer. This is a process that can rapidly alter microbial 
genomes through the acquisition of large segments of DNA, known as 
genomic islands, from unrelated organisms via transduction, transformation or 
conjugation. Genomic islands characteristically have a base composition, 
determined by the percentage of guanine and cytosine residues (% G + C), 
that is different from that of the host core genome. They are typically found 
within or adjacent to genetic elements involved in DNA mobility, such as 
plasmids, phages, transposases, integrases and direct repeat sequences. In 
addition, DNA insertion sites are frequently associated with genes encoding 
transfer ribonucleic acids (tRNAs), as these can act as chromosomal 
integration points for certain bacteriophages. Many genes involved in bacterial 
virulence are located to clusters of horizontally acquired DNA and in these 
cases, such regions are referred to as pathogenicity islands (PAIs) (Hensel, 
2006). 
 
Genomic sequence analysis of S. Typhimurium LT2 has revealed that this 
serovar has a mosaic genome, which has been greatly influenced by 
horizontal gene transfer. 29% of genes in S. Typhimurium are absent in the 
non-pathogenic ancestor Escherichia coli (E. coli) (McClelland et al., 2001). 
The chromosome consists of 4,875 kilobases (kbs) and has a G + C content 
of 53% (McClelland et al., 2001). Approximately 4% (200 genes), or more, of 
the genome is required for systemic disease in mice (Bowe et al., 1998, 
Lawley et al., 2006, Chaudhuri et al., 2009). These genes are located within at 
least 12 PAIs, 4 prophages (Gifsy-1, Gifsy-2, Fels-1 and Fels-2) and within an 
approximately 90 kb extrachromosomal self-transmissible plasmid, pSLT 
(Sabbagh et al., 2010, McClelland et al., 2001). A diverse array of virulence 
determinants are encoded within these regions, which include regulatory 
systems, biosynthetic enzymes, nutrient transporters, adhesins, secretion 
systems and their effectors.  
	   35	  
1.5.2. The PhoPQ regulon 
 
S. enterica must survive a wide range of changing environmental conditions 
and antimicrobial defenses during the course of an infection within the host 
and of course, during transmission to new hosts. These include alterations in 
pH, osmolarity and oxygen tension and in addition, the presence of 
antimicrobial substances that are secreted in the intestine and produced 
within specific immune effector cells. To enable adaptation to these stressful 
environments, bacteria possess complex networks of two-component 
regulatory systems, transcriptional regulators and alternate sigma factors that 
control the spatiotemporal expression of many genes. One of the best 
characterised transcriptional regulons, that is important for S. enterica 
pathogenesis, is that controlled by the PhoP/PhoQ (PhoPQ) two-component 
regulatory system. 
 
PhoPQ is a major transcriptional regulator in Salmonella and controls the 
transcription, positively or negatively, of more than 40 virulence genes of S. 
Typhimurium (Miller et al., 1989, Groisman et al., 1989, Miller and Mekalanos, 
1990). Interestingly, only 25% of PhoPQ-modulated genes are involved in S. 
enterica virulence (Garcia Vescovi et al., 1994). In addition, phoP homologues 
are present within numerous other pathogenic and non-pathogenic bacteria. 
Together, this suggests that PhoPQ represents an ancient system that served 
to regulate genes unrelated to virulence, such as those required for survival in 
the environment. However, selective pressure experienced by S. enterica has 
caused this system to evolve to enable these bacteria to respond to 
conditions experienced within living hosts. 
 
Although the signals regulating PhoPQ in vivo have not been fully defined, 
activation can be induced in vitro under several conditions, including: acidic 
pH, low concentration of divalent cations (Mg2+ and Ca2+), and in the 
presence of certain AMPs (Alpuche-Aranda et al., 1992, Vescovi et al., 1996, 
Bader et al., 2005).	  The kinase, PhoQ, can sense these environmental signals 
and respond by phosphorylating the transcriptional activator, PhoP (Gunn et 
al., 1996). PhoPQ is fully activated several hours following uptake by host 
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macrophages, as bacteria become enclosed within an acidic, nutrient limiting 
phagosome that is rich in AMPs (Alpuche-Aranda et al., 1992, Valdivia and 
Falkow, 1997). The expression of a diverse set of genes, termed pags (PhoP-
activated genes), is activated by this regulon and these promote survival of S. 
enterica within host tissues. Pags are multifunctional and include enzymes, 
that modify LPS to confer resistance to AMP-mediated killing, cation 
transporters, outer membrane proteins and genes involved in acid tolerance 
(Prost et al., 2007). In addition, PhoP represses the transcription of other 
genes, namely those associated with the SPI-1 T3SS (see below) and flagella 
that are required for invasion and motility, respectively (Prost et al., 2007). 
These are designated prgs (PhoP-repressed genes). The importance of 
PhoPQ is evident by the severe attenuation of a non-functional PhoP mutant 
of S. Typhimurium for replication and survival within macrophages in vitro and 
for systemic virulence in mice (Fields et al., 1989, Miller et al., 1989, 
Thompson et al., 2011) and because a phoPQ-deleted S. Typhi strain was 
significantly attenuated in humans (Hohmann et al., 1996). Deletions of 
individual or several pags does not significantly alter the virulence of S. 
Typhimurium (Gunn et al., 1998), except for the MgtC mutant (Blanc-Potard 
and Groisman, 1997), suggesting a functional redundancy within these genes. 
Notably, a S. Typhimurium mutant with a constitutively activated PhoPQ 
system is also attenutated in mice, indicating that appropriate regulation of 
pags and prgs is also an important virulence trait (Miller and Mekalanos, 
1990). 
 
1.5.3. Type 3 secretion systems 
 
T3SSs are widespread among pathogenic Gram-negative bacteria and 
provide a mechanism to enable the delivery of bacterial proteins or effectors 
directly into the host cell cytosol and membranes, to subvert host cell 
functions (Hueck, 1998). The secretion or injectisome machinery is highly 
conserved and resembles flagellar export apparatus, suggesting they evolved 
from a common ancestor. Approximately 20 proteins assemble to form a 
basal body that spans the inner and outer bacterial membranes, a needle-like 
hollow tube that extends from the bacterial surface and a translocon or pore 
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that inserts into the host cell membrane. Effector translocation is driven by an 
adenosine triphosphatase (Eichelberg et al., 1994). In addition, several 
chaperones help to maintain effector proteins in an unfolded or partially-folded 
conformation for efficient secretion (Stebbins and Galan, 2001, Luo et al., 
2001). Although components of the secretion apparatus are highly conserved, 
the effector proteins are diverse. Salmonella enterica is unusual in that it 
expresses two separate T3SSs. These are the SPI-1 and SPI-2 T3SSs, which 
are important for invasion of host cells (Galan et al., 1989) and intracellular 
replication (Ochman et al., 1996), respectively. Since genes within SPI-1 are 
only distantly related to those of SPI-2 (Shea et al., 1996) and only SPI-1 is 
present in S. bongori (Hensel et al., 1997), this suggests that both PAIs were 
acquired as independent horizontal transfer events. Interestingly, the 
expression of both secretion systems is controlled by local and global 
regulators (Garmendia et al., 2003, Altier, 2005, Fass and Groisman, 2009), 
which suggests that integration into existing regulatory pathways has 
presumably evolved, enabling the expression of these virulence genes to be 
controlled in a coordinate and appropriate manner. 
 
1.5.3.1. The SPI-1 T3SS 
 
SPI-1 represents a 40 kb large cluster of genes situated within centisome 63 
of the S. enterica chromosome (Mills et al., 1995). Although not associated 
with a tRNA gene, the SPI-1 locus has a G + C content of 47%, significantly 
lower than the core S. enterica genome. This PAI encodes the structural, 
effector and regulatory proteins of the SPI-1 T3SS (Darwin and Miller, 1999), 
which has been directly visualised as a rigid, hollow tube on the surface of S. 
Typhimurium by electron microscopy (Kubori et al., 1998). The transcriptional 
regulator HilA plays a central role in controlling SPI-1 gene expression (Altier, 
2005). Activation of this virulence system is induced by high osmolarity, low 
oxygen, near-neutral pH and in the presence of the short-chain fatty acid, 
acetate (Altier, 2005). These environmental signals are likely to be found in 
the distal ileum, where the SPI-1 T3SS mediates invasion of the intestinal 
epithelium.  
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At least 15 effector proteins are translocated into the host cell by the SPI-1 
T3SS and these include effectors encoded within and outside SPI-1 (McGhie 
et al., 2009). A major function of the SPI-1 T3SS is to induce bacterial 
internalisation into non-phagocytic mammalian cells and mutants that do not 
express a functional SPI-1 T3SS are attenuated approximately 50-fold 
following oral inoculation of mice (Galan et al., 1989). This demonstrates that 
the invasive properties conferred by the SPI-1 T3SS contribute to efficient 
penetration of the intestinal epithelium and establishment of a systemic 
infection. 
 
Upon translocation, SipA, SipC, SopB, SopD, SopE and SopE2 either directly 
or indirectly induce the spatiotemporal rearrangement of the actin 
cytoskeleton (Fig. 1.3). SipC is a translocon component of the SPI-1 T3SS 
and inserts into the host cell plasma membrane (Scherer et al., 2000). Within 
the host cell, SipC stimulates filamentous actin (F-actin) polymerisation, by 
nucleating globular actin, and subsequently bundles the actin filaments 
(Hayward and Koronakis, 1999). SipA enhances the activity of SipC, by 
binding to and stablising acting filaments and inhibiting their depolymerisation 
(Zhou et al., 1999, McGhie et al., 2001, McGhie et al., 2004). The activity of 
both SipA and SipC is thought to direct the spatial localisation of actin 
polymerisation underneath the bacteria. SopE and SopE2 are homologues 
that mimic cellular guanidine nucleotide exchange factors (GEFs) and activate 
Rho guanine nucleotide triphosphatases (GTPases), including Rac-1 and 
Cdc-42 (Wood et al., 1996, Hardt et al., 1998, Bakshi et al., 2000). However, 
SopE-dependent Rac-1 activation is most important for bacterial invasion 
(Patel and Galan, 2006). SopB is an inositol phosphatase, encoded within 
SPI-5, that is likely to alter cellular phosphoinositide phosphate and inositol 
phosphate metabolism (Norris et al., 1998). Through this activity, SopB 
indirectly activates Cdc-42 (Zhou et al., 2001) and another GTPase, RhoG 
(Patel et al., 2006), the latter mediated by stimulation of an endogenous SH3-
containing GEF. Activation of GTPases is essential for internalisation of S. 
enterica, as a triple SopE/E2/B mutant is completely defective for invasion 
(Zhou et al., 2001). Together, these activated GTPases initiate complex 
signalling events that lead to actin nucleation, polymerisation, branching and 
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cross-linking, which induces ruffling and extension of the host cell membrane 
to engulf the bacterium (Patel and Galan, 2005). Following invasion, SopB, 
together with SopD, enhance membrane fission and promote 
macropinocytosis (Hernandez et al., 2004, Bakowski et al., 2007). 
Downregulation of actin remodelling occurs shortly after and is mediated by 
the GTPase activating protein (GAP) activity of SptP, which downregulates 
Cdc-42 and Rac-1 (Fu and Galan, 1999). 
 
 
 
Another prominent function of the SPI-1 T3SS is the generation of a potent 
inflammatory response, characterised by PMN transmigration into the 
intestinal lumen, which is a hallmark of S. enterica-induced colitis. This is 
likely to be mediated by several mechanisms (Fig. 1.3). SipA has been shown 
to trigger the release of pathogen-elicited epithelial chemoattractant, now 
ACTIN 
REMODELLING 
SptP 
SipC, SipA, SopE, SopE2, SopB 
FLUID  
SECRETION 
INFLAMMATION 
(Cytokines,  
PMN recruitment) 
Pyroptosis SipB 
AvrA 
Membrane sealing 
SopB, SopD 
Figure 1.3. Functions of SPI-1 T3SS effectors. SipC, SipA, SopE, SopE2 and SopB 
are involved in actin rearrangements that lead to uptake of S. Typhimurium by non-
phagocytic cells. These events are terminated by SopB and SopD, which contribute to 
membrane sealing, and SptP, which downregulates actin rearrangements. Several 
effectors also promote intestinal inflammation and fluid secretion, including SipA, SopE, 
SopE2 and SopB. This inflammation is enhanced by SipB-induced pyroptosis. Other 
effectors, namely SptP and AvrA act to downregulate these responses. 
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known as hepoxillin A3, by epithelial cells (Lee et al., 2000, Criss et al., 2001, 
Mrsny et al., 2004). Other effectors, SopE, SopE2 and SopB, mediate the 
activation of Cdc-42, which upregulates mitogen-activated protein kinase 
(MAPK) pathways and activates nuclear factor-kappa beta (NF-κB) signalling 
within epithelial cells (Galyov et al., 1997, Patel and Galan, 2006, Bruno et al., 
2009). This stimulates the release of proinflammatory cytokines, such as IL-8 
and macrophage inflammatory protein-2-alpha. Flagellin secretion appears to 
promote these responses (Gewirtz et al., 2001, Huang et al., 2004). In 
addition, SopA, an E3 ubiquitin ligase, has also been reported to promote 
PMN transmigration into the intestinal lumen (Wood et al., 2000, Zhang et al., 
2006). 
 
The SPI-1 T3SS also induces host cell death, although biological significance 
of this is still unclear. SPI-1-induced cytotoxicity involves the activity of the 
translocon component, SipB (Hersh et al., 1999), and flagellin (Miao et al., 
2006, Franchi et al., 2006), which produces rapid cytotoxicity in macrophages 
and DCs, termed pyroptosis (Chen et al., 1996, Monack et al., 1996, van der 
Velden et al., 2003). SipB and flagellin activate caspase-1, leading to 
cleavage and activation of the pro-inflammatory cytokines IL-1β and IL-18, 
which promote local inflammatory responses (Fink and Cookson, 2007). SipB 
also produces a delayed caspase-1-independent form of cell death in infected 
macrophages (Hernandez et al., 2003).  
 
Other functions of SPI-1 effectors include the development of diarrhoea 
observed in NTS. SopB can activate epithelial cell chloride channels, through 
its inositol phosphatase activity, and promote fluid secretion into the intestinal 
lumen (Galyov et al., 1997, Norris et al., 1998). This effector, along with SopE, 
SopE2 and SipA, has also been shown to stimulate fluid secretion by 
disrupting epithelial tight junctions, which most likely occurs via Rho GTPase 
signalling (Boyle et al., 2006). SopA is also likely to contribute to fluid 
secretion (Wood et al., 2000). 
 
Interestingly, the function of some SPI-1 effectors is to oppose the actions of 
other effectors, translocated by the same secretion system (Fig. 1.3). As 
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mentioned above, the GAP activity of SptP causes downregulation of actin 
cytoskeleton rearrangements. In addition, both GAP and tyrosine 
phosphatase activities displayed by SptP can reverse MAPK responses to 
reduce inflammation (Murli et al., 2001), Another effector, AvrA, has been 
implicated in the suppression of multiple SPI-1 effector-mediated cellular 
responses. This includes the opposition of tight-junction disruption, leading to 
a reduction of epithelial cell permeability and intestinal fluid accumulation 
(Liao et al., 2008) and inhibition of apoptosis, through acetyltransferase-
mediated blockade of MAPK kinase activation (Jones et al., 2008). SopB has 
also been shown to inhibit apoptosis of host cells (Knodler et al., 2005b). 
Collectively, these findings demonstrate the multifunctional capabilities of the 
SPI-1 T3SS-secreted effectors and highlight the complex nature of the host 
responses that they regulate. 
 
1.5.3.2. The SPI-2 T3SS 
 
SPI-2 occupies 40 kb at centisome 30 on the S. Typhimurium chromosome 
and lies adjacent to a tRNA gene, valV (Hensel et al., 1995, Hensel et al., 
1997). Genes encoding the secretion system are located within a 26 kb region 
towards one end of the island that has a G + C content of 43%, significantly 
lower than that of the core genome. The major direct regulator of SPI-2 gene 
expression is the SsrAB two-component system, encoded within the SPI-2 
locus (Valdivia and Falkow, 1997, Cirillo et al., 1998). Activation of SPI-2 
occurs intracellularly, within the SCV (Valdivia et al., 1997, Cirillo et al., 1998); 
a specialised compartment that S. enterica replicates within once inside host 
cells. However, SPI-2 has also been shown to be expressed within the 
intestinal lumen (Brown et al., 2005). Nutrient limitation within the SCV lumen 
is likely to trigger expression of the SPI-2 genes (Deiwick et al., 1999). 
Acidification of this compartment also activates SPI-2 genes (Cirillo et al., 
1998) and is important for assembly of the secretion apparatus (Beuzon et al., 
1999, Rappl et al., 2003). Effector translocation subsequently occurs once 
translocon pore formation exposes the bacterium to the neutral pH of the host 
cell cytosol (Yu et al., 2010). 
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SPI-2 T3SS-deficient S. Typhimurium mutants have replication defects within 
epithelial cells and macrophages (Ochman et al., 1996, Cirillo et al., 1998, 
Hensel et al., 1998) and are significantly attenuated in mice, following oral or 
i.p. inoculation (Hensel et al., 1995, Shea et al., 1996). This correlates with an 
inability to colonise the MLN, liver and spleen (Cirillo et al., 1998, Shea et al., 
1999). However, the survival of S. Typhi within human monocyte-like cells has 
been shown to be independent of the SPI-2 T3SS (Forest et al., 2010). Over 
20 effectors, encoded within SPI-2, pSLT or elsewhere in the chromosome, 
have been shown to require the SPI-2 T3SS for their translocation (McGhie et 
al., 2009), although only the function of a few of these proteins has so far 
been identified. The major role of the SPI-2 effectors is to support intracellular 
bacterial replication (Helaine et al., 2010), which involves manipulation of 
vesicular trafficking and signalling pathways. 
 
During infection of epithelial cells, the SCV gradually migrates from the 
periphery of the host cell towards a perinuclear region (Salcedo and Holden, 
2003). It is thought that this facilitates interactions with secretory vesicles of 
the nearby Golgi, which may provide nutrients and/or membrane to support 
bacterial replication. Retention of the SCV at a juxtanuclear position is 
necessary for efficient replication and requires the concerted action of the 
SPI-2 T3SS effectors, SseF and SseG (Salcedo and Holden, 2003, Abrahams 
and Hensel, 2006) (Fig. 1.4). The precise mechanism underlying SCV 
positioning is not completely understood. Both recruitment of the minus end-
directed microtubule motor, dynein, to the SCV (Abrahams et al., 2006) and 
tethering of the SCV to the Golgi (Ramsden et al., 2007) have been 
implicated. 
 
Upon reaching a perinuclear position, S. Typhimurium begins to replicate and 
in epithelial cells, this is accompanied by the formation of Salmonella-induced 
filaments (Sifs), which radiate from the microcolony towards the periphery of 
the cell (Garcia-del Portillo et al., 1993). These are lysosomal membrane 
glycoprotein-rich tubules that are closely associated with the microtubule 
network and are thought to represent the outcome of successive late 
endosome fusion events with the SCV. SifA is essential for the formation of 
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Sifs (Stein et al., 1996) and this activity is augmented by the actions of other 
effectors, including SseG, SseF, PipB2 and SopD2 (Guy et al., 2000, Jiang et 
al., 2004, Knodler and Steele-Mortimer, 2005) (Fig. 1.4). In contrast, SseJ has 
been suggested to oppose Sif formation (Ruiz-Albert et al., 2002). 
Interestingly, recent work has revealed the presence of additional tubules 
containing Golgi-derived secretory carrier membrane protein-3 (Mota et al., 
2009) or sorting nexin-3 (Braun et al., 2010). The induction of tubule networks 
by S. Typhimurium is intriguing and the physiological relevance of these 
structures is still not clear. They may facilitate nutrient and/or membrane 
acquisition, direct harmful molecules away from the SCV or represent a 
means that bacteria deal with dynein and kinesin tension on the SCV. 
Alternatively, they could be an epiphenomenon of no physiological 
importance. However, mutants that lack any of the effectors involved in SCV 
tubulation are attenuated in mice (Hensel et al., 1998, Beuzon et al., 2000, 
Knodler et al., 2003, Jiang et al., 2004). 
 
 
Figure 1.4. Functions of the SPI-2 T3SS effectors. The main functions of SPI-2 T3SS-
associated effectors include modification of the SCV membrane and position (green box), 
downregulation of immune signalling (black box), interference with the host actin 
cytoskeleton (red box) and potentially modification of cellular ubiquitin (blue box). The 
effectors involved in each aspect of SPI-2 T3SS function are coloured accordingly. DUB 
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S. Typhimurium strains that lack SifA lose their vacuolar membrane and 
display a profound growth defect within macrophages and in mice (Beuzon et 
al., 2000). This provides a clear indication that SifA has a crucial role in 
maintaining the stability of the vacuolar membrane (Fig. 1.4). Interestingly, a 
sifA sseJ double mutant is retained within an intact vacuole, suggesting that 
SseJ, a glycerophospholipid:cholesterol acyltransferase, is involved in the 
loss of SCV integrity (Ruiz-Albert et al., 2002). SopD2 also appears to 
contribute to vacuolar membrane loss (Schroeder et al., 2010). 
 
Another phenonemon associated with the SPI-2 T3SS activity is the assembly 
of a F-actin meshwork around the SCV (Méresse et al., 2001). This is 
promoted by the kinase, SteC (Poh et al., 2008), and inhibited by SpvB (Miao 
et al., 2003) (Fig. 1.4). However, the function of actin meshwork formation is 
unclear, given that a SteC mutant does not appear to exhibit a virulence 
defect in mice (Geddes et al., 2005, Poh et al., 2008). 
 
Another effect associated with the SPI-2 T3SS is host cell death (van der 
Velden et al., 2000) (Fig. 1.4). This is observed in vitro as a delayed form of 
apoptosis in epithelial cells and macrophages that involves caspase-3 and 
possibly, caspase-1 (Monack et al., 2001, Paesold et al., 2002). SPI-2-
dependent cytotoxicity is mediated by the adenosine diphosphate-ribosylase 
activity of SpvB, encoded on the spv operon, which causes actin 
depolymerisation and destabilisation of the eukaryotic actin cytoskeleton 
(Libby et al., 2000, Lesnick et al., 2001, Browne et al., 2002, Browne et al., 
2008). The deubiquitinase, SseL, also seems to contribute to this cytotoxic 
effect (Rytkonen et al., 2007), although the mechanistic basis underlying this 
remains undefined. The importance of delayed SPI-2-dependent cytotoxicity 
to S. enterica pathogenesis requires further clarification, however it is possible 
that it might contribute to bacterial spreading within host tissues (discussed in 
Section 1.6.2).  
 
Another effector, SrfH (also known as SseI), appears to influence bacterial 
movements in vivo. One group has reported that infected phagocytes display 
increased dissemination away from the intestinal lumen to the liver and 
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spleen, in an SrfH-dependent manner (Worley et al., 2006). Therefore, the 
authors argue that SrfH promotes the development of a systemic infection. 
However, another study suggested that SrfH inhibits the motility of infected 
phagocytes to the spleen and therefore, promotes the establishment of a 
persistent infection (McLaughlin et al., 2009). Further work is required to 
explain these apparently contradictory results. Nevertheless, the possibility 
that S. enterica may influence the movement of host cells to enhance 
bacterial dissemination or persistence in vivo presents an exciting and novel 
area of Salmonella research. 
 
Several SPI-2 effectors also seem to be involved in downregulating cellular 
immune responses (Fig. 1.4). SpvC displays phosphothreonine lyase activity 
and irreversibly inhibits MAPK signalling (Li et al., 2007, Mazurkiewicz et al., 
2008). In addition, the E3 ubiquitin ligase, SspH1 (Rohde et al., 2007) and the 
deubiquitinase, SseL (Coombes et al., 2007, Rytkonen et al., 2007), have 
been suggested to inhibit NF-κB activity, possibly by modulating the 
ubiquitination of host proteins (Haraga and Miller, 2003, Haraga and Miller, 
2006, Le Negrate et al., 2008). However, conflicting results for SseL were 
obtained by our group (Rytkonen et al., 2007). SspH2 and SlrP have also 
been identified as E3 ubiquitin ligases (Quezada et al., 2009, Bernal-Bayard 
and Ramos-Morales, 2009), although their functions are yet to be determined. 
 
Other functions of the SPI-2 T3SS include avoidance of Phox (Mastroeni et 
al., 2000b, Gallois et al., 2001), although this has been challenged recently 
(Helaine et al., 2010, Aussel et al., 2011), and iNOS activity (Chakravortty et 
al., 2002), conferring resistance to oxidative and nitrosative stress, 
respectively. In addition, SPI-2 T3SS-associated effectors have been reported 
to inhibit antigen presentation (Mitchell et al., 2004, Cheminay et al., 2005), by 
interfering with peptide loading on to MHC class II complexes (Halici et al., 
2008) and/or inducing polyubiquitination-mediated removal of peptide loaded 
MHC class II complexes from the host cell surface (Lapaque et al., 2009). 
However, the molecular mechanisms and effectors involved in these 
processes are not yet fully understood.  
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Therefore, the SPI-2 T3SS delivers effectors into host cells, which are able to 
interfere with a diverse range of cellular processes. However, much work is 
required to provide a more complete understanding of this virulence system to 
S. enteria pathogenesis in vivo. Lastly, it is important to mention that several 
SPI-1-translocated effectors have been implicated in SCV biogenesis, 
positioning, membrane integrity and interference with endosomal trafficking 
pathways (McGhie et al., 2009). Furthermore, certain SPI-1 T3SS-associated 
proteins have been shown to be expressed in the MLN and spleens of mice 
after several days of infection (Giacomodonato et al., 2007, Gong et al., 
2009). Recently, translocation of SopB in the MLN of mice has even been 
demonstrated (Giacomodonato et al., 2011) and some SPI-1 genes have also 
been implicated in long-term systemic infection in mice (Lawley et al., 2006). 
However, set against this are data showing that SPI-1 T3SS-null mutants 
display no apparent virulence defect following intraperitoneal (i.p.) inoculation 
of mice (Galan et al., 1989). Nevertheless, several lines of evidence now 
exist, which challenge the view that the SPI-1 and SPI-2 secretion systems 
represent functionally distinct virulence factors. 
 
1.5.4. The spv operon 
 
Many different S. enterica serovars contain plasmids that are associated with 
virulence, such as the 90 kb pSLT plasmid of S. Typhimurium (Gulig and 
Curtiss, 1987). This contains an approximately 8 kb region that contains the 
spv operon (Gulig et al., 1993): spvR, which encodes a transcriptional 
regulator and four genes, spvABCD. Spv genes are required for systemic 
growth of S. Typhimurium in mice (Gulig and Doyle, 1993) and have also 
been implicated in invasive NTS infections in humans (Fierer et al., 1992). 
Currently, functions have only been ascribed for SpvB and SpvC and both 
these proteins appear to be largely responsible for the spv-mediated virulence 
of S. Typhimurium in mice (Matsui et al., 2001). These two effectors are 
translocated by the SPI-2 T3SS and their functions are described above. 
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1.6. Dynamics of growth and dissemination of S. enterica during 
systemic disease  
 
1.6.1. Multiple routes of systemic dissemination 
 
Following ingestion, S. Typhimurium uses several routes to traverse the 
intestinal barrier and gain access to systemic sites (Fig. 1.5). The primary site 
of intestinal invasion is in the distal ileum (Carter and Collins, 1974). Here, the 
SPI-1 T3SS enables bacteria to translocate an array of proteins into host cells 
to drive their own uptake. In this manner, S. Typhimurium invades both 
enterocytes and M cells enriched within the follicule-associated epithelium 
(FAE) that overlies the PP (Clark et al., 1994, Jones et al., 1994). Examination 
of infected ileal loops by electron microscopy (Jones et al., 1994), together 
with the finding that a SPI-1 T3SS mutant is significantly attenuated in 
systemic virulence following oral inoculation (Galan et al., 1989), 
demonstrates that SPI-1-directed invasion of M cells represents the 
predominant route of intestinal traversal. However, S. Typhimurium has also 
been shown to traverse the intestinal epithelium via PP-independent routes, 
including via CD18+ phagocytes (Vazquez-Torres et al., 1999), lamina propria 
DCs (Rescigno et al., 2001, Niess et al., 2005, Chieppa et al., 2006), villous 
M-cells (Jang et al., 2004) and M-cells within the FAE overlying solitary 
intestinal lymphoid tissues (Halle et al., 2007). Infections carried out using 
SPI-1 T3SS mutants revealed that several of these PP-independent routes 
involve SPI-1 T3SS-independent mechanisms (Vazquez-Torres et al., 1999, 
Niess et al., 2005, Halle et al., 2007). 
 
Following invasion of the intestinal epithelium, presumably lymphatic drainage 
of the PP and/or lamina propria transports S. Typhimurium from these tissues 
to the MLN. However, it is not known how bacteria are transported in the 
lymph. In the MLN, the majority of S. Typhimurium-infected cells represent 
DCs (Voedisch et al., 2009, Cheminay et al., 2005). These cells might have 
migrated from the PP (Hopkins et al., 2000) or lamina propria (Bogunovic et 
al., 2009). Indeed, modulation of DC migration had a significant influence on 
colonisation of the MLN by S. Typhimurium (Voedisch et al., 2009). 
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Furthermore, DCs are known to be important for transporting commensal 
bacteria to the MLN (Macpherson and Uhr, 2004). Therefore, DCs in the 
lymph could transport S. Typhimurium to the MLN from the PP and/or lamina 
propria (Fig. 1.5). However, S. Typhimurium can also be found within 
macrophages within the MLN (Macpherson and Uhr, 2004, Monack et al., 
2004a) and studies suggest that other cells or extracellular bacteria might also 
contribute to traffic towards this tissue (Voedisch et al., 2009). Indeed, both 
free and cell-associated bacteria were apparently observed within pseudo-
afferent lymph in mesenteric lymphadectomised rats (Tam et al., 2008). 
Alternatively, in a model of bovine typhoid, up to 99% of S. Dublin found in 
lymph draining distal ileal loops were susceptible to gentamicin, indicating that 
these bacteria were extracellular (Pullinger et al., 2007). However, it is 
possible that the proportion of cell-associated and free bacteria depends on 
the host and/or bacterial strain. 
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Figure 1.5. Alternative routes of dissemination of S. Typhimurium from the 
intestinal lumen to extraintestinal sites in the mouse. (1) After reaching the distal 
ileum, the majority of S. Typhimurium invade M cells that overlie PP. (2-4) Most bacteria 
are likely to reach the MLN by carriage within DCs via the lymphatic system. DCs 
transport S. Typhimurium from the PP (2), intestinal lumen (3) or lamina propria (LP) (4). 
(5) It is possible that S. Typhimurium can be transported directly from the PP to the liver 
and spleen, but large numbers of bacteria are unlikely to migrate out of the MLN (6). (7) 
S. Typhimurium can also be carried directly from the intestine to the liver and spleen via a 
haematogenous route involving carriage within CD18+ phagocytes, most likely monocytes 
or DCs. (8) After prolonged infection, S. Typhimurium can be transported between organs 
via the bloodstream. (9) Bile excretion from the liver also carries bacteria to the 
gallbladder. (10) Gallbladder colonisation presumably leads to re-infection of the intestine 
through bile secretion. 
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S. Typhimurium is found in distal organs, such as the liver and spleen, after 
an increase in numbers in the PP and MLN (Carter and Collins, 1974). 
Therefore, it is thought that bacteria disseminate further to these organs after 
reaching the MLN. Efferent lymph from the MLN drains into the systemic 
circulation through the thoracic duct, therefore bacteria presumably reach the 
liver and spleen via the bloodstream. Indeed, after inoculation of ligated ileal 
loops with signature-tagged S. Dublin mutants in a model of bovine typhoid, 
the same clones in the same proportions, were found in the MLN, efferent 
lymph, liver and spleen (Pullinger et al., 2007). However, studies of S. 
Typhimurium dissemination in murine typhoid suggest an alternative route. 
Mesenteric lymphadectomised mice developed exacerbated infections with S. 
Typhimurium, characterised by accelerated liver and spleen colonisation, 
compared to their untreated counterparts (Voedisch et al., 2009, Griffin et al., 
2011). This indicated that the MLN might act to restrict the onward 
dissemination of S. Typhimurium. Perhaps the routes of bacterial 
dissemination in bovine and murine typhoid differ. However, further 
experiments are required to confim this, as the detailed population structure of 
bacteria in the MLN and spleen has not been directly compared in murine 
typhoid. 
 
S. Typhimurium can also traverse the intestinal barrier and seed the spleen 
directly from the gut, by migrating within CD18+ mononuclear phagocytes 
(Vazquez-Torres et al., 1999) (Fig. 1.5). Further examination revealed that 
this involved haematogenous transport and was SPI-1 T3SS-independent. 
This activity has additionally been suggested to be SPI-2-dependent (Worley 
et al., 2006). The identity of these CD18+ phagocytes (DCs, monocytes or 
macrophages) is presently unclear. Using intravital imaging, protrusions from 
lamina propria DCs have been visualised taking up S. Typhimurium directly 
from the gut lumen through the intestinal epithelium (Niess et al., 2005, 
Chieppa et al., 2006). In addition, another study reported that DC-mediated 
traffic influenced liver and spleen colonisation by S. Typhimurium (Uematsu et 
al., 2006). However, by modulating DC migration, Voedisch and colleagues 
found that DC-mediated traffic is not involved in transport of S. Typhimurium 
to the liver and spleen (Voedisch et al., 2009). Nevertheless, since mature 
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macrophages are not thought to migrate out of resident tissues, it is likely that 
monocytes and possibly DCs represent the CD18+ population that transports 
S. Typhimurium from the intestine directly to the liver and spleen. However, 
CD18-independent routes also account for the population of bacteria that 
seed the spleen, as invasion-deficient bacteria still managed to colonise the 
spleens of CD18-knockout mice (Vazquez-Torres et al., 1999).  
 
In conclusion, much evidence now demonstrates that S. Typhimurium exploits 
several distinct pathways and utilises a range of mechanisms to disseminate 
systemically from the gastrointestinal tract and colonise host tissues. 
However, further work is required to determine the significance of these 
alternative routes and the precise virulence factors involved in colonising 
different tissues.  
 
1.6.2. Bacterial spreading within host tissues 
 
Precisely how S. Typhimurium colonises individual organs is still not well 
understood. Microscopic examination of infected liver sections showed that S. 
Typhimurium-infected cells are typically found in clusters that form distinct, 
spatially separated foci surrounded by apparently normal tissue (Richter-
Dahlfors et al., 1997). Each focus most likely results from clonal expansion of 
one bacterial cell and spread between individual foci does not occur 
(Sheppard et al., 2003). Interestingly, bacterial growth within organs occurs 
primarily as a result of an increase in the number of foci rather than the size of 
individual foci (Sheppard et al., 2003). Therefore, some degree of bacterial 
dissemination from established foci to form secondary foci must also take 
place.  
 
How intracellular S. Typhimurium spreads to new cells is a subject of debate. 
It is generally thought that this occurs through a process of cell death 
induction and subsequent phagocytosis. Indeed, S. Typhimurium can induce 
host cell cytotoxicity by various SPI-1 or 2-directed mechanisms (discussed in 
Sections 1.5.3.1. and 1.5.3.2.). However, the contributions of different forms 
of cell death to infection are poorly understood. Since the virulence of SPI-1 
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T3SS mutants is unaffected during the systemic phase of disease (Galan et 
al., 1989), SPI-1-mediated cytotoxicity is unlikely to be important for organ 
colonisation. Instead, SPI-2-dependent apoptosis is thought to be relevant to 
bacterial spread, as the SPI-2 T3SS is required for growth in systemic organs 
(Shea et al., 1999). SPI-2 dependent cytotoxicity is observed in vitro as a 
delayed form of apoptosis in macrophages and appears to involve the 
effectors SseL (Rytkonen et al., 2007) and SpvB (Libby et al., 2000). Indeed, 
apoptosis has been observed in S. Typimurium-infected livers in mice and 
increases throughout the infection (Richter-Dahlfors et al., 1997). Exploitation 
of apoptotic pathways to facilitate uptake into new host cells could be 
beneficial for bacteria, as they would remain protected from extracellular-
mediated host defences. Apoptosis is also anti-inflammatory, therefore 
activation of host cell microbicidal defences would be avoided. In contrast, 
Mastroeni and colleagues used mathematical modelling, in conjunction with 
microscopy data, to suggest that necrotic cell lysis, causing extracellular 
release of bacteria, predominates and that this occurrs stochastically (Brown 
et al., 2006). Necrotic cell death is observed in S. enterica lesions in mice 
(Nakoneczna and Hsu, 1980, Nakoneczna and Hsu, 1983) and humans (Mert 
et al., 2004). Therefore, it is likely that different forms of cell death contribute 
to spreading and organ colonisation by S. Typhimurium. This is further 
supported by the findings that both humoral and cell-mediated immune 
responses are required for efficient control of a S. enterica infection 
(discussed in Section 1.4). 
 
1.6.3. Bacterial growth dynamics within systemic organs 
 
Studying bacterial growth within infected tissues is an important aspect of 
understanding how S. Typhimurium colonises individual organs. In addition, 
measuring bacterial growth is a sensitive means to test the importance of 
bacterial and host factors in bacterial pathogenesis. Enumerating CFU in 
different organs of infected animals at defined time points has traditionally 
been used to obtain information about the global population growth dynamics 
of S. Typhimurium in vivo. However, to better understand the factors 
underlying overall growth rate, the contributions of bacterial replication and 
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killing must be considered, as well as the heterogeneity of growth within the 
bacterial population. 
 
Early approaches to distinguish between bacterial replication and killing were 
based on measuring the amount and distribution of non-replicating elements 
within the growing bacterial population. This strategy was pioneered by 
Meynell, by using a superinfecting phage technique (Meynell, 1959, Maw and 
Meynell, 1968). Lysogenised S. Typhimurium were superinfected with a 
differentially marked mutant of their prophage that was unable to lysogenise 
or replicate in vivo. As bacteria divide, the amount of superinfecting phage is 
halved with each generation of replication (Fig. 1.6), while all bacteria carry 
the stably integrated prophage. Therefore, the mean number of divisions 
undergone by bacteria can be measured by determining the proportion of 
bacteria carrying the superinfecting phage. In this manner, up to 10 
generations of bacterial replication could be measured. Furthermore, by 
subtracting the amount of replication measured by phage dilution from the 
total number of bacteria measured by CFU, the extent of bacterial killing can 
be determined. Maw and Meynell used phage dilution to show for the first time 
that the rate of replication and killing of S. Typhimurium in the spleens of mice 
was relatively low (Maw and Meynell, 1968). Later, the same technique was 
used to demonstrate that S. Typhimurium replicated more slowly in Slc11a1-
resistant mice, compared to susceptible mice (Hormache 1980). 
Unfortunately, this technique is somewhat laborious, as the enumeration of 
bacteria requires induction of lysogenisation and detection of two different 
phages on two different indicator strains. Furthermore, stable integration and 
spontaneous growth of the superinfecting phage in vivo could produce 
misleading results.  
 
A more sophisticated technique based on the principle of phage dilution was 
developed in 1990 (Benjamin et al., 1990). Instead of a non-replicating phage, 
this technique involved the use of pHSG422, a plasmid with a temperature-
sensitive origin of replication, that does not efficiently replicate in mice (above 
30°C) (Hashimoto-Gotoh et al., 1981). pHSG422 contains an antibiotic 
resistance marker to enable the identification of plasmid-containing bacteria. 
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The proportion of bacteria carrying the plasmid, following bacterial growth in 
vivo, provides a measure of the mean number of divisions undergone by the 
bacterial population (Fig. 1.6). Assuming plasmid-bearing and non-bearing 
strains are killed at equivalent rates, the amount of bacterial killing can be 
determined by counting the remaining number of plasmid-containing bacteria 
(Benjamin et al., 1990). Plasmid dilution has demonstrated that Slc11a1 
(Benjamin et al., 1990), the Salmonella virulence plasmid (Gulig and Doyle, 
1993) and the SPI-2 T3SS (Shea et al., 1999) predominantly influence S. 
Typhimurium replication rather than killing in the mouse.  
 
 
A more comprehensive analysis of global population dynamics was provided 
by Mastroeni and colleagues (Grant et al., 2008). They used a collection of 
phenotypically identical wild-type S. Typhimurium strains that can be 
differentiated on the basis of different 40 base-pair (bp) DNA tags 
incorporated into a non-essential chromosomal site (wild-type isogenic tagged 
strains [WITS]). After several hours or days post-inoculation (p.i.) of mice, 
WITS were recovered from infected tissues and cultured on agar plates. All 
bacterial colonies were subsequently scraped from the plates and their 
A. 
+ inducer 
! inducer 
B. 
Figure 1.6. Approaches used to measure bacterial growth dynamics. (A) Principle 
of superinfecting phage / temperature-sensitive plasmid dilution. The number of bacteria 
carrying a non-replicating genetic marker halves with each division. Enumerating the 
proportion of bacteria carrying the marker is used to determine the number of 
generations of replication undergone. (B) Principle of fluorescence dilution. A pre-
formed pool of inducible fluorescence (green) halves with each bacterial division. 
Detecting the decrease in fluorescence by flow cytometry is used to determine the 
number of generations of replication undergone. In this system, another fluorescent 
protein is expressed constitutively (red) and acts as a marker to identify all bacterial 
cells. 
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chromosomal DNA was purified. Quantifying the numbers of tagged strains by 
quantitative polymerase chain reaction (PCR), in conjunction with 
mathematical modelling, was used to generate estimates of bacterial 
replication and killing: increasing abundance of individual WITS and 
decreasing diversity of WITS provided proxy measures of mean replication 
and killing, respectively. Furthermore, assessing the proportion of these 
strains in different organs was used as an indicator of bacterial spread. In this 
way, bacterial growth kinetics could also be interpreted on a gross 
spatiotemporal level. The authors also used Phox-deficient mice, lacking the 
oxidative burst, to examine the influence of an innate host defence 
mechanism on S. Typhimurium growth. They found that S. Typhimurium 
undergoes rapid replication and Phox-mediated killing within hours after 
entering the spleen, afterwhich both replication and killing slows, as Phox-
mediated resistance becomes predominantly bacteriostatic (Grant et al., 
2008). Interestingly, bacterial expansion was shown to be restricted to 
individual tissues until late stages of infection, when large numbers of bacteria 
accumulated within organs and haematogenous transfer of S. Typhimurium 
between different sites was observed (Grant et al., 2008) (Fig. 1.5). 
 
The approaches used to study the dynamics of bacterial population growth 
are becoming more sophisticated and are transforming our perception of how 
S. Typhimurium colonises host tissues. However, to gain a more detailed 
understanding of this, the detailed structure of bacterial populations needs to 
be assessed at the individual tissue level. Furthermore, observations at the 
tissue level must be complemented with knowledge of what occurs at the host 
single cell level. Therefore, our group (Helaine et al., 2010) designed a 
technique based on fluorescence dilution (Roostalu et al., 2008) to directly 
measure bacterial replication. This technique requires bacteria to carry a 
plasmid that enables the inducible production of a fluorescent protein, so that 
when grown in the presence of the inducer, bacteria produce this protein. 
Subsequent removal of the inducer prevents further protein synthesis and the 
preformed pool of this protein is then shared between bacteria as they divide 
(Fig. 1.6). Measuring the decrease in fluorescence intensity, by flow 
cytometry, can be used to measure bacterial replication. This is based on the 
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principle that the amount of fluorescent protein is halved with each bacterial 
division. In addition, the plasmid also encodes another fluorescent protein 
under the control of a constitutive promoter. This second marker allows 
replicating bacteria, that no longer contain detectable levels of the diluted 
protein, to be identified easily. In this manner, the entire population of bacteria 
is available for analysis. Therefore, not only could the mean replication of the 
bacterial population be quantified, but the variation of bacterial replication 
within a population could also be assessed. Furthermore, by analysing 
infected host cells, the replication of intracellular populations of bacteria could 
also be examined. In addition, similar to the method described by Meynell, 
coupling the direct measurement of bacterial replication by fluorescence 
dilution with net growth from CFU could provide a measure of bacterial killing.  
 
The principle of dilution that forms the basis of the technique resembles 
carboxyfluorescein succinimidyl ester (CFSE) dye dilution that has been used 
extensively in immunological studies to monitor lymphocyte proliferation-
dependent responses (Lyons, 2000, Wallace et al., 2008). This has also been 
used in bacteria (Ueckert et al., 1997). However, using a fluorescence marker 
instead of CFSE avoids the potential side effects of this ester on bacterial cell 
function, since CFSE covalently bonds to intracellular proteins. Fluorescence 
dilution has been described recently as a method to characterise differences 
in cell division within a bacterial population (Roostalu et al., 2008). Using 
green fluorescent protein (GFP) dilution, Roostalu and colleagues identified a 
persistent population of E. coli in stationary-phase liquid cultures. However, 
they did not exploit fluorescence dilution to quantify replication rates. In 
addition, since their system was based only on the expression of one dilutable 
marker, bacteria that had replicated and emitted levels of GFP fluorescence 
intensity below the limit of detection were lost from analysis. The technique 
described in this thesis relies on the co-expression of two fluorescent 
markers: one for bacteria and the other for cell division. Thus, even bacteria 
that have gone through many rounds of division can still be identified.  
 
In conclusion, unlike previous methods, the technique developed by our group 
(hereafter referred to as ‘fluorescence dilution’) should provide a direct 
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measure of bacterial replication at both the mean population and single 
bacterial cell level. This will allow the rate and diversity of replication within a 
population to be characterised. Furthermore, fluorescence dilution could be 
used to analyse the intracellular replication of bacteria within individual host 
cells. Therefore, applying fluorescence dilution to study S. Typhimurium 
replication in mice should provide a more comprehensive understanding of 
how bacterial replication contributes to colonisation of host tissues during 
systemic disease. 
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1.7. Aims of the project 
 
The aim of my research project was to develop and validate fluorescence 
dilution as a tool to directly measure bacterial replication and subsequently, to 
use this technique to gain a more detailed understanding of the 
spatiotemporal replication dynamics of S. Typhimurium during systemic 
disease. 
 
The following objectives were set: 
1. To validate fluorescence dilution as a measure of bacterial replication in 
vitro. 
2. To adapt fluorescence dilution as a tool to measure bacterial replication in 
mice. 
3. To study the extent, rate and population variation in replication of S. 
Typhimurium during acute systemic disease in mice, following oral 
inoculation.  
4. To analyse the contribution of the SPI-2 T3SS to S. Typhimurium 
replication, during a systemic infection 
5. To determine the host cell type that S. Typhimurium preferentially 
replicates within, during a systemic infection. 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Bacterial strains and plasmids 
 
S. Typhimurium wild-type 12023 from the National Collection of Type Cultures 
was used in this study. Where appropriate, strains carrying the indicated 
plasmids (Table 2.1) were used. E. coli DH5〈 (Invitrogen) was used during 
plasmid construction. 
 
Plasmid Description Source 
pFPV25 promoterless gfpmut3a (Cormack et al., 1996) 
pFPV25.1 rpsM::gfpmut3a promoter fusion in pFPV25 (Valdivia and Falkow, 1996) 
pDsRed PBAD::DsRed.T3_S4T promoter fusion in pBAD18 Prof D. Bumann 
pmCherry Bacterial expression vector Clontech 
pGara PBAD::gfpmut3a promoter fusion in pBAD18 Mei Liu 
pCara PBAD::mCherry promoter fusion in pBAD18 This study 
pDiGc PBAD::DsRed.T3_S4T and rpsM::gfpmut3a promoter fusions in pBAD18  
(Helaine et al., 
2010) 
pDiGi PBAD::DsRed.T3_S4T and Plac::gfpmut3a promoter fusions in pBAD18  
(Helaine et al., 
2010) 
pFCcGi rpsM::mCherry and PBAD::gfpmut3a promoter fusions in pFPV25 This study 
pFCiGi PBAD::mCherry and Plac::gfpmut3a promoter fusions in pFPV25 This study 
 
Table 2.1. Plasmids used in this study 
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2.1.2. Bacterial culture conditions 
 
S. Typhimurium was grown in Mg-MES minimal medium (MM) containing 170 
mM 2-[N-morpholino]ethane-sulphonic acid at pH 5.0 or pH 2.0 where 
indicated,	  5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 1 mM KH2PO4, 10 
mM MgCl2, 38 mM glycerol and 0.1% casamino acids (Beuzon et al., 1999), 
Luria-Bertani (LB) broth, LB supplemented with 1.5% (w/v) agar or super 
optimal broth with catabolite repression (SOC) containing 2% (w/v) bacto-
tryptone, 0.5% (w/v) yeast extract, 0.5g/l NaCl, 2.5 mM KCl, 10 mM MgCl2 
and 20 mM glucose (Sambrook and Russell, 2001). E. coli DH5〈 was grown in 
super optimal broth (SOB) containing 2% (w/v) bacto-tryptone, 0.5% (w/v) 
yeast extract, 8.56 mM NaCl, 2.5 mM KCl (Sambrook and Russell, 2001), 
SOC or LB broth. Where appropriate, medium was supplemented with 0.2% 
(w/v) L-arabinose, 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), 50 
µg/ml carbenicillin or 5-40 µg/ml tetracycline. Cultures were incubated at 37°C 
in a shaking incubator at 200 rpm with aeration unless otherwise stated. 
Where anaerobic conditions were required, bacteria were incubated in an 
anaerobic cabinet at 37°C in a reducing anaerobic atmosphere (10% CO2, 
10% H2, 80% N2). To ensure efficient oxygen dissipation from the media, 
cultures were shaken at 200 rpm for at least 1 h after placement inside the 
cabinet, then left standing. 
 
2.1.3. Eukaryotic cells and culture conditions 
 
RAW264.7 murine macrophage-like cells and HeLa human epithelial-like cells 
were obtained from the European Collection of Animal and Cell Cultures. 
Cells were grown in Dulbecco’s modified Eagle's medium (DMEM, PAA 
laboratories) supplemented with 10% heat inactivated fetal calf serum (FCS, 
PAA laboratories) at 37°C in 5% CO2. Cells were passaged no more than 10 
times.  
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2.1.4. Mouse strains 
 
6-8 week or 8-12 week old female BALB/c mice (Charles River) were used 
where indicated. Mice were housed in a specific pathogen-free facility in filter 
top cages and provided food and water ad libitum. 
 
2.1.5. Antibodies and dyes 
 
Rabbit polyclonal anti-GFP antibody (Invitrogen) was used at a dilution of 
1:500 (flow cytometry) and 1:50 000 (immunoblotting). Rabbit monoclonal 
anti-GFP antibody (Invitrogen) was used at a dilution of 1:50. Goat polyclonal 
anti-Salmonella common structural antigen (CSA)-1 antibody (Kirkegaard and 
Perry Laboratories) was used at a dilution of 1:300 (ex vivo) and 1:400 (in 
vitro). Alexa Fluor 488-, 633- (Invitrogen) and Cy5- (Jackson Immunoresearch 
Laboratories) conjugated anti-rabbit, goat and rat antibodies were used at a 
dilution of 1:400. Horse radish peroxidase (HRP)-conjugated goat anti-rabbit 
(Santa Cruz Biotechnology) antibody was used at a dilution of 1:10 000. 
Hamster anti-mouse CD11c- and rat anti-mouse CD11b-conjugated 
microbeads (Miltenyi Biotec) were used at a concentration of approximately 
10 µl per 107 total cells. Mouse fragment, crystallisable region receptors for 
immunoglobulin (FcR) blocking reagent (Miltenyi Biotec) was used at a 
dilution of 1:10. Rat monoclonal anti-mouse F4/80 antibody (Serotec) was 
used at a dilution of 1:50 and the corresponding isotype control, rat anti-
mouse immunoglobulin class G2b (IgG2b) antibody was used at a dilution of 
1:100. DRAQ5™ (Biostatus Limited) was used at a dilution of 1:200. 
 
2.2. Manipulation of DNA 
 
2.2.1. Preparation of plasmid DNA 
 
Plasmids were purified using GenElute™ Mini (Sigma-Aldrich) or QIAfilter™ 
Midi (Qiagen) plasmid purification kits, according to the manufacturer’s 
instructions. DNA was eluted in sterile water. DNA purity was assessed by 
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electrophoresis through a 1% (w/v) agarose gel in 1 x Tris-acetate-
ethylenediaminetetraacetic acid (EDTA, TAE), containing 40 mM Tris-acetate 
and 1 mM EDTA at pH 8.0. Plasmid yield was estimated using a NanoVue 
Plus (GE Healthcare).  
 
2.2.2. PCR 
 
Primers used in this study are listed in Table 2.2. PCR was preformed using 
2.6 units of Expand High Fidelity DNA polymerase (Roche) in 50 µl, to amplify 
insert sequences for cloning, or 2.5 units of Taq DNA Polymerase (Sigma) in 
100 µl, to check transformants. DNA polymerases were added to solution 
containing 1 x their respective reaction buffers, 0.2 µM of each 
deoxyribonucleotide triphosphate and 0.1 µM of each primer and incubated 
with the template DNA. Reaction conditions varied for each primer set but 
followed this general programme: denaturation at 95°C for 5 min; 30 cycles of 
denaturation at 94 - 95°C for 30 s, annealing at 50 - 60°C for 30 s and 
extension at 68 or 72°C for 1 to 2 min, followed by a 7 min post-well 
amplification at 72°C. PCR products were purified with a QIAquick® PCR 
purification kit (Qiagen), according to the manufacturer’s instructions. 
Methylated template DNA was removed by digestion with DpnI (NEB). 
 
2.2.3. Construction of dual fluorescence-encoding expression vectors 
 
When appropriate, blunting, dephosphorylation and ligations were performed 
with Klenow large fragment DNA polymerase (Invitrogen), shrimp alkaline 
phosphatase (Promega) or calf intestinal phosphatase (NEB) and T4 DNA 
Ligase (GE Healthcare), respectively. Digestion fragments were recovered by 
electrophoresis using 0.7% to 1.5% (w/v) agarose, depending on fragment 
size, in 1 x TAE gels and purified using a QIAquick® gel extraction kit 
(Qiagen), according to the manufacturer’s instructions. Plasmid constructs 
were confirmed by assessing transformants for positive antibiotic resistance 
and appropriate fluorescence expression, re-digesting plasmids with 
appropriate enzymes and/or nucleotide sequencing. 
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2.2.3.1. Construction of pFCcGi 
 
pFPV25.1 was cleaved with XbaI and HindIII, to release gfpmut3a. mCherry 
was amplified by PCR from pmCherry using C1 and C2. The PCR product 
was digested and ligated into the open pFPV25.1 vector. Next, this vector was 
cleaved with EcoRV to allow insertion of a PBAD::gfpmut3a promoter fusion. 
This fragment was obtained from pGFP-arabinose (pGara), which was 
digested with ClaI and HindIII.  
 
2.2.3.2. Construction of pFCiGi 
 
pDsRed was cleaved with SmaI and HindIII, to release PBAD::DsRed.T3_S4T. 
The digested mCherry PCR product (described above) was ligated into the 
open pDsRed vector to generate pmCherry-arabinose (pCara). pCara was 
then cleaved with ClaI and HindIII to release the PBAD::mCherry promoter 
fusion. Next, the Plac::gfpmut3a promoter fusion was amplified by PCR from 
pDiGi using the primers G1 and G2 and subsequently digested with ClaI and 
NaeI. Finally, pFPV25 was cleaved with SmaI and HindIII. This open vector, 
along with the digested fragments containing Plac::gfpmut3a and 
PBAD::mCherry were then ligated together. 
 
2.2.4. Nucleotide sequencing and sequence analysis 
 
Nucleotide sequencing was carried out by the Medical Research Council 
Clinical Sciences Centre (Hammersmith Hospital, Imperial College London). 
Nucleotide sequences were analysed and translated using 4Peaks (version 
1.7) and Serial Cloner (version 1.3) software. 
 
2.2.5. Preparation of competent cells 
 
Chemically competent E. coli DH5〈 were prepared by growing bacteria in 5 ml 
SOB medium overnight. Bacteria were next subcultured in SOB medium at a 
dilution of 1:100. After growth to an optical density (OD600) of approximately 
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0.3, bacteria were kept on ice for 10 min. Next, following centrifugation at 
1200 g for 10 min at 4°C, bacterial pellets were resuspended in cold buffer 
medium (10 mM potassium acetate pH 7.0, 10% glycerol, 80 mM CaCl2, 20 
mM MnCl2, 10 mM MgCl2) at a dilution of 1:0.25 the starting volume of SOB. 
Bacteria were kept on ice for a further 4 h and centrifuged as before, 
resuspending the pellet in the buffer at a dilution of 1:12 the starting volume of 
buffer. Bacterial suspensions were aliquoted, snap frozen in liquid nitrogen 
and kept at -80°C.  
 
Electrocompetent S. Typhimurium were prepared by growing bacteria 
overnight in LB broth. Bacteria were then subcultured at a dilution of 1:200 in 
fresh LB broth. After growth to OD600 0.4-0.6, bacteria were kept on ice and 
washed twice with cold water and twice with 10% cold glycerol, centrifuging at 
2200 g for 7 min at 4°C between washes. Cells were resuspended in a final 
volume of 250 µl cold 10% glycerol, kept on ice and used immediately. 
 
2.2.6. Bacterial transformations 
 
Plasmid preparations and ligation mixtures were transformed into chemically 
competent E. coli DH5〈 cells by heat shock or electrocompetent S. 
Typhimurium by electroporation. DNA was added to 75 µl competent bacteria 
and incubated on ice for approximately 20 min prior to transformation. Heat 
shock was carried out at 42°C for 30 s followed by incubation on ice for 2 min. 
Electroporation was performed using an ice cold 2 mm electroporation cuvette 
(Molecular BioProducts) and a GenePulser II system (BioRad) at 2.5 kV, 25 
mF and 200 Ω for ≥4.8 ms. Immediately after transformation, 250 µl -1 ml 
SOC medium was added and bacteria were allowed to recover for 1 h at 37°C 
at 200 rpm. Following recovery, bacteria were plated onto LB agar plates with 
appropriate antibiotics and incubated overnight at 37°C.  
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2.3. In vitro studies 
 
2.3.1. Replication and fluorescence stability assays 
 
Bacteria were grown for 9-16 h in LB broth or MM pH 5.0 supplemented with 
arabinose, IPTG or antibiotics, as required. Cultures were normalised to an 
OD600 of 0.01 and subcultured in fresh medium with arabinose, IPTG or 
antibiotics where necessary. This was defined as time = 0 h (t0h). When 
required, arabinose or IPTG was removed by centrifugation at 16 000 g for 2 
min or 2200 g for 10 min at room temperature (RT) and washing once with 
phosphate-buffered saline (PBS). To facilitate DsRed maturation, prior to 
subculture, bacteria were placed in 5 ml PBS supplemented with carbenicillin 
and IPTG when appropriate and incubated overnight at 37°C with aeration 
and shaking at 200 rpm. Where washes were performed mid-growth, pellets 
were resuspended in an equivalent volume of fresh MM pH 5.0 as before the 
wash.  
 
Throughout the experiments, bacteria were kept at 37°C shaking at 200 rpm 
with aeration or in an anaerobic cabinet when indicated. Aliquots were 
removed at desired time-points. To quantify bacterial replication by CFU, the 
OD600 was measured and serial dilutions in PBS were plated onto duplicate 
LB agar plates. To assess bacterial replication by fluorescence dilution or 
analyse fluorescence stability, bacteria were prepared for flow cytometric 
analysis. To do this, bacteria were fixed by first centrifuging at 16 000 g for 2 
min, resuspending pellets in PBS and adding paraformaldehyde (PFA) to a 
final concentration of 4%. Bacteria were incubated in PFA for 10 min at RT, 
then centrifuged as before and kept in PBS at 4°C, for no longer than 1 week, 
until analysis. Bacterial replication was measured as described in Section 
2.9.2. Where intrabacterial GFP detection by flow cytometry or 
immunoblotting was required, bacteria were treated as described in Section 
2.5. and Section 2.6., respectively. Where fluorescence recovery after 
incubation in MM pH 2.0 or anaerobic conditions was assessed, aliquots were 
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centrifuged at 16 000 g for 2 min, then resuspended in PBS and kept at 37°C 
shaking at 200 rpm with full aeration, until fixation and analysis by flow 
cytometry. 
 
2.3.2. Infection of macrophages 
 
All medium was warmed to 37°C before adding to cultured cells. RAW264.7 
macrophages were added to wells in 24-well tissue culture plates at a density 
of 1 x 105 cells per well and incubated for 12 h to 24 h in DMEM 10% FCS 
before infection. Bacteria were grown for 16 h to stationary phase in MM 
supplemented with arabinose, IPTG or antibiotics, as required. The OD600 of 
cultures was measured and appropriate volumes of bacteria were removed 
(approximately 40 µl). Bacteria were then opsonised for 20 min at RT in 170 
µl DMEM with 10% FCS and 10% mouse serum (Sigma). Opsonised bacteria 
were subsequently diluted with 600 µl DMEM with 10% FCS and 60 µl of this 
mixture was added to each well of macrophages at a multiplicity of infection 
(moi) of 10:1. This was defined as t0h. To increase uptake, plates were 
centrifuged at 110 g for 5 min at RT and incubated at 37°C for a further 25 
min in 5% CO2. To synchronise infection and remove extracellular bacteria, 
infected macrophages were washed 2 times with PBS and incubated in 
DMEM 10% FCS supplemented with 100 µg/ml gentamicin for 1 h, after which 
they were washed again and placed in DMEM 10% FCS supplemented with 
20 µg/ml gentamicin for the remainder of the infection. For sequential 
fluorescence dilution experiments, DMEM 10% FCS was supplemented with 
12.5 µg/ml IPTG. When required, IPTG was removed as described for 
gentamicin.  
 
Serial dilutions of the inoculum were plated on LB agar to confirm the moi and 
that similar numbers of CFU of each strain were added, as predicted by OD600 
readings. To recover intracellular bacteria for CFU enumeration and flow 
cytometric analysis, cells were washed three times with PBS then lysed in 1 
ml 0.1% Triton X-100 in PBS for 2-5 min at RT at indicated time points. Serial 
dilutions of the lysate in PBS were plated on LB agar and the remaining 
aliquot was centrifuged at 16 000 g for 2 min, to remove the detergent, and 
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resuspended in PBS. Bacteria were fixed as described in Section 2.3.1. and 
kept at 4°C until analysis. Bacterial net growth or replication was measured as 
described in Section 2.9.2. 
 
2.3.3. Infection of epithelial cells 
 
All medium was warmed to 37°C before adding to cultured cells. HeLa cells 
were added to wells, with or without glass coverslips when necessary, in 24-
well tissue culture plates at a density of 5 x 104 cells per well in DMEM 10% 
FCS for 12 h to 24 h before infection. Bacteria were grown for 16 h in MM with 
arabinose and antibiotics as required, then subcultured at a dilution of 1:25 in 
LB broth with arabinose and antibiotics as required, until the culture reached 
an OD600 1.5-2.0. Bacteria were then added to epithelial cells at a moi of 
100:1 in Earle’s Balanced Salt Solution (Invitrogen) and this was defined as 
t0h. Invasion was allowed to proceed for 20 min at 37°C, 5% CO2. Washes 
were carried out as for infection of macrophages, described in Section 2.3.2.  
 
Serial dilutions of the inoculum were plated on LB agar to confirm the moi and 
that similar numbers of CFU of each strain were added, as predicted by OD600 
readings. Invasion assays were conducted by enumerating the intracellular 
CFU at 2 h post-invasion, after gentamicin incubation, as described in Section 
2.3.2. To examine infected cells by microscopy, coverslips were removed at 
desired time-points, washed three times with PBS and incubated in 4% PFA 
for 20 min at RT in darkness. This was followed by an additional wash in PBS 
and incubation in 10 mM NH4Cl in PBS for 10 min at RT or overnight at 4°C, 
to remove any remaining aldehyde. 
 
2.4. In vivo studies 
 
2.4.1. Mouse infection conditions 
 
For experiments described in Chapter 3, 8-12 week old mice were inoculated 
with 200 µl PBS containing a total of 1 x 105 or 5 x 105 CFU for i.p. infections 
and 3 x 108 CFU for intragastric (i.g.) infections. To prepare the inoculum, 
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bacteria were grown for 16 h in MM with carbenicillin, as required and 
subcultured at a dilution of 1:33 for 2.5 h in LB broth with carbenicillin, as 
required. Strains in mixed inoculums were prepared at a ratio of 1:1. Mice 
were sacrificed by CO2 inhalation 48 h after i.p. inoculation or 4 and 6 days 
after i.g. inoculation. For experiments described in Chapters 4 and 5, 6-8 
week old mice were inoculated with 200 µl of 3% NaHCO3 in PBS containing 
2 x 1010 CFU for i.g. infections and with 100 µl PBS containing 200-1000 CFU 
for intravenous (i.v.) infections. Bacteria were grown for 16 h in MM with 
arabinose, IPTG and antibiotics, as required, and subcultured in LB broth in 
the same conditions, but at a dilution of 1:10 for 3.5 h (OD600 1.7). Mice were 
sacrificed by neck dislocation at different times post-inoculation (p.i.) and used 
in groups as indicated. Serial dilutions of the inoculum were plated on LB agar 
to confirm the correct bacterial dose was added, as predicted by OD600 
readings. 
 
2.4.2. Preparation of tissue samples 
 
For experiments described in Chapter 3, spleens were removed and 
homogenised manually with a plastic rod, in 500 µl cold PBS. Samples were 
allowed to settle on ice for 5 min, after which supernatants were transferred to 
fresh tubes and centrifuged at 16 000 g for 2 min to pellet the bacteria. Cells 
were lysed by resuspension in 1 ml sterile water and serial dilutions in PBS 
were plated on LB agar for CFU enumeration. When required, strains were 
distinguished by fluorescence expression or growth on antibiotic-containing 
medium. Competitve index (CI) values were determined by dividing the ratio 
of wild-type and plasmid carrying strain in the output by their ratio in the input 
(Beuzon et al., 2001).  
 
For experiments described in Chapters 4 and 5, the small intestine (and 
associated PP), MLN and spleen of each mouse was recovered under aseptic 
conditions and pooled together. Tissues and solutions were kept on ice 
throughout the entire procedure. Firstly, all identifiable PP (6-10 per mouse) 
were removed from each small intestine and rinsed. The small intestines were 
then pooled together and vortexed vigorously in cold PBS to obtain the 
	   69	  
luminal contents. The solid contents were allowed to settle twice for 
approximately 10 min, after which the supernatant was filtered through a 100 
µm cell strainer. To lyse host cells and obtain bacterial cell suspensions, the 
PP, MLN and spleens were homogenised using the plastic end of a 5 ml 
pipette in sterile petri dishes, through the mesh of a 100 µm cell strainer in 20 
ml Lysis buffer (0.3% Triton X-100 in 20% PBS). To obtain intact host cell 
suspensions, homogenisation was carried out as before, however 20 ml 
Buffer A (Ca2+ and Mg2+ free Hank’s balanced salt solution [HBSS, 
Invitrogen], 2% FCS and 10 mM Hepes) was used instead. Following this, 
homogenates were passed through a 40 ⎧m cell strainer. Petri dishes and 
filters were rinsed once with 10 ml of the same buffer. When required, 
samples were centrifuged at 3-400 g for 5 min at 4°C, then treated with 0.83% 
NH4Cl for 5 min at RT to lyse red blood cells. This reaction was stopped with 
the addition of 30 ml HBSS and immediate centrifugation. 
 
2.4.3. Release of intracellular bacteria without identification of host cell 
type 
 
Cell suspensions in Lysis buffer were vigorously vortexed to ensure efficient 
host cell lysis. These, along with the intestinal contents, were then centrifuged 
at 5000 g for 10 min at 4°C. Bacterial pellets were resuspended in PBS and 
either plated for CFU enumeration, on LB agar alone (MLN, spleen) or agar 
supplemented with carbenicillin (luminal contents, PP), or fixed in 1% PFA for 
10-15 min at RT. Following fixation, samples were kept in PBS at 4°C, for no 
longer than 1 week, prior to flow cytometric analysis. Where intrabacterial 
GFP detection by flow cytometry was required, bacteria were treated as 
described in Section 2.5. 
 
2.4.4. Fluorescence analysis of bacteria within specific host cell types 
 
Unless otherwise stated, samples were centrifuged at 3-400 g for 5 min at 
4°C. Whole cell suspensions in Buffer A were centrifuged and pellets were 
resuspended in Buffer B (PBS pH 7.2, 0.5% bovine serum albumin [BSA, 
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sigma] and 2 mM EDTA) at a concentration of approximately 100 µl per 107 
cells. Where indicated, magnetic CD11c or CD11b-conjugated beads (Miltenyi 
Biotec) were then added at a concentration of approximately 10 µl per 107 
cells, incubated at 4°C for 15 min in darkness, on a roller or standing, with 
gentle tapping every 5 min. To avoid non-specific CD11c labelling, samples 
were incubated with mouse FcR blocker (Miltenyi Biotec) at a dilution of 1:10 
for 10 min at 4°C prior to incubation with CD11c-conjugated beads. Following 
magnetic labelling, unbound material was diluted out by addition of 1 ml (PP) 
or 5 ml (MLN, spleen) per 107 cells. Samples were centrifuged and 
resuspended in 50 µl (PP) or 100 µl (MLN, spleen) Buffer B per 107 cells. 
Magnetic separation was carried out according to manufacturer’s instructions. 
This generated CD11b+, CD11c+ and unlabelled cell fractions (containing 
extracellular bacteria), where appropriate. 
 
For fluorescence dilution analysis or CFU enumeration of intracellular 
bacteria, cell fractions were centrifuged and resuspended in Lysis buffer for 2 
min at 4°C. Samples were then centrifuged at 16 000 g for 2 min, 
resuspended in PBS and either plated on duplicate LB agar plates or fixed in 
1% PFA for 10 min at RT. Fixed samples were kept in PBS at 4°C until flow 
cytometric analysis. Alternatively, to examine infected cells by microscopy, 
approximately 1 x 106 cells in 40 µl Buffer B were seeded onto poly-D-lysine 
coated glass coverslips that had been placed into wells of a 24-well plate (BD 
Biocoat). Care was taken not to spill cells over the edge of the coverslips. 
These were allowed to adhere for 1 h at 37°C. Non-adherent cells were 
removed by washing once with PBS at RT and remaining cells were fixed in 
1% PFA for 20 min at RT in darkness. These were then incubated in PBS with 
10 mM NH4Cl for 15 min at RT, to remove any remaining free aldehyde, then 
labelled with antibodies as described in Section 2.8. 
 
2.5. Immunolabelling of S. Typhimurium cells in suspension 
 
To facilitate detection of intracellular GFP, bacteria were permeabilised to 
allow immunolabelling of cytosolic GFP. Samples from bacterial cultures in 
liquid media (see Section 2.3.1.) were normalised to a concentration 
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representing 1 ml at an OD600 0.01. Where bacteria were recovered from 
infected mice (see Section 2.4.3.), the entire sample was used for further 
analysis. Permeabilisation of bacterial cells in suspension was preformed as 
described in (Schlumberger et al., 2005). All incubations were carried out in 
darkness, with rotation (for times exceeding 20 min) and in buffer volumes of 
no less than 100 µl. When required, samples were centrifuged at 21 000 g for 
1 min.  
 
To label cell-surface expressed CSA-1 and intracellular GFP in permeabilised 
bacteria, non-specific antibody labelling was first blocked with 10% horse 
serum in PBS (HS-PBS) for at least 10 min at RT. Samples were then 
incubated with primary antibodies for 1 h at RT. Next, samples were washed 
once with PBS and incubated with secondary antibodies in HS-PBS for 30 
min at RT. Samples were kept in PBS at 4°C and analysed by flow cytometry 
within 2 h. When required, samples were centrifuged at 21 000 g for 1 min. 
 
2.6. Detection of cytosolic proteins in bacterial lysates by protein 
immunoblotting 
 
To ensure that equal numbers of cells were analysed, samples from bacterial 
cultures in liquid media were adjusted so that a volume corresponding to 1 ml 
of a culture of OD600 0.01 was lysed in 20 µl protein sample buffer (0.25 mM 
Tris-Cl pH 6.8, 10% sodium dodecyl suplhate (SDS), 50% glycerol, 5% β-
mercaptoethanol). Samples were boiled for 5-10 min at 100°C and used 
immediately or stored at -20°C. Proteins were resolved using 12% SDS-
polyacrylamide gel electrophoresis (PAGE) in running buffer (25 mM Tris-Cl, 
250 mM glycine, 2% SDS). SDS-PAGE gels were equilibrated in transfer 
buffer (44 mM Tris-Cl, 29 mM glycine, 20% methanol), for 1 min and 
Immunobilon-P (Millipore) membranes were activated for 10 s in methanol, 
washed in MilliQ water and equilibrated for 10 min in transfer buffer. The 
membrane and gel were placed between three sheets of filter paper soaked in 
transfer buffer. Transfer of proteins from the gel to the membrane was 
preformed using a semi-dry transfer cell (BioRad) at 80 mA for 1 h. Non-
specific labelling was blocked by incubating membranes for 1 h at RT in 
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blocking buffer (5% milk, 0.1% Tween®-20 in PBS), on a roller. This was 
followed by overnight incubation at 4°C with the primary antibody diluted in 
blocking buffer. Membranes were washed three times for 5-10 min in 0.1% 
Tween-20 in PBS and incubated with the secondary antibody conjugated to 
HRP diluted in blocking buffer for 1 h at RT. Five further washes were carried 
out as before, after which proteins were detected using the enhanced 
chemiluminescence detection system (GE Healthcare) according to 
manufacturer’s instructions and high performance chemiluminescence film 
(GE Healthcare). 
 
2.7. Flow cytometry  
 
All samples recovered from infected murine tissues were filtered immediately 
prior to analysis using a 40 µm cell strainer. Wild-type S. Typhimurium or 
tissues from uninfected mice were used to control for autofluorescence. 
Secondary antibodies alone were used to control for non-specific antibody 
labelling. For each sample 10 000 - 30 000 events (liquid culture), 50 000 
events (macrophage infection) or up to 10 000 events (mouse infections) were 
analysed. Samples were acquired on a FACSCalibur cytometer (BD) using 
Cell Quest Pro software or on a LSR II (BD) or LSRFortessa cytometer (BD) 
using FACSDiva software. Fluorophores were excited at 488 nm, 532 nm or 
561 nm and 640 nm, when appropriate. On the FACScalibur, green and red 
fluorescence were detected at 510/20 nm and 595/20 nm, respectively. On 
the LSR II and LSRFortessa, green fluorescence was detected at 525/50 or 
530/30 nm, red fluorescence at 610/10 or 610/20 nm and far-red fluorescence 
at 670/14 nm. Data were analysed with FlowJo Software version 8.6.6. (Tree 
Star, Inc.). For single red and green fluorescence dilution, bacteria were gated 
on high green or red fluorescence, respectively. When both fluorescent 
proteins were diluted in vivo, bacteria were identified based on anti-CSA-1 
labelling and fluorescence expression as described in Section 4.2.5.1. 
Bacterial fluorescence is represented in dot plots or as histograms that show 
the frequency of events at each intensity of fluorescence obtained. 
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2.8. Fluorescence microscopy 
 
When required, coverslips were washed once in PBS and incubated with 
primary antibodies in HS-PBS for 1 h at RT in darkness in a humidified 
chamber. Coverslips were then washed twice with PBS and incubated with 
secondary antibodies in HS-PBS for 30 min as before. Following another two 
washes with PBS, cell nuclei were stained with DRAQ5™ in PBS containing 
0.5 mg/ml Ribonuclease A (Sigma) for 20 min as before. Lastly, labelled (or 
unlabelled) coverslips were washed twice with PBS and distilled water, 
mounted onto glass slides using Mowiol and kept at 4°C for at least 12 h until 
observation. All cells were examined on an epifluorescent microscope (Zeiss 
AxioImager.D1) using a 100x oil immersion objective and this was also used 
for differential interference contrast (DIC) imaging. Z-stacks were acquired on 
a confocal laser scanning microscope (Zeiss Axiovert LSM510). Images were 
processed using Adobe Photoshop software (Adobe Systems). 
 
2.9. Data analysis  
 
2.9.1. Processing of in vivo fluorescence dilution data 
 
Since very few events might not provide a profile representative of the entire 
population, bacterial fluorescence data was not quantified in experiments 
where only a total of 20 or less bacteria were detected in a sample. Bacterial 
populations recovered from the small intestinal lumen (SI) and PP, which 
displayed fluorescence profiles that were characteristic of replication-
independent GFP fluorescence loss (heterogeneous, low intensity of green 
fluorescence), were excluded from further analysis. The proportions of 
replicating and non-replicating bacteria were subsequently calculated with 
respect to the remaining population(s) of bacteria. When no replication-
independent GFP fluorescence loss was observed, the proportions of 
replicating and non-replicating bacteria were calculated with respect to the 
total population of bacteria detected. The fluorescence of replicating bacteria 
was not quantified if the proportion of these bacteria represented less than 
10% of the total population and at the same time, represented only 20 
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bacteria or less. This was because so few events might not be representative. 
Since fluorescence dilution cannot accurately measure more than 6 
generations of replication, measurements of approximately 6 generations or 
more were not examined further, as these were likely to represent an 
underestimation of the true extent of division.  
 
2.9.2. Measurement of bacterial replication and killing 
 
Bacterial replication profiles measured by CFU and fluorescence dilution were 
generally represented by the increase in generations over time. Fold 
replication (F) for CFU (1) and fluorescence dilution (2) were calculated using 
the following equations: 
 
where Ft is fold at time (t), Ct is the cell count (CFU/ml) or the geometric mean 
of fluorescence intensity (MFI) at time (t) and C0 is the cell count or MFI at t = 
0. Fold replication and generation number (N) are related as follows: 
 
 
This is derived from the principle that cell counts double with each division or 
generation, while the fluorescence intensity is halved. Therefore, the number 
of generations measured by cell counts and fluorescence dilution at a 
specified time (Nt) were calculated as: 
 
 
 
 
To generate a killing rate or index (generations/h), the rate of net growth 
(generations/h) obtained by CFU was subtracted from the replication rate 
(generations/h) obtained by fluorescence dilution (Helaine et al., 2010). 
Where indicated, the rate of replication was also calculated as h/generation. 
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2.10. Statistical analysis 
 
Data were analysed using a Student’s t test. The parameters used in each 
analysis are indicated as appropriate. Significance was indicated by a 
probability (p) value < 0.05. Unless otherwise indicated, graphs show the 
mean ± one standard error from the mean (SEM) for a least 3 independent 
experiments. 
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3. VALIDATION OF FLUORESCENCE DILUTION AS A TOOL TO 
MEASURE BACTERIAL REPLICATION IN VITRO AND ADAPTATION OF 
THE TECHNIQUE FOR USE IN VIVO 
 
3. 1. Introduction 
 
To provide a direct measure of intracellular bacterial replication, our group 
(Helaine et al., 2010) designed a technique based on fluorescence dilution. 
This system uses the decrease in fluorescence intensity resulting from halving 
of a pool of fluorescent protein within a bacterial cell as a surrogate marker for 
cell division (Fig. 1.6B). In this chapter, I describe the validation of 
fluorescence dilution as a tool to measure S. Typhimurium replication in 
different environments in vitro. I also describe the development of optimised 
systems to allow fluorescence dilution to be applied to murine studies, so that 
this technique can be used to characterise S. Typhimurium replication during 
murine typhoid disease.  
 
3.2. Results 
 
3.2.1. Measurement of S. Typhimurium replication in vitro by 
fluorescence dilution 
 
3.2.1.1. pDiGc fluorescence reporter system 
 
Our fluorescence dilution method requires bacteria to carry a dual 
fluorescence-encoding reporter plasmid (Fig. 3.1A). This was constructed and 
transformed into S. Typhimurium 12023. The vector backbone was derived 
from the bacterial expression vector pBAD18 and has a ColE1 origin of 
replication (ori) (Guzman et al., 1995). In this vector, the repressor of primer 
(rop) gene is disrupted, giving rise to a high plasmid copy number of 
approximately 50-100 copies per cell (Twigg and Sherratt, 1980, Cesareni et 
al., 1982). This plasmid encodes a Discosoma-red fluorescent protein variant 
DsRed.T3_S4T (DsRed) that has been optimised for faster maturation (Bevis 
and Glick, 2002) and brightness (Sorensen et al., 2003) in bacteria. DsRed 
was placed under the regulation of the arabinose-inducible promoter PBAD. In 
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addition, enhanced GFP, encoded by gfpmut3a (Cormack et al., 1996), was 
placed under the regulation of the constitutive promoter rpsM (Valdivia and 
Falkow, 1996). DsRed and GFP have been widely used in S. enterica 
research and their spectral properties allow them to be easily distinguished 
when expressed simultaneously (Table 3.1). A gene for ampicillin resistance 
is present in the plasmid to ensure plasmid maintenance. Hereafter, this 
plasmid will be referred to as pDiGc (DsRed-inducible GFP-constitutive).  
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Figure 3.1. Influence of pDiGc on S. Typhimurium replication in vitro. (A) Map of 
pDiGc. DsRed and GFP are under the control of the arabinose-inducible PBAD promoter and 
the constitutive rpsM promoter, respectively. AmpR denotes the gene for ampicillin 
resistance. The vector backbone is derived from pBAD18. (B) Net growth of wild-type S. 
Typhimurium (triangles) and the same strain carrying pDiGc (squares) in MM without 
arabinose, determined by CFU enumeration. (C-D) Wild-type S. Typhimurium and the same 
strain carrying pDiGc (C) or pGara (D) were grown overnight in MM, with or without 
arabinose where indicated. Net growth in RAW macrophages from 2 h to 16 h post-uptake 
was determined by fold change in CFU enumeration at these time points. Data represent 
the mean ± SEM for 2 (D) or 3 (A-C) independent experiments. Data were analysed using a 
paired, one-tailed Student’s t test and values that were significantly different (P < 0.05) from 
the wild-type strain carrying no plasmid are indicated with an asterisk (*).  
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3.2.1.2. Influence of pDiGc carriage and associated fluorescent protein 
production on S. Typhimurium replication in minimal medium and 
macrophages 
 
The growth of wild-type S. Typhimurium and the same strain carrying pDiGc 
was compared during culture in MM at pH 5.0, as this medium is thought to 
mimic the conditions experienced by S. Typhimurium inside the SCV in 
macrophages (Beuzon et al., 1999). Experiments were conducted in the 
absence of arabinose and growth was measured by enumerating bacterial 
CFU. S. Typhimurium carrying pDiGc grew more slowly than the wild-type 
strain (Fig. 3.1B). However, bacterial counts of both strains were similar by 10 
h. 
 
Given that the growth of S. Typhimurium carrying pDiGc was reduced in MM 
and that some expression vectors and the production of certain fluorescent 
proteins have been implicated in reducing bacterial virulence (Coulson et al., 
1994, Wendland and Bumann, 2002, Rang et al., 2003, Abromaitis et al., 
2005, Clark et al., 2009, Knodler et al., 2005a), I examined the influence of 
pDiGc on S. Typhimurium growth during infection of the RAW264.7 
macrophage-like cell line. RAW264.7 macrophages were infected with wild-
type S. Typhimurium and the same strain carrying pDiGc that had been grown 
overnight in MM with or without arabinose (as indicated). The infection was 
allowed to proceed in the absence of arabinose and the fold increase in 
bacterial CFU between 2 h and 16 h was measured. The fold increase of S. 
Typhimurium carrying pDiGc was over 2.5 times less than the wild-type strain 
(p = 0.0144 and 0.0183 for strains grown without and with arabinose, 
respectively) (Fig. 3.1C). However, there was no significant difference in 
growth between S. Typhimurium carrying pDiGc, when grown in the presence 
or absence of arabinose, showing that the production of DsRed did not impair 
bacterial growth (Fig. 3.1C). Furthermore, arabinose-induced bacteria carrying 
pGara, which is another derivative of pBAD18 that instead encodes GFP 
downstream of PBAD, or bacteria carrying pFPV25.1, from which GFP is 
synthesised constitutively, grew at a similar rate as the wild-type strain in 
RAW264.7 macrophages (Fig. 3.1D and data not shown). This indicates that 
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the production of GFP also did not impair bacterial growth, which is consistent 
with other reports (Knodler et al., 2005a, Clark et al., 2009). Therefore, the 
attenuated growth of S. Typhimurium carrying pDiGc in macrophages is due 
to the burden or nature of the plasmid DNA, rather than fluorescent protein 
production per se. 
 
3.2.1.3. Validation of fluorescence dilution using pDiGc 
 
To test the regulation of fluorescent protein production in S. Typhimurium 
carrying pDiGc, bacteria were grown overnight in MM containing arabinose 
and then subcultured in MM without or with arabinose. Bacteria were fixed 
and their fluorescence was detected by flow cytometry (Fig. 3.2A; adapted 
from BSc report). In the presence of arabinose, both red and green 
fluorescence were expressed at high levels (Fig 3.2A). Removing arabinose 
resulted in the loss of red fluorescence with bacterial growth (Fig. 3.2B). As 
expected, this loss was not observed when arabinose was maintained (Fig. 
3.2C). Bacteria were also subcultured for 24 h in MM containing a 
bacteriostatic concentration of tetracycline, an antibiotic known to inhibit 
bacterial protein synthesis by interfering with ribosomal function (Goldman et 
al., 1983). This confirmed that in the absence of bacterial replication and 
protein synthesis, high red and green fluorescence levels were maintained 
(Fig. 3.2D). This demonstrates that DsRed and GFP are stable over at least 
24 h.  
 
 
Figure 3.2. Validation of fluorescence dilution using pDiGc. Flow cytometric detection of 
red and green fluorescence expression by S. Typhimurium carrying pDiGc after growth 
overnight in MM with arabinose (A) and subsequent subculture for 24 h in MM without 
arabinose (B) with arabinose (C) and with a bacteriostatic concentration of tetracycline (D). 
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3.2.1.4. Bacterial replication measured by single (DsRed) fluorescence 
dilution 
 
Next, I determined the suitability of fluorescence dilution to measure bacterial 
replication. S. Typhimurium carrying pDiGc was grown for 9 h in MM 
containing arabinose, so that all bacteria expressed both red and green 
fluorescence. This was followed by an overnight incubation at 37°C in PBS 
without arabinose, to facilitate maximum production of red fluorescence 
through maturation of DsRed in the absence of bacterial growth. Following 
incubation in PBS, bacteria were subcultured in MM without arabinose and 
growth was monitored by fluorescence dilution. Removing arabinose resulted 
in the dilution of red fluorescence with bacterial growth (Fig. 3.3A). This 
dilution proceeded in a homogenous manner, represented by a series of 
overlapping, normally distributed curves, which is indicative of uniform growth 
by the entire bacterial population.  
 
Enumeration of CFU is the most widely used method to measure bacterial net 
growth. Accordingly, I compared the replication profile determined by 
fluorescence dilution during growth in MM with that obtained by measuring 
bacterial CFU. The replication profiles obtained by both methods were 
indistinguishable for more than 6 generations (Fig. 3.3B) and indicated 
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Figure 3.3. Bacterial replication measured by single (DsRed) fluorescence dilution. Pre-
induced S. Typhimurium carrying pDiGc subcultured in MM without arabinose. (A) 
Representative red fluorescence profiles detected by flow cytometry at hourly time-points. (B) 
Bacterial replication measured by CFU (black) and DsRed dilution (red). Data represent the 
mean ± SEM for at least 3 independent experiments. 
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replication at a rate of approximately 1 h per division. Thereafter, CFU counts 
indicated continued bacterial growth, whereas a plateau was observed in the 
replication profile determined by fluorescence dilution (Fig. 3.3B). This 
divergence represents the dilution of red fluorescence intensity to levels below 
the limit of detection. Therefore, these data demonstrate that fluorescence 
dilution provides an alternative to CFU to monitor bacterial replication, over at 
least 6 generations.  
 
3.2.2. Sequential fluorescence dilution in vitro 
 
3.2.2.1. pDiGi reporter system 
 
I hypothesised that the dynamic range of fluorescence dilution could be 
extended by initiating the dilution of a second fluorescent protein (GFP), 
following the dilution of DsRed. To enable the sequential dilution of DsRed 
and GFP, a modified version of pDiGc was constructed. The constitutive 
promoter rpsM was replaced by the IPTG-inducible promoter Plac, so that both 
GFP and DsRed were under inducible control (Fig. 3.4A). Hereafter this 
plasmid will be referred to as pDiGi (DsRed-inducible GFP-inducible). 
 
3.2.2.2. Influence of pDiGi carriage on S. Typhimurium replication in 
minimal medium 
 
I examined the fitness cost of pDiGi carriage on S. Typhimurium by comparing 
the growth of wild-type bacteria and the same strain carrying pDiGi. 
Experiments were conducted in MM without arabinose and growth was 
measured by CFU enumeration. S. Typhimurium carrying pDiGi grew slightly 
slower than the wild-type strain (Fig. 3.4B). However, this reduction was not 
as marked as in the strain carrying pDiGc (Fig. 3.1B) and bacterial counts of 
both strains were similar by 8 h (Fig. 3.4B). Therefore, pDiGi does not exert 
as great a fitness cost on S. Typhimurium as pDiGc. 
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3.2.2.3. Bacterial replication measured by single (GFP) fluorescence 
dilution 
 
Prior to monitoring the sequential dilution of DsRed and GFP, it was important 
to establish whether GFP dilution was also suitable to measure bacterial 
replication. S. Typhimurium carrying pDiGi was grown overnight in MM 
containing IPTG, to induce GFP production. Bacteria were then subcultured in 
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Figure 3.4. Bacterial replication measured by single (GFP) fluorescence dilution. (A) Map 
of pDiGi. DsRed and GFP are under the control of the arabinose-inducible P
BAD
 and the IPTG-
inducible P
lac
 promoters, respectively. AmpR denotes the gene for ampicillin resistance. The 
vector backbone is derived from pBAD18. (B) Net growth of wild-type S. Typhimurium 
(triangles) and the same strain carrying pDiGi (squares) in MM without arabinose, determined 
by CFU enumeration at designated time-points. (C-D) Pre-induced S. Typhimurium carrying 
pDiGi subcultured in MM without arabinose or IPTG. (C) Representative profiles of bacterial 
green fluorescence detected by flow cytometry at hourly time-points. (D) Bacterial replication 
measured by CFU (black) and GFP dilution (green). Data in B and D represent the mean ± 
SEM for 3 independent experiments. 
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MM without IPTG. Removal of IPTG resulted in the dilution of green 
fluorescence with bacterial growth (Fig. 3.4C) and these profiles resembled 
those obtained by DsRed dilution (Fig. 3.3A). As expected, comparison of the 
replication profiles obtained by both CFU and fluorescence dilution were 
indistinguishable over more than 6 generations (Fig. 3.4D). Thereafter, the 
two profiles diverged as described earlier (Fig. 3.3B), as a result of a limitation 
in the sensitivity of detection of low levels of fluorescence intensity. This 
confirms that monitoring the dilution of GFP is also a suitable means to 
measure bacterial replication, for over at least 6 generations.  
 
3.2.2.4. Bacterial replication measured by sequential (DsRed and GFP) 
fluorescence dilution 
 
Having confirmed that DsRed and GFP dilution were both suitable measures 
of bacterial replication and could independently monitor over 6 generations of 
replication, I next investigated the extent of replication that could be 
determined by the sequential dilution of these two fluorescent proteins. 
 
S. Typhimurium carrying pDiGi was grown in MM containing arabinose and 
IPTG, to induce red and green fluorescence production, respectively. After full 
DsRed maturation in PBS, bacteria were subcultured in MM with IPTG but 
without arabinose, to initiate DsRed dilution (Fig. 3.5A). After 4 h, before the 
limit of DsRed fluorescence dilution was reached (Fig. 3.5C), IPTG was 
removed, to initiate GFP dilution (Fig. 3.5B). Samples were removed at hourly 
intervals and replication was monitored by CFU and bacterial fluorescence 
dilution (Fig. 3.5C). The removal of IPTG did not affect bacterial replication 
(Fig. 3.5D). After removal of IPTG, bacteria were allowed to grow for a further 
4 h, by which time they had reached stationary phase. Comparison of the 
replication profiles obtained by fluorescence dilution and CFU shows that at 
least 10 generations of bacterial replication (corresponding to a greater than 
1000-fold increase in bacterial numbers) can be measured by sequential 
fluorescence dilution (Fig. 3.5C). Bacterial growth was restimulated by 
carrying out a further subculture without arabinose and IPTG at 8 h. This 
confirmed that the limit of GFP fluorescence detection had been reached after 
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10 generations of bacterial replication, as no further increase in bacterial 
replication was measurable by GFP dilution, despite the increase in CFU (Fig. 
3.5C).  
 
Figure 3.5. Bacterial replication measured by sequential fluorescence dilution. (A-B) Flow 
cytometric detection of red (A) and green (B) fluorescence from pre-induced S. Typhimurium 
carrying pDiGi after removal of arabinose and IPTG, respectively. (C) Bacterial replication 
measured by CFU (black) and sequential dilution of DsRed (red) and GFP (green). Arrows 
indicate removal of arabinose at t
0h
, IPTG at t
4h
 and initiation of an additional subculture at t
8h
. 
Data are representative of 3 independent experiments. (D) Growth of pre-induced S. 
Typhimurium carrying pDiGi during subculture in MM with IPTG and without arabinose (solid 
line). Growth was determined by CFU enumeration at hourly intervals. IPTG was washed out 
from half the culture at t
4h
 (arrow) and growth continued to be measured by CFU every 2 hours, 
in the absence of IPTG (dotted line). Data are representative of 3 independent experiments. 
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3.2.3. Measurement of S. Typhimurium replication in macrophages 
 
3.2.3.1. Intramacrophage replication measured by single fluorescence 
dilution 
 
Having confirmed that fluorescence dilution provides a suitable measure of 
bacterial replication, I used this technique to measure the replication of S. 
Typhimurium in macrophages. RAW264.7 macrophages were infected with S. 
Typhimurium carrying pDiGc that was grown overnight in MM containing 
arabinose, to induce DsRed production. A DsRed maturation step in PBS was 
not required in these experiments. This was because preliminary results 
showed that full DsRed maturation occurred by 2 h post-uptake into 
macrophages, as S. Typhimurium does not replicate significantly during this 
time period. The infection was conducted in the absence of arabinose and 
bacterial fluorescence was monitored by flow cytometry every 2 h. Bacteria 
replicated at a rate of approximately 4 h per division from 2 h to 6 h (Fig. 
3.6A). Thereafter, the replication increased to a rate of approximately 1 h per 
division, which was comparable to the replication rate in MM. After 10 h, no 
further dilution of DsRed could be detected. This plateau could represent 
either a true reduction in the rate of bacterial replication or the limit of 
fluorescence detection. Intramacrophage replication was subsequently 
measured by sequential fluorescence dilution, to discriminate between these 
two possibilities.  
 
3.2.3.2. Measurement of S. Typhimurium replication in macrophages by 
sequential fluorescence dilution 
 
RAW264.7 macrophages were infected with S. Typhimurium carrying pDiGi 
that was grown overnight in MM containing arabinose and IPTG, to induce 
both red and green fluorescence production, respectively. The infection was 
conducted in the absence of arabinose, however IPTG was maintained until 8 
h post-uptake. Replication was determined by monitoring changes in bacterial 
fluorescence intensity every 2 h. Bacterial replication measured by DsRed 
dilution displayed similar kinetics to the experiment described above, using 
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pDiGc (Fig. 3.6B). On removal of IPTG at 8 h post-uptake, GFP dilution 
proceeded in a manner representative of continued rapid bacterial replication 
(approximately 1.5 h per division) and at 16 h post-uptake bacteria appeared 
to have replicated over approximately 400 fold. This indicated that the 
previous plateau observed by DsRed fluorescence dilution (Fig. 3.6A) was 
indeed due to a limitation in detection of low levels of fluorescence intensity.  
  
Interestingly, unlike growth in MM, the fluorescence profiles of S. 
Typhimurium inside macrophages revealed that the bacterial population was 
heterogeneous (Fig. 3.6C). A sub-population of bacteria replicated in a 
uniform manner, while another sub-population did not replicate. Dr J. 
Thompson of our group conducted experiments to further examine the 
intracellular sub-population of S. Typhimurium that persisted without 
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Figure 3.6. Characterisation of S. Typhimurium replication in macrophages by fluorescence 
dilution. (A) Replication of pre-induced S. Typhimurium carrying pDiGc in RAW macrophages after 
removal of arabinose. At 2 h intervals, bacterial replication was measured DsRed dilution. (B) 
Replication of S. Typhimurium carrying pDiGi in RAW macrophages. At 2 h intervals, replication 
was measured DsRed (red) and GFP (green) dilution, after removal of arabinose and IPTG, 
respectively. (C) Representative red fluorescence profiles, detected by flow cytometry, of S. 
Typhimurium carrying pDiGc, at indicated timepoints post-uptake, after removal of arabinose. Arrow 
indicates non-replicating bacteria. (D) Proportion of heat killed (i) and non-replicating (ii) S. 
Typhimurium that colocalise with Cathepsin D (CtsD) at designated times post-uptake by bone 
marrow derived (bm) macrophages (n = 150–300 macrophages). Quantification was carried out at 
different times, as heat-killed bacteria are no longer visible after 2 h p.i. and non-replicating bacteria 
can only be adequately distinguished from replicating bacteria after 24 h p.i. (E) Fluorescence 
microscopy of bm macrophages infected with S. Typhimurium carrying pDiGc at 24 h post-uptake, 
showing replicating bacteria (green only) and those that have not replicated (green and red), 
surrounded by LAMP-1 positive vacuoles. Scale bars: 10 µm. Unless otherwise indicated, data 
represent the mean ± SEM for at least 3 independent experiments. Data in (D) and (E) are provided 
by Dr. J. Thompson. 
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replicating. This demonstrated that the majority of heat-killed bacteria 
colocalised with the lysosomal enzyme Cathepsin D (Fig. 3.6 Di), whereas 
non-replicating bacteria did not (Fig 3.6Dii), persisting instead within a 
lysosomal-associated membrane protein (LAMP)-1+ vacuole (Fig. 3.6E), 
characteristics of normal SCVs (Helaine et al., 2010).  
 
3.2.4. Adaptation of fluorescence dilution for murine studies 
 
3.2.4.1. Suitability of pDiGc for murine studies 
 
The main aim of this study was to apply fluorescence dilution to characterise 
the replication dynamics of S. Typhimurium during murine typhoid. Therefore, 
after validating the technique in vitro and using the pDiGc reporter system to 
enable measurement of S. Typhimurium replication in MM and macrophages 
by fluorescence dilution, I assessed the behaviour of the pDiGc reporter 
system in vivo. Experiments were conducted to determine the impact of 
pDiGc on S. Typhimurium virulence in mice and to assess the suitability of 
this strain as a model to study the replication dynamics of S. Typhimurium 
following i.g. inoculation of mice.  
 
pDiGc was stably maintained in S. Typhimurium after 2 days in mice (Table 
3.2). However, S. Typhimurium carrying pDiGc displayed a significant 
virulence attenuation with respect to the wild-type strain (CI = 0.003) after i.p. 
inoculation and also displayed low levels of spleen colonisation after 2 days 
post-i.p. inoculation (Dr. S. Helaine, personal communication). Moreover, 
preliminary invasion assays conducted using HeLa epithelial cells revealed 
that S. Typhimurium carrying pDiGc were unable to invade non-phagocytic 
cells, which is required for efficient penetration of the intestinal wall and 
establishment of a systemic infection in orally inoculated mice (Galan et al., 
1989). It is possible that carriage of pDiGc may be associated with 
suppressed prgH activity (Clark et al., 2009), which would indicate low levels 
of SPI-1 T3SS induction. However, this was not investigated. Collectively, 
these results demonstrate that, although pDiGc is a useful reporter system for 
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studying bacterial replication in macrophages in vitro, this plasmid is 
unsuitable for in vivo studies.  
 
3.2.4.2. Development of alternative reporter systems for murine studies 
 
In light of the limitations of S. Typhimurium carrying pDiGc for in vivo work, I 
developed modified reporter systems to overcome these issues. To avoid any 
detrimental effects of the pBAD18-derived vector backbone, the bacterial 
expression vector pFPV25 (Cormack et al., 1996), with a ColE1 ori, was 
chosen as an alternative. This plasmid has a copy number of approximately 
15-30 copies per cell. S. Typhimurium carrying pFPV25.1 (Valdivia and 
Falkow, 1996), which carries the rpsM promoter upstream of gfpmut3a on the 
pFPV25 vector backbone, is widely used in S. enterica research and has 
been shown to grow at a similar rate as the wild-type strain in RAW264.7 
macrophages (Knodler et al., 2005). S. Typhimurium SL1344 carrying 
pFPV25.1 has only a mild virulence attenuation (CI of 0.45) after i.p. 
inoculation (Knodler et al., 2005) and another study, using strain 12023, 
stated that in terms of lethality and overall bacterial numbers, bacteria 
carrying pFPV25.1 were indistinguishable from wild-type bacteria in mice 3 
days post-i.p. inoculation (Salcedo et al., 2001).  
 
DsRed has been suggested to attenuate the virulence of S. Typhimurium in 
mice (Prof. D. Bumann, personal communication). This could potentially be 
due to aggregation of the protein within bacterial cells (Jakobs et al., 2000), 
given that DsRed exists as a tetramer. In addition, although engineered to 
have faster replication kinetics (Sorensen et al., 2003), experiments carried 
out in this study showed that the maturation of this protein still requires 
Total number of bacteria  
(CFU / spleen) 
Number of bacteria carrying pDiGc  
(CFU / spleen) 
pDiGc stability (%) 
1 2.5 x 106 2.5 x 106 100 
2 1.4 x 10
6 1.4 x 106 100 
Table 3.2. Stability of pDiGc in S. Typhimurium in vivo. The proportion of S. Typhimurium that 
retained pDiGc in the spleens of mice after 48 h post-i.p. inoculation. Plasmid retention was 
determined by green fluorescence expression after growth on LB agar. 
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several hours (data not shown). Therefore, an alternative red fluorescent 
protein, mCherry, was chosen. mCherry was derived from wild-type DsRed 
via targeted mutagenesis (Shaner et al., 2004). However unlike its precursor, 
mCherry undergoes fast maturation (approximately 15 min) and is 
monomeric, which should reduce the likelihood of protein aggregation within 
bacterial cells. The spectral properties of mCherry also make it a good 
candidate for use in conjunction with GFP (Table 3.1). 
 
Next, to test which fluorescent protein was most suitable as the reporter for 
replication, different combinations of protein regulation were designed. These 
consisted of a system to allow either mCherry or GFP dilution and were 
termed  pFCiGc (FPV25 backbone mCherry-inducible GFP-constitutive; Fig. 
3.7A) and pFCcGi (FPV25 backbone mCherry-constitutive GFP-inducible; Fig. 
3.7B), respectively. In both plasmids, PBAD was the arabinose-inducible 
promoter and rpsM was the constitutive promoter. Another plasmid termed 
pFCiGi (pFPV25 backbone mCherry-inducible GFP-inducible; Fig. 3.7C) was 
also designed. This was because our group found that the pDiGi reporter (Fig. 
3.4A) could be used as a tool to assess the viability of intracellular S. 
Typhimurium, based on metabolic activity (Helaine et al., 2010). Using pDiGi, 
bacteria that persisted within macrophages without replicating (Fig. 3.6C) 
were shown to retain viability by their ability to respond to the presence of 
arabinose, detected by de novo synthesis of DsRed (Helaine et al., 2010). For 
this reason, I designed an optimised system to assess S. Typhimurium 
viability in vivo. Similar to pDiGi, pFCiGi carries the genes encoding mCherry 
and GFP upstream of an arabinose- and IPTG-inducible promoter, 
respectively (Fig. 3.7C).  
 
Of the plasmids described above, pFCiGi was constructed first. Experiments 
with pFCiGi showed that in S. Typhimurium, the fluorescence intensity of 
mCherry was very low when produced following arabinose induction on the 
pFPV25 backbone (see below). Therefore, mCherry dilution would provide a 
limited dynamic range of measurement of bacterial replication, since one of 
the factors that restricts this is the starting fluorescence intensity. For this 
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reason, I did not continue constructing pFCiGc and only pFCcGi was brought 
forward for validation. 
 
3.2.5. Suitability of the optimised reporter systems for murine studies 
 
3.2.5.1. Validation of fluorescence dilution using pFCcGi 
 
To check the regulation of fluorescent protein production in S. Typhimurium 
carrying pFCcGi, experiments were conducted as described in Section 
3.2.1.3. S. Typhimurium carrying pFCcGi that was grown overnight in MM 
containing arabinose displayed high levels of red and green fluorescence 
intensity (Fig. 3.8Ai, 3.8Bi). The fluorescence intensity of GFP was similar to 
that produced constitutively by S. Typhimurium carrying pFPV25.1 (Fig. 
3.8Aii). Pre-induced S. Typhimurium carrying pFCcGi that was subcultured for 
8 h in MM without arabinose lost green fluorescence (Fig. 3.8Bii), while 
maintenance of arabinose prevented this loss (Fig. 3.8Biii). These results 
were consistent with the expected regulation of GFP production. In addition, 
pre-induced bacteria carrying pFCcGi that were subcultured in the presence 
of a bacteriostatic concentration of tetracycline, to block de novo protein 
synthesis and prevent replication, retained high levels of red and green 
fluorescence intensity (Fig. 3.8Biv), indicating that GFP and mCherry are 
stable over at least 8 h. Both these fluorescent proteins were shown to be 
stable for over 72 h in later experiments (see Section 4.2.3.). 
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Figure 3.8. Fluorescence dilution of S Typhimurium carrying pFCcGi in MM. (A-B) Profiles 
of red and green fluorescence, detected by flow cytometry, of S. Typhimurium carrying pFCcGi 
(Ai, Bi) or pFPV25.1 (Aii) after growth in MM with arabinose for 16 h and subsequent subculture 
of S. Typhimurium carrying pFCcGi for 8 h in MM without arabinose (Bii), with arabinose (Biii) 
and with a bacteriostatic concentration of tetracycline (Biv). Data are representative of 2 
independent experiments. (C) Profiles of green fluorescence expression in pre-induced S. 
Typhimurium carrying pFCcGi, detected by flow cytometry at hourly intervals, after subculture in 
MM without arabinose. (D) Bacterial replication measured by CFU (black) and GFP dilution 
(green). Data represent the mean ± SEM for 2 independent experiments.  
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Next, experiments were conducted to examine the fluorescence dilution 
profile of S. Typhimurium carrying pFCcGi during bacterial replication in MM 
and to determine the number of generations that could be measured using 
this reporter system. Pre-induced S. Typhimurium carrying pFCcGi were 
subcultured in MM without arabinose and bacterial replication was measured 
by fluorescence dilution and CFU over hourly intervals. A series of normally 
distributed profiles of green fluorescence intensity was observed (Fig. 3.8C), 
which were characteristic of bacterial replication measured by DsRed (Fig. 
3.3A) and GFP (Fig. 3.4C) dilution in MM. Furthermore, comparison of the 
bacterial replication profiles obtained by fluorescence dilution and CFU (Fig. 
3.8D) demonstrated that fluorescence dilution and CFU were indistinguishable 
for over at least 6 generations of bacterial growth. Therefore, pFCcGi is a 
suitable reporter system to facilitate the measurement of S. Typhimurium 
replication by fluorescence dilution. 
 
3.2.5.2. Validation of fluorescence dilution using pFCiGi 
 
Experiments were carried out as described in Section 3.2.1.3. to check the 
regulation of fluorescence protein production in S. Typhimurium carrying 
pFCiGi. This showed that bacteria grown for 16 h in MM, in the presence of 
both inducers, produced a similar level of green fluorescence intensity 
compared to pre-induced bacteria carrying pFCcGi (Fig. 3.9Ai-ii). However, 
significantly lower levels of red fluorescence intensity were consistently 
observed (Fig. 3.9Aii). This became even more pronounced after bacterial 
culture in LB broth (data not shown). One likely explanation for this is the 
lower fluorescence yield of mCherry compared to GFP (Shaner et al., 2005). 
When grown for 16 h in MM in the absence of both inducers, S. Typhimurium 
carrying pFCiGi remained non-fluorescent (Fig. 3.9Aiii), confirming the 
expected regulation of mCherry and GFP.  
 
 
 
 
 
	   94	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next, to confirm the robustness of the fluorescence dilution technique, I also 
used pFCiGi to establish whether the simultaneous dilution of two fluorescent 
proteins was comparable. Pre-induced dual fluorescent S. Typhimurium 
carrying pFCiGi were subcultured in MM without arabinose and IPTG and 
bacterial fluorescence was monitored by flow cytometry over hourly intervals. 
The fluorescence intensity of both proteins diluted in a uniform manner (Fig. 
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Figure 3.9. Fluorescence dilution of S Typhimurium carrying pFCiGi in MM. Flow 
cytometric detection of green and red fluorescence of S. Typhimurium carrying pFCcGi after 
growth in MM with arabinose (Ai) or carrying pFCiGi after growth in MM with (Aii) or without 
(Aiii) arabinose and IPTG for 16 h. (B-C) Flow cytometric detection of green (B) and red (C) 
fluorescence of pre-induced S. Typhimurium carrying pFCiGi, after subculture without 
arabinose and IPTG. Data are representative of 2 independent experiments. (D) Bacterial 
replication measured by simultaneous dilution of GFP (green) and mCherry (red). Data 
represent the mean ± SEM for 2 independent experiments. 
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3.9B-C) and at an approximately equal rate for over 5 generations of bacterial 
division (Fig. 3.9D). After this time, the level of red fluorescence intensity had 
reached the limit of detection, preventing further measurements (data not 
shown). This shows that GFP and mCherry are diluted at equivalent rates 
within the same cell during bacterial replication. However, these results also 
demonstrate that the dynamic range of mCherry dilution, in strains carrying 
pFCiGi, is more limited than GFP. 
 
3.2.5.3. Behaviour of S. Typhimurium carrying pFCcGi in MM and 
different host cells  
 
Having confirmed that the fluorescence expression of S. Typhimurium 
carrying pFCcGi is suitable for use as a reporter system to measure bacterial 
replication, the fitness cost of this plasmid on S. Typhimurium was next 
investigated. These experiments were conducted with pFCcGi and not 
pFCiGi, as the aim was to use pFCcGi as a tool to measure S. Typhimurium 
replication. Nevertheless, pFCcGi and pFCiGi share the same vector 
backbone and fluorescent proteins, therefore it is likely that these two 
plasmids will possess similar properties.  
 
The influence of pFCcGi on S. Typhimurium replication was first examined in 
MM. Wild-type S. Typhimurium and the same strain carrying pFCcGi were 
grown overnight in MM alone, then subcultured in fresh medium. The increase 
in CFU was measured over 8 h. This showed that S. Typhimurium carrying 
pFCcGi grew at similar rate compared to the wild-type strain (Fig. 3.10A). 
Therefore, the vector backbone and constitutive synthesis of mCherry has no 
significant impact on the replication of S. Typhimurium in MM. 
 
Following this, the influence of pFCcGi on S. Typhimurium growth in murine 
macrophage-like cells was assessed. RAW264.7 macrophages were infected 
with wild-type S. Typhimurium or the same strain carrying pFCcGi that had 
been grown overnight in MM with arabinose. Pre-induced dual fluorescent 
bacteria were used in these experiments, as these are the conditions under 
which infections would be carried out when the replication of S. Typhimurium 
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was to be assessed. The infection was allowed to proceed in the absence of 
arabinose and the fold increase in bacterial CFU between 2 h and 16 h was 
measured. The fold increase of S. Typhimurium carrying pFCcGi was similar 
to the wild-type strain (Fig. 3.10B), demonstrating that pFCcGi is also well 
tolerated by S. Typhimurium during growth inside macrophages. 
Figure 3.10. Behaviour of S. Typhimurium carrying pFCcGi in MM and inside different 
host cells. (A) Growth of S. Typhimurium wild-type (triangles) and the same strain carrying 
pFCcGi (squares) in MM, determined by CFU enumeration at designated time intervals. (B) 
Net growth of pre-induced S. Typhimurium carrying the pFCcGi compared to the wild-type 
(wt) strain, in RAW macrophages from 2 h to 16 h post-uptake, determined by fold change in 
CFU at both time points. Data represent the mean ± SEM 3 independent experiments. (C) 
Number of intracellular S. Typhimurium carrying the indicated plasmids at 2 h post-invasion 
of HeLa cells. Data represent the mean ± SEM for 2 independent experiments carried out in 
triplicate. (D) Fluorescence microscopy of pre-induced S. Typhimurium carrying pFCcGi at 
indicated times post-invasion of HeLa cells, showing replicating bacteria (red) and non-
replicating bacteria (green / orange). Scale bars: 10 µm. 
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Next, the ability of S. Typhimurium carrying pFCcGi to invade non-phagocytic 
cells was investigated. Since pFPV25.1 moderately reduces the invasiveness 
of S. Typhimurium (Knodler et al., 2005), the invasion capacity of bacteria 
carrying pFCcGi was compared to strains carrying pFPV25.1 instead of wild-
type S. Typhimurium alone. Therefore, wild-type S. Typhimurium carrying 
pFPV25.1 or pFCcGi were grown overnight in MM containing arabinose, then 
subcultured in LB broth containing arabinose until late logarithmic growth, at 
which time the SPI-1 T3SS is strongly expressed (Steele-Mortimer et al., 
1999). HeLa epithelial-like cells were subsequently infected with these 
bacteria and the infection was allowed to proceed in the absence of 
arabinose. Enumeration of intracellular bacteria at 2 h post-invasion showed 
that S. Typhimurium carrying pFCcGi was able to invade these cells at levels 
similar to bacteria carrying pFPV25.1 (Fig. 3.10C). This shows that pFCcGi 
carriage does not significantly impair the ability of S. Typhimurium to invade 
non-phagocytic host cells. Interestingly, microscopic analysis of infected HeLa 
cells also revealed that, as for macrophages, S. Typhimurium displayed 
heterogeneous behaviour, with some bacteria having replicated and others 
that did not replicate (Fig. 3.10D).  
 
3.2.5.4.cBehaviourr of S. Typhimurium carrying pFCcGi in  mice 
 
Assessment of the behaviour of S. Typhimurium carrying pFCcGi was next 
extended to the mouse model of typhoid fever. First, plasmid maintenance 
was checked and this showed that pFCcGi was stably maintained in S. 
Typhimurium in mice over 5 days (Table 3.3). Following this, a CI test of S. 
Typhimurium carrying pFCcGi against the wild-type strain was conducted. 
Bacteria were grown overnight in MM containing arabinose and then 
subcultured in LB broth containing arabinose for 2.5 h. Mice were injected i.p. 
with 5 x 105 CFU consisting of wild-type bacteria and those carrying pFCcGi 
at a 1:1 ratio. After 2 days, mice were sacrificed and bacteria were recovered 
from the spleens. S. Typhimurium carrying pFCcGi had a CI value of 0.44 ± 
0.04 (Fig. 3.11A). This showed that pFCcGi conferred a much reduced 
virulence attenuation on S. Typhimurium than pDiGc. The influence of 
pFPV25.1 on S. Typhimurium virulence was also tested under these 
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conditions. I found that strains carrying pFPV25.1 had a mild virulence 
attenuation, with a CI of 0.42 ± 0.1 (Fig. 3.11A), which was not significantly 
different from strains carrying pFCcGi. This is in agreement with another 
report (Knodler et al., 2005). In addition, single strain infections of mice were 
carried out using wild-type S. Typhimurium or the same strain carrying 
pFCcGi and the splenic bacterial loads of each strain were compared. Mice 
were inoculated orally, as this was the desired route of inoculation in later 
experiments, for the measurement of S. Typhimurium replication in vivo. 
Although the number of bacteria carrying pFCcGi in the spleen was less than 
the wild-type strain on day 4 (Fig. 3.11B), both strains reached a similar level 
of colonisation on day 6 (Fig. 3.11C). Indeed, S. Typhimurium carrying 
pFPV25.1 has been reported to be as lethal to mice as the wild-type strain 
(Salcedo et al., 2001). This demonstrates that S. Typhimurium carrying 
pFCcGi is only mildly attenuated in virulence with respect to the wild-type 
strain and furthermore, these findings indicate that S. Typhimurium carrying 
pFCcGi were able to successfully penetrate the intestinal wall and replicate to 
reach high loads in the spleens of mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11. Behaviour of S. Typhimurium carrying pFCcGi in mice. (A) CI test of S. Typhimurium 
carrying pFCcGi against the wild-type strain after 2 days post-i.p. inoculation of mice. Each symbol 
represents the mean from independent experiments, in which 5 mice were used per group. (B-C) 
Bacterial load in the spleen after 4 days (B) or 6 days (C) post-i.g. inoculation of mice with single 
strains of S. Typhimurium wild-type (wt) or the same strain carrying pFCcGi. Each symbol represents 
the mean from independent experiments, in which 3 mice were used per group. Data were analysed 
using a paired one-tailed student’s t test and an asterisk (*) indicates data that is significantly different 
(p <0.05) compared to the wild-type. 
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Table 3.3. Stability of pFCcGi in S. Typhimurium in mice. The proportion of wild-type S. Typhimurium 
that retained pFCcGi in the spleens of mice after 5 days p.i. Plasmid retention was determined by red 
fluorescence expression after growth on LB agar. Groups of 2 mice were used in each experiment. 
 Experiment 
Total number of bacteria  
(CFU / spleen) 
Number of bacteria carrying pFCcGi  
(CFU / spleen) 
pFCcGi stability (%) 
1 6.0 x 105 6.0 x 105 100 
2 7.0 x 10
5 7.0 x 105 100 
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3.3. Summary 
 
In this chapter, I described the use of pDiGc to demonstrate that fluorescence 
dilution is a suitable tool to quantify bacterial replication directly at the mean 
population level. This technique also revealed that intracellular populations of 
S. Typhimurium were heterogeneous with respect to replication. In RAW264.7 
macrophages, bacterial replication is rapid and homogeneous, with the 
exception of a sub-population of bacteria that do not replicate. In this chapter, 
I also described the development of an alternative plasmid, pFCcGi, that is a 
suitable reporter system for the measurement of S. Typhimurium replication 
by fluorescence dilution. Importantly, this plasmid can overcome the invasion 
deficiency and virulence attenuation of S. Typhimurium caused by carriage of 
pDiGc. S. Typhimurium carrying pFCcGi is virulent in susceptible mice after 
i.g. inoculation and colonises their spleens almost as efficiently as the wild-
type strain. An additional system, pFCiGi was also developed as a tool to 
assess bacterial viability in vivo. Both these modified systems, pFCcGi and 
pFCiGi, can now be used to study the replication dynamics and viability, 
respectively, of S. Typhimurium during orally-induced systemic disease in 
mice. 
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4. VALIDATION OF FLUORESCENCE DILUTION AS A TOOL TO 
MEASURE BACTERIAL REPLICATION IN VIVO 
 
4.1. Introduction 
 
In Chapter 3, I described the development of an optimised plasmid-based 
reporter system, pFCcGi, to allow the characterisation of the replication 
dynamics of S. Typhimurium during orally-induced murine salmonellosis. Prior 
to embarking on such investigations, experiments were carried out to validate 
the use of fluorescence dilution as a tool to measure bacterial replication in 
mice. This was because animal models are considerably more complex than 
tissue culture models. More variables exist that could compromise the use of 
bacterial fluorescence as a reporter of replication, namely the potential basal 
induction of inducible fluorescent proteins in vivo, exposure to acid in the 
stomach, and oxygen deprivation in the intestinal lumen. 
 
4.2. Results 
 
4.2.1. Identification of S. Typhimurium in infected tissue homogenates 
by red fluorescence emission 
 
Prior to conducting experiments in mice with S. Typhimurium, an appropriate 
means to identify bacteria from infected host tissue debris was established. 
This was carried out with S. Typhimurium carrying pFCcGi that constitutively 
produce red fluorescence. It has been shown that tissue debris can emit a 
significant amount of autofluorescence, both in the green and red spectra 
(Bumann, 2002). Unless bacterial fluorescence intensity is relatively high, 
bacteria cannot be adequately distinguished from background autofluorescent 
molecules. Red fluorescent bacteria cultured in MM or LB broth can be easily 
identified by flow cytometry, according to size (forward scatter; FSC) and 
granularity (side scatter; SSC) and high red fluorescence (Fig. 4.1Ai-ii). In 
uninfected mice, no high red fluorescent particles of a similar size and 
granularity to bacteria were detected (Fig. 4.1Bi-ii). However, in the tissues of 
mice infected with S. Typhimurium carrying pFCcGi, a distinct high red 
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fluorescent population was observed after gating on particles with similar FSC 
and SSC properties to bacteria (Fig. 4.1Ci-ii). Therefore, constitutive red 
fluorescence of S. Typhimurium carrying pFCcGi is an effective means of 
identifying bacteria from autofluorescent host tissue debris.  
 
4.2.2. Investigating the levels of arabinose in mice 
 
To use GFP fluorescence as a reporter of replication, it is important to ensure 
that the production of this protein by S. Typhimurium carrying pFCcGi is under 
strict control. In earlier experiments conducted in vitro, this was confirmed by 
culturing bacteria in the absence and presence of arabinose. However, given 
that arabinose is a natural sugar, it is possible that it could be present in 
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Figure 4.1. Identification of S. Typhimurium in murine tissues by red fluorescence emission. 
Flow cytometric detection of pre-induced S. Typhimurium carrying pFCcGi in liquid culture (A), 
uninfected murine tissue (B) or infected murine tissue (C). Bacteria are identified by first gating on 
fragments with similar FSC and SSC properties to S. Typhimurium (Ai, Bi, Ci), followed by a 
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digested food in the gastrointestinal tract of mice or as metabolised products 
in the blood. Therefore, experiments were conducted to establish whether 
there were sufficient levels of arabinose available in murine tissues to induce 
fluorescent protein production. Mice were inoculated orally with S. 
Typhimurium carrying pFCcGi that had not been incubated with arabinose 
prior to inoculation. Bacteria were then recovered from the PP and MLN at 48 
h p.i. and flow cytometry was used to examine their levels of green 
fluorescence compared to bacteria in the inoculum. There was no significant 
increase of green fluorescence intensity in bacteria that had been recovered 
from infected mice compared to those in the inoculum (Fig. 4.2A). Therefore, 
in murine tissues, arabinose is not present at levels sufficient to induce PBAD-
mediated fluorescence production in S. Typhimurium carrying pFCcGi.  
 
 
4.2.3. Fluorescence stability of intrabacterial mCherry and GFP under 
acidic and anaerobic conditions in vitro 
 
During passage through the gastrointestinal tract, S. Typhimurium is exposed 
to many stressful conditions, some of which could alter the levels of 
intrabacterial GFP and mCherry fluorescence intensity. This is a particularly 
important consideration if fluorescence dilution is to be used as a tool to 
measure bacterial replication in vivo, since information about replication is 
based exclusively on the decrease of bacterial fluorescence intensity. 
Therefore, a change in fluorescence due to factors other than replication 
could lead to misinterpretation of the results.  
 
Bacteria entering the stomach are exposed to gastric acid, formed mainly of 
hydrochloric acid. This can create environments as acidic as pH 1 or 2 and 
Figure 4.2. Arabinose induction of intrabacterial 
GFP in mice. Mice were inoculated orally with 
uninduced S. Typhimurium carrying pFCcGi and 
sacrificed after 48 h. The red and green fluorescence 
emission of bacteria in the inoculum (grey) and after 
recovery from the PP (black) and MLN (red) was 
detected by flow cytometry. 
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acts as an effective barrier to infection. Short chain fatty acids present in the 
intestine can also exert acid stress on S. Typhimurium in the intestine 
(Bohnhoff et al., 1964). With this in mind, it is known that fluorescent proteins 
can be sensitive to pH. Indeed, the fluorescence intensity of purified GFP 
(Doherty et al., 2010), and cytosolic GFP in Streptococcus gordonii (Hansen 
et al., 2001), decreased when placed in a gradually lower ambient pH from ≥ 
7.0 to ≤ 4.5. Indeed, the fluorescence intensity of GFP can act as a pH 
indicator (Llopis et al., 1998). In contrast, mCherry is reported to be more 
resistant to fluctuations in pH, as the purified protein maintained a relatively 
constant fluorescence intensity when resuspended in a range of acidic to 
alkaline buffers (Doherty et al., 2010). Therefore, experiments were 
conducted to examine whether culturing S. Typhimurium in a very acidic 
environment, to mimic the conditions that bacteria might be exposed to in the 
stomach, would alter the fluorescence intensity of intrabacterial GFP and 
mCherry.  
 
S. Typhimurium carrying pFCcGi emits high levels of green and red 
fluorescence when grown overnight in MM pH 5.0 in the presence of 
arabinose (Fig. 3.8Ai). When these dual fluorescent bacteria are then 
exposed to an ambient pH of 2.0, in the presence of a bacteriostatic 
concentration of tetracycline to inhibit protein synthesis and prevent 
replication, all bacteria rapidly (within 5 min) lost green fluorescence (Fig. 
4.3A). This pH also caused 100% bacterial death, as determined by a 
subsequent lack of growth on LB agar plates (data not shown). Therefore, it 
was unsurprising that the green fluorescence loss could not be rescued when 
bacteria were returned to a medium of neutral pH (Fig. 4.3B). However, it was 
interesting that a decrease in red fluorescence was never observed (Fig. 
4.3A), indicating that mCherry remains highly stable after exposure of bacteria 
to ambient acidic conditions and can maintain fluorescence even in dead 
bacteria.  
 
Another factor that could potentially alter the fluorescence of intrabacterial 
GFP and mCherry in vivo is the availability of oxygen. This was of particular 
concern in the gastrointestinal tract, where oxygen levels have been shown to 
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progressively decrease from the stomach to the rectum in living mice (He et 
al., 1999). In addition, it is generally believed that the lumen of the intestine 
represents an anaerobic environment, with oxygen rich regions localised to 
small zones above the microvilli (Marteyn et al., 2010). Both GFP and 
mCherry require molecular oxygen for maturation of the fluorophore (Heim et 
al., 1994, Remington, 2006, Marteyn et al., 2010, Doherty et al., 2010). 
However, GFP and mCherry maturation can occur in very low levels of 
oxygen (Hansen et al., 2001, Carroll et al., 2010, Marteyn et al., 2010) and 
partial fluorophore formation was observed in the caeca of mice, when GFP 
was synthesised by S. Typhimurium in vivo (Rollenhagen and Bumann, 
2006). It is unclear whether a continued supply of oxygen is required to 
maintain the stability of fluorescence after complete maturation of the protein 
in the presence of oxygen. This is an important point to consider, as 
fluorescence dilution relies entirely on the stability of a pre-formed fluorescent 
protein. Therefore, experiments were conducted to establish whether oxygen 
withdrawal might affect the stability of intrabacterial GFP and mCherry after 
prior synthesis and maturation of the proteins in oxygen replete conditions. S. 
Typhimurium carrying pFCcGi was grown overnight in medium with arabinose 
under aerobic conditions at 37°C. Arabinose was then washed out and a 
bacteriostatic concentration of tetracycline was added, to block further protein 
synthesis and prevent replication. From this point onwards, half the culture 
was kept in aerobic conditions and the other half was placed in anaerobic 
conditions at 37°C. The fluorescence intensity of GFP and mCherry was 
monitored by flow cytometry over 3 days. In aerobic conditions, the 
fluorescence of both GFP and mCherry was approximately 100% stable over 
72 h (Fig. 4.3C-D), indicating that in S. Typhimurium these proteins have very 
long half-lives. However, when placed under anaerobic conditions in vitro, 
GFP lost green fluorescence after 24 h (Fig. 4.3C), while mCherry 
fluorescence remained relatively unaffected (Fig. 4.3D). This shows that after 
a period of at least 24 h after the removal of oxygen, the fluorophore of 
mature GFP becomes unstable. Furthermore, these changes were 
permanent, as no recovery of green fluorescence was observed after 
subsequent incubations in fully aerated media at 37°C for up to 24 h (Fig. 
4.3E). 
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Together, these results show that in contrast to mCherry, intrabacterial GFP is 
more unstable when bacteria are exposed to ambient anaerobic and acidic 
conditions and this becomes apparent by loss of green fluorescence. These 
findings also demonstrate that intrabacterial GFP is more sensitive to an 
ambient drop in pH, rather than the removal of oxygen. In light of this, 
mCherry seems more suitable than GFP, as the dilutable fluorescence 
reporter to measure bacterial replication in vivo. However, unfortunately the 
low fluorescence yield of mCherry from pFCiGi (Fig. 3.9Aii) significantly 
restricts the number of bacterial divisions that can be measured by 
fluorescence dilution. The fluorescence intensity of mCherry is particularly 
low, when S. Typhimurium is grown in LB broth compared to MM (data not 
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Figure 4.3. Fluorescence stability of intrabacterial mCherry and GFP under acidic and 
anaerobic conditions in vitro. (A-B) Flow cytometric detection of fluorescence expression in 
pre-induced S. Typhimurium carrying pFCcGi after exposure to ambient acidic conditions, in the 
absence of arabinose and in a bacteriostatic concentration of tetracycline. (A) Red and green 
fluorescence of bacteria before (orange) and after exposure to pH 2.0 for 5 min (red). (B) Green 
fluorescence of pre-induced bacteria before (black) and after exposure to pH 2.0 for 2 h (red), 
followed by culture of bacteria in PBS for a further 24 h (grey). Data are representative of 3 
independent experiments. (C-E) Flow cytometric detection of fluorescence expression in pre-
induced S. Typhimurium carrying pFCcGi after exposure to anaerobic conditions, in the 
absence of arabinose and in a bacteriostatic concentration of tetracycline. (C-D) Percentage 
loss of green (C) and red (D) fluorescence intensity compared to the intensity of fluorescence at 
t0h, in pre-induced S. Typhimurium carrying pFCcGi, during culture in the presence (filled 
triangles) of absence (open squares) of oxygen. Data represents the mean ± SEM for 3 
independent experiments. (E) Green fluorescence of pre-induced bacteria before (black) and 
after culture in anaerobic conditions for 48 h (red), followed by culture of bacteria in aerobic 
conditions for a further 24 h (grey). Data are representative of 3 independent experiments. 
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shown). Therefore, the dynamic range of measurement using mCherry 
dilution would be even more restricted in murine studies, since bacteria must 
be subcultured in LB broth prior to inoculation of mice. 
 
4.2.4. Using the levels of GFP fluorescence intensity and intracellular 
protein to detect replication-independent loss of fluorescence 
 
4.2.4.1. Correlation between levels of GFP fluorescence intensity and 
intracellular protein 
 
To test whether a replication-independent loss of green fluorescence would 
occur in vivo, I developed the following hypothesis: if loss of fluorescence is 
exclusively due to replication, then the decrease in fluorescence intensity will 
correlate with a decrease in the amount of intracellular fluorescent protein 
(Fig. 4.4). This is because the pre-formed pool of fluorescence protein halves 
between bacteria as they divide (Fig. 1.6B). Accordingly, if loss of 
fluorescence occurs due to factors other than replication, then assuming the 
level of intracellular protein remains unaffected, the levels of fluorescence 
intensity and intracellular fluorescent protein will not correlate. By 
permeabilising bacteria and labelling with fluorescently-labelled antibodies 
specific to GFP, this should provide a means to quantify the levels of GFP 
fluorescence and intracellular protein using flow cytometry.  
 
Prior to testing this hypothesis in fluorescent bacteria recovered from mice, I 
conducted experiments to determine whether the two scenarios of replication-
dependent and independent fluorescence loss could be distinguished during 
controlled conditions in vitro.  
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4.2.4.2. Detection of intracellular GFP following bacterial replication 
 
Firstly, I wished to establish whether anti-GFP labelling of permeabilised 
bacteria was an effective means to quantify intracellular GFP levels. To do 
this, wild-type bacteria and the same strain carrying pFCcGi were grown 
overnight in the presence of arabinose. Bacteria carrying pFCcGi produced 
both red and green fluorescence and the wild-type strain was non-fluorescent. 
Following this, bacteria were fixed, permeabilised and labelled with primary 
anti-GFP antibodies and secondary antibodies conjugated to a far-red 
fluorescent protein, then analysed by flow cytometry. Bacteria emitting high 
levels of green fluorescence displayed substantially greater levels of antibody 
labelling compared to those that were labelled with secondary antibody alone 
or compared to non-fluorescent wild-type bacteria labelled with both primary 
and secondary antibodies (Fig. 4.5A). This shows that anti-GFP labelling is 
specific. Furthermore, although levels of intracellular protein labelling were 
Replication 
Loss of fluorescence will correlate with 
loss of fluorescent protein. 
Other factors  
Loss of fluorescence will NOT correlate 
with loss of fluorescent protein. 
A. B. 
Figure 4.4. Level of green fluorescence intensity and intracellular protein in bacteria 
under different situations. Diagram showing the hypothesised relationship between 
intrabacterial GFP and green fluorescence under different scenarios. (A) If green 
fluorescence loss is due to replication, then the decrease in fluorescence intensity will 
correlate with a decrease in the level of intracelluar fluorescent protein. (B)  However, if loss 
of green fluorescence is due to factors other than replication, the decrease in green 
fluorescence intensity will not correlate with a decrease in intracellular fluorescent protein 
levels. The amount of intracellular GFP can be detected by antibody labelling.  
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sometimes variable, in most cases up to 100% of bacteria that expressed 
green fluorescence, also showed high levels of antibody labelling (Fig. 4.5A). 
This confirms that anti-GFP antibodies can efficiently detect intracellular 
protein.	   
 
Next, experiments were carried out to verify that the level of intracellular GFP 
decreased in parallel with the decrease of green fluorescence intensity during 
bacterial replication. Dual fluorescent S. Typhimurium carrying pFCcGi were 
subcultured in LB broth alone (to allow replication to proceed) or LB broth 
supplemented with a bacteriostatic concentration of tetracycline (to prevent 
replication). At various times, bacteria were fixed, permeabilised, labelled with 
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Figure 4.5. Detection of intracellular GFP following bacterial replication. (A) Flow 
cytometric fluorescence detection of wild-type (black) or pre-induced S. Typhimurium carrying 
pFCcGi (green) after labelling with primary and secondary antibodies and pre-induced S. 
Typhimurium carrying pFCcGi after labelling with secondary antibody only (red). (B and D) 
Flow cytometric fluorescence detection of pre-induced S. Typhimurium carrying pFCcGi at 
hourly intervals during subculture in LB broth without arabinose and in the absence (B) or 
presence (D) of a bacteriostatic concentration of tetracycline. Bacteria were labelled with 
primary and secondary antibodies to detect intracellular GFP. (C) The fold decrease of 
bacterial green fluorescence intensity (green) and intracelluar protein (black) during 
subculture in LB broth was calculated at each time-point. Data represent the mean ± SEM for 
3 independent experiments. 
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anti-GFP antibodies and analysed by flow cytometry. A small proportion of the 
starting culture often had lower levels of antibody labelling, despite emitting 
high levels of green fluorescence (Fig. 4.5B and D). The reason for this is 
unclear, considering that equivalent numbers of bacteria were labelled at each 
time point and all samples were treated identically. It is possible that 
alterations in cell structure associated with being in stationary phase may 
affect the efficiency of bacterial permeabilisation. In any case, bacteria were 
always efficiently labelled 1 h after subculture. When replication was allowed 
to proceed, a decrease of intracellular protein levels was observed and this 
roughly paralleled the decrease of green fluorescence intensity, at 
approximately the same rate (Fig. 4.5B-C). However, when replication was 
prevented, a decrease in green fluorescence intensity and intracellular protein 
levels was not observed (Fig. 4.5D). Therefore, the decrease in intracellular 
GFP correlates with the decrease in green fluorescence intensity during 
bacterial replication in vitro. In addition, the increased variation obtained when 
using protein immunolabelling and detection by flow cytometry to measure 
replication demonstrates that this method is not as sensitive as monitoring 
fluorescence intensity. This is not surprising, considering that detection of 
intracellular protein is indirect and requires several intermediate processing 
steps.  
 
4.2.4.3. Detection of intrabacterial GFP following exposure to anaerobic 
or acidic conditions 
 
Next, I carried out experiments to test a second hypothesis: that intracellular 
protein levels would not correlate with fluorescence intensity if fluorescence 
was lost due to replication-independent factors, such as anoxia or low pH. 
Pre-induced S. Typhimurium carrying pFCcGi were permeabilised and 
labelled for intracellular GFP before and after exposure to anaerobic 
conditions for up to 72 h (Fig. 4.6A) or acidic conditions (pH 2.0) for 5 min 
(Fig. 4.6B). In case these conditions caused conformational changes in GFP 
that masked or altered the antibody epitopes, I used both mono- and 
polyclonal anti-GFP antibodies that were capable of recognising denatured 
GFP. Throughout the experiment, bacteria were kept in medium containing a 
	   110	  
bacteriostatic concentration of tetracycline to prevent bacterial replication. 
Levels of green fluorescence intensity and intracellular GFP were detected by 
flow cytometry.  
 
As expected, the levels of both green fluorescence intensity and intracellular 
protein were high after culture in non-stressful conditions (black, Fig. 4.6A-B). 
However, when green fluorescence was lost after exposure of bacteria to both 
acidic and anaerobic conditions, intrabacterial GFP could no longer be 
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Figure 4.6. Detection of intracellular protein following exposure to anaerobic and 
acidic conditions. (A-B) Flow cytometric fluorescence detection of pre-induced S. 
Typhimurium carrying pFCcGi before (black) and after (red) exposure to anaerobic 
conditions for 72 h (A) or pH 2.0 for 5 min (B). Bacteria were labelled with monoclonal 
(top panel) or polyclonal (bottom panel) anti-GFP antibodies. Bacteria labelled with 
secondary antibody only are also shown (grey). (C) Immunoblotting of intrabacterial 
GFP in pre-induced S. Typhimurium carrying pFCcGi, after subculture in aerobic or 
anaerobic conditions for 72 h or exposure to pH 2.0 for 5 min, in a bacteriostatic 
concentration of tetracycline. Pre-induced bacteria that were also grown in aerobic 
conditions for 16 h without tetracycline (last lane). Data are representative of at least 3 
independent experiments. 
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detected by permeabilisation and antibody labelling with either mono- or 
polyclonal antibodies (red, Fig. 4.6A-B). This was evident because the level of 
antibody labelling in these bacteria was at a similar level to those labelled with 
secondary antibody alone (grey, Fig. 4.6A-B). This suggested that the loss of 
green fluorescence observed under ambient anaerobic or acidic stress could 
be due to degradation of intracellular GFP. However, it was possible that after 
exposure to acidic and anaerobic conditions, intracellular GFP was still 
present but no longer detectable by anti-GFP antibody labelling. This was 
suggested by the inefficient antibody labelling of highly green fluorescent 
bacteria taken from stationary-phase cultures (Fig. 4.5B and D and Fig. 4.6B). 
Therefore, this assay was not able to distinguish between replication-
dependent or independent loss of bacterial fluorescence. In both scenarios, 
bacteria that had lost green fluorescence also appeared to have decreased 
levels of intracellular protein.  
 
In an attempt to provide a better means to distinguish between replication-
dependent and independent loss of green fluorescence, an independent 
method to detect intracellular GFP was used. Instead of permeabilising 
bacteria and detecting GFP in situ, bacteria were lysed to release their 
intracellular proteins, so as to improve access of antibodies to GFP. Samples 
containing pre-induced bacteria, carrying pFCcGi, cultured in MM under 
different conditions were normalised to an OD600 of 0.01 to ensure that the 
same concentration of bacteria were analysed in each condition. Interestingly, 
this showed that GFP is indeed still present in bacteria after loss of 
fluorescence in anaerobic or acidic conditions (Fig. 4.6C), indicating that this 
protein was not degraded, but rather, was not detected by anti-GFP antibody 
while contained within the bacteria. In addition, pre-induced S. Typhimurium 
carrying pFCcGi was subcultured in aerobic conditions for 16 h without 
tetracycline, to allow replication to proceed under oxygen-rich conditions. As 
expected, the absence of intracellular GFP was confirmed within these 
bacteria that had replicated, demonstrating the specificity of the antibodies for 
GFP (Fig. 4.6C). 
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Therefore, these results are consistent with the hypothesis that the levels of 
intracellular GFP decrease only if green fluorescence is lost during bacterial 
replication. Importantly, these findings also show that protein immunoblotting 
of bacterial lysates, rather than flow cytometric detection of intracellular 
protein in bacterial suspensions, is a suitable means to detect intracellular 
GFP in replication-independent conditions. 
 
4.2.5. Using pFCiGi to allow direct comparison of mCherry and GFP 
dilution 
 
Although I established protein immunoblotting of bacterial lysates as a 
suitable method to identify replication-independent loss of GFP fluorescence, 
unfortunately this technique was not applicable for analysis of S. Typhimurium 
fluorescence in vivo. This was because preliminary experiments revealed that 
bacteria recovered from murine tissues often displayed a heterogeneous 
profile of green fluorescence intensity and protein immunoblotting can only 
provide analysis at the global population level. For this reason, I decided to 
use an alternative approach, which was capable of detecting population 
variation of green fluorescence, to determine whether replication-independent 
bacterial fluorescence loss occurs in vivo.  
 
The previous experiments highlighted the increased stability of intrabacterial 
mCherry compared to GFP after exposure to extremely low ambient pH (Fig. 
4.3A) and in the complete absence of oxygen (Fig. 4.3D), two factors that 
could potentially alter fluorescent protein stability in vivo. Therefore, I took 
advantage of the increased stability of mCherry to address whether GFP was 
unstable in vivo. To do this, pFCiGi was used, as this system allows the 
stability of intrabacterial mCherry and GFP to be compared directly in the 
same bacterial cell. Given that mCherry and GFP were shown to dilute at a 
similar rate in S. Typhimurium carrying pFCiGi during replication under non-
stressful conditions in vitro (Fig. 3.9D), the profile of GFP fluorescence should 
resemble that of mCherry if there is no replication-independent loss of GFP 
fluorescence. However, if bacteria are exposed to conditions that could alter 
protein stability, GFP is more likely to be affected compared to mCherry. In 
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this situation, the fluorescence of GFP should be different from that of 
mCherry. In addition, by using pFCiGi and expressing both fluorescent 
proteins from the same plasmid, inter-experiment variation can be avoided. 
Otherwise, two parallel infections of different mice would have to be 
conducted, using two bacterial strains producing either inducible-GFP or 
mCherry from a different plasmid. Furthermore, using pFCiGi also rules out 
any effects that might be attributed to differences in virulence, which could 
result from variations in the reporter constructs, if two bacterial strains 
carrying different plasmids were used.  
 
4.2.5.1. Identification of S. Typhimurium in infected tissue homogenates 
by CSA-1 labelling 
 
Unlike pFCcGi, there is no constitutive fluorescent marker encoded within 
pFCiGi to enable the detection of bacteria from autofluorescent host tissue 
fragments. Therefore, these bacteria were labelled with antibody against 
surface-expressed CSA-1, followed by secondary labelling with antibodies 
conjugated to a far-red fluorescent dye. To determine whether antibody 
labelling is a suitable method of identifying S. Typhimurium from host-tissue 
fragments, the efficiency and specificity of anti-CSA-1 antibody labelling was 
tested using S. Typhimurium carrying pFCcGi, which can be easily identified 
in infected tissue homogenates, based on red fluorescence detection (Fig. 
4.1Cii and Fig. 4.7Ai). To do this, mice were inoculated orally with S. 
Typhimurium carrying pFCcGi and sacrificed after 72 h. Various tissues were 
removed, including the PP and MLN. These were homogenised and fixed, 
then incubated with primary anti-CSA-1 antibodies and secondary far-red 
fluorescent-conjugated antibodies and analysed by flow cytometry. 
Approximately 100% of bacteria, identified by high red fluorescence, were 
labelled with anti-CSA-1 antibody (Fig. 4.7Aii). Therefore, anti-CSA-1 can 
label S. Typhimurium very efficiently in infected tissue homogenates. 
However, when gating on all anti-CSA-1 positive events that are of a similar 
size and granularity to S. Typhimurium (Fig. 4.7Bi), only approximately 65% of 
these simultaneously emitted high levels of red fluorescence (Fig. 4.7Bii), 
enabling them to be identified unambigously as bacteria. It is likely that non-
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specific anti-CSA-1 labelling is due to antibody binding to bacterial debris that 
are no longer fluorescent. Indeed, other groups also reported high levels of 
background labelling when using anti-Salmonella specific antibodies in 
infected tissues (Bumann, 2002, Rydstrom and Wick, 2007). This 
demonstrates that detecting the fluorescence intensity of a constitutively 
synthesised fluorescent protein is a more effective method of identifying S. 
Typhimurium from autofluorescent host tissue fragments, compared to 
labelling with anti-CSA-1.  
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Figure 4.7. Identification of S. Typhimurium in murine tissues by CSA-1 labelling. Flow 
cytometric detection of pre-induced S. Typhimurium carrying pFCcGi in infected murine 
tissue, after labelling with primary anti-CSA-1 antibodies and secondary antibodies 
conjugated to a far-red fluorescent dye. Bacteria are identified from autofluorescent host 
tissue fragments of a similar size by high red fluorescence (Ai) or high far-red fluorescence 
(Bi) emission. Bacteria that have been labelled with anti-CSA-1 antibodies emit high 
intensities of far-red fluorescence (black, Aii), compared to unlabelled bacteria in the 
inoculum (grey, Aii). Alternatively, CSA-1 labelled particles, which represent bacteria, emit 
high intensities red fluorescence (black, Bii), compared to CSA-1 labelled uninfected murine 
tissue (grey, Bii). Note, data in (Ai) has been reproduced from Fig. 4.1Cii. 
65% 
99% 
Ai. Aii. 
Bi. Bii. 
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The high degree of non-specific labelling with anti-CSA-1 antibody presented 
a problem for experiments requiring the use of pFCiGi, as this method could 
not be used to reliably distinguish S. Typhimurium from autofluorescent host 
tissue fragments. However, a means to overcome this was developed. Anti-
CSA-1 labelling was used as a first round of gating to eliminate the majority of 
autofluorescent host tissue fragments. Following this, further non-specific 
labelling was excluded by gating only on events with very high levels of red 
fluorescence, which should represent intact bacteria. Therefore, only bacteria 
that had not replicated or that had undergone 1 or 2 divisions were analysed. 
 
Importantly, prior to conducting experiments using pFCiGi in mice, S. 
Typhimurium carrying pFCiGi were assessed for correct fluorescence 
production in vivo. Earlier experiments established that arabinose was not 
present in sufficient levels within the gastrointestinal tract of mice, to induce 
PBAD-mediated expression of mCherry (Fig. 4.2). Indeed, similar results 
carried out with uninduced S. Typhimurium carrying pFCiGi showed that there 
was also no significant increase in the level of PBAD-mediated red 
fluorescence production in these bacteria, compared to the inoculum (Fig. 
4.8A). Since Plac can be induced by the natural sugar lactose, as well as the 
artifical sugar IPTG, the possibility that lactose could be present in sufficient 
levels induce fluorescence production in vivo was tested. As expected, these 
experiments also showed that there was no significant increase of Plac-
mediated green fluorescence production in S. Typhimurium in mice (Fig. 
4.8B).  
Figure 4.8. Arabinose and IPTG induction of intrabacterial fluorescent proteins in 
mice. Mice were infected orally with uninduced S. Typhimurium carrying pFCiGi and 
sacrificed after 72 h. Infected tissue homogenates were labelled with primary anti-CSA-1 
antibodies and secondary antibodies conjugated to a far-red fluorescent dye, then analysed 
by flow cytometry. Bacteria from the inoculum (grey), PP (black) and MLN (red) that emitted 
high levels of far-red fluorescence were subsequently analysed for arabinose-induced red 
(A) and IPTG-induced green (B) fluorescence production. 
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4.2.5.2. Fluorescence profiles of mCherry and GFP in S. Typhimurium 
recovered from the SI, PP and MLN 
 
Next, experiments were conducted to compare the fluorescence profiles of 
mCherry and GFP in mice, to determine if replication-independent loss of 
bacterial GFP fluorescence occurs in vivo. The fluorescence profiles of 
bacteria recovered from different tissues were examined, as the changing 
environments at different sites may exert different levels of stress on the 
bacteria. These investigations were also conducted at early time-points p.i. for 
two reasons: in order to be accurately compared, the fluorescence intensity of 
both mCherry and GFP must be above the limit of detection and alongside 
this, preliminary experiments showed that bacterial replication in vivo was 
often very rapid. 
 
S. Typhimurium carrying pFCiGi was grown for 16 h in MM, with arabinose 
and IPTG, and subcultured in LB broth to induce SPI-1 T3SS expression. 
These bacteria were then resuspended in an alkaline buffer (3% NaHC03 in 
PBS) at a concentration of  2 x 1010 CFU, to aid neutralisation of gastric acid 
and increase the numbers of bacteria reaching the intestine and other 
extraintestinal organs. Mice were inoculated i.g. and after 6 h, animals were 
sacrificed and the SI, PP and MLN were removed and prepared for flow 
cytometric analysis. Each sample represents the pooled tissues from 5 mice. 
Following host tissue homogenisation and cell lysis, samples were labelled 
with anti-CSA-1 antibody, followed by a secondary labelling with antibody 
conjugated to a far-red fluorescent dye. Bacteria were identified from 
autofluorescent host tissue fragments as described above (Section 4.2.5.1.): 
CSA-1 labelled particles emitting high levels of red fluorescence intensity 
were considered bacteria. The green fluorescence profile of this high red 
fluorescent population was then examined for evidence of a population with 
low green fluorescence intensity. This would represent a replication-
independent loss of fluorescence. 
 
In both the SI and PP, there was a proportion of bacteria with high red 
fluorescence that simultaneously displayed a heterogeneous, low intensity of 
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green fluorescence (Fig. 4.9A-B). Given that intrabacterial mCherry is more 
stable than GFP, this provides strong evidence that a significant proportion of 
the GFP fluorescence loss observed in bacteria recovered from the SI and PP 
is due to replication-independent factors. The degree of replication-
independent green fluorescence loss was quantified by calculating the 
proportion of bacteria that displayed a level of green fluorescence intensity 
that was below the level of corresponding red fluorescence intensity. All 
bacteria that were analysed at each site were those that expressed a level of 
red fluorescence intensity similar to that of the inoculum (Fig. 4.9Ai, Bi, Ci). 
Therefore, the amount of GFP instability was quantified by drawing a gate to 
determine the proportion of bacteria that displayed a green fluorescence 
intensity lower than that of the inoculum (Fig. 4.9Aii, Bii, Cii). This 
demonstrated that although the majority of green fluorescence expressed by 
bacteria in the SI and PP was at an intensity comparable to that of the 
inoculum, in the SI approximately 40% of bacteria had a green fluorescence 
intensity lower than that of the inoculum (Table 4.1). In the PP, this proportion 
was approximately 30% (Table 4.1). However, it is possible that some of the 
events in the PP represent contamination of bacteria from the SI, as these 
anatomical sites are part of a continuum and are difficult to completely 
separate by dissection. In conclusion, the proportion of intrabacterial GFP 
instability identified in the SI and PP must be taken into account when 
analysing fluorescence dilution data based on measurement of GFP dilution. 
 
For reasons that are unclear, bacterial seeding of the MLN was very variable 
and therefore, the data from the MLN represents only one experiment (of a 
group of 5 mice). However, interestingly, when S. Typhimurium was 
recovered from the MLN, greater than 95% of the intrabacterial GFP 
fluorescence intensity corresponded to the same level of intensity with respect 
to the inoculum as mCherry (Table 4.1). This demonstrates that negligible 
replication-independent loss of GFP fluorescence occurred at this site. 
Furthermore, this indicates that only bacteria that have avoided or resisted 
factors present in the gastrointestinal tract that might affect their fluorescence, 
progress to successfully seed the MLN. Therefore, these experiments also 
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highlight the use of pFCiGi as a sensor to derive information about bacterial 
stress within different murine tissues.  
 
Figure 4.9. Fluorescence profiles of intrabacterial mCherry and GFP in the SI, PP and 
MLN. Mice were infected orally with pre-induced S. Typhimurium carrying pFCiGi. After 6 h, 
bacteria were recovered from the SI (A), PP (B) and MLN (C) and analsyed by flow cytometry. 
Bacteria were identified by CSA-1 labelling, followed by gating on high red fluorescence 
intensity. The level of intrabacterial mCherry fluorescence (red; Ai, Bi, Ci) and GFP 
fluorescence (green; Aii, Bii, Cii) was compared to that of the inoculum (black). Gates indicate 
the proportion of bacteria that have a level of GFP intensity higher or lower than that of the 
inoculum. Data is representative of 1 (C) and 2 (A-B) independent experiments. In each 
experiment, groups of 5 mice were used. 
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Table 4.1. Percentage replication-independent loss of intrabacterial GFP fluorescence in 
different body sites in mice. The proportion of bacteria with a greater loss of GFP 
fluorescence compared to mCherry fluorescence in the SI, PP and MLN. 
Body site Replication-independent GFP fluorescence loss (%) 
SI 41 ± 1.9 
PP 32 ± 0.7 
MLN 2.46 
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4.2.5.3. Fluorescence profiles of mCherry and GFP in S. Typhimurium 
recovered from the spleen 
 
Next, experiments were carried out to determine whether there was any 
replication-independent loss of intrabacterial GFP fluorescence in the spleen. 
In contrast to the previous experiments, this was conducted using an i.v. route 
of inoculation, because preliminary experiments revealed that after oral 
inoculation, S. Typhimurium did not reach the spleen in substantial numbers 
until after approximately 48 h. In addition, these preliminary experiments 
showed that the majority of bacteria that reached the spleen after oral 
inoculation had already divided several times, reducing the fluorescence 
intensity of a dilutable fluorescent protein to levels too low to derive any 
meaningful measurements. Therefore, i.v. inoculation provided a rapid and 
direct route to seed the spleen. Mice were inoculated intravenously with 200-
1000 CFU of pre-induced dual fluorescent S. Typhimurium carrying pFCiGi. 
Bacteria were prepared in the same manner as described for the experiments 
above (Section 4.2.5.2.). However, PBS alone was used for final 
resuspension of the inoculum, as this buffer has a neutral pH, similar to blood. 
Mice were sacrificed after 1 h and spleens were removed and prepared for 
flow cytometric analysis. Since preliminary experiments showed that 
replication was very rapid in the spleen, the red fluorescence of S. 
Typhimurium was too low to use as a means to discard anti-CSA-1 labelling of 
bacterial debris as outlined earlier (Section 4.2.5.1.). As an alternative 
method, I used green fluorescence emission to discard non-specific anti-CSA-
1 labelling (Fig. 4.10A). Bacteria were clearly identified as a single population 
with a homogeneous, relatively high level of green fluorescence intensity. 
There were no particles that displayed intermediate levels of green 
fluorescence, which would be suggestive of replication-independent green 
fluorescence loss. To investigate this further, I examined the red fluorescence 
intensity of these bacteria, to determine if it was similar to their intensity of 
green fluorescence.  
 
It was first noted that the profiles of fluorescence intensity of both fluorescent 
proteins were uniform and characteristic of the profiles observed during S. 
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Typhimurium replication in MM (Fig. 3.9B-C). To determine if GFP and 
mCherry had been diluted to the same extent, the decrease in red and green 
fluorescence of bacteria was compared to that of the inoculum (Fig. 4.10B-C). 
By calculating the ratio of the fold decrease of each fluorescent protein, this 
showed that both fluorescent proteins had diluted at a similar rate. Therefore, 
this provides strong evidence that there is no replication-independent loss of 
intrabacterial GFP fluorescence in the spleen.  
 
  
4.3. Summary 
 
In this chapter, I have described experiments to test several variables that 
might influence the use of GFP fluorescence dilution as a reporter system to 
measure the replication of S. Typhimurium in mice. Importantly, I developed a 
system to detect whether the fluorescence of a pre-formed pool of GFP in S. 
Typhimurium might be altered by factors other than replication in vivo. The 
results demonstrated that a significant proportion of replication-independent 
loss of intrabacterial GFP fluorescence occurs in the SI and PP, which is likely 
to represent exposure of S. Typhimurium to acid stress in the gastrointestinal 
tract. In contrast, no replication-independent loss of GFP fluorescence was 
observed in the MLN and spleen. Furthermore, since these experiments 
highlighted the increased sensitivity of intrabacterial GFP to environmental 
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Figure 4.10. Fluorescence dilution profiles of intrabacterial GFP and mCherry in the 
spleen. Mice were inoculated i.v. with pre-induced S. Typhimurium carrying pFCiGi. After 1 h, 
bacteria were recovered from the spleen and analsyed by flow cytometry. Bacteria were identified 
by CSA-1 labelling, followed by gating on high green fluorescence intensity. (A) Representative 
green fluorescence of infected splenic tissue after gating on CSA-1 labelled particles. Gate 
indicates CSA-1 labelled particles with high green fluorescence that are identified as bacteria. (B-
C) Representative profiles of intrabacterial GFP fluorescence (green; B) and mCherry 
fluorescence (red; C) compared to that of the inoculum (black). Data represents the mean ± SEM 
for 2 independent experiments. Groups of 5 mice were used in each experiment. 
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stress, compared to mCherry, this facilitates the exploitation of pFCiGi as a 
sensor of bacterial stress in vivo. Interestingly, this revealed that only non-
stressed bacteria from the SI and/or PP are capable of seeding the MLN.  
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5. SPATIOTEMPORAL REPLICATION DYNAMICS OF S. TYPHIMURIUM 
DURING SYSTEMIC DISEASE 
 
5.1. Introduction 
 
Until recently, it has been difficult to obtain information about how the 
replication of S. enterica relates to its colonisation of host tissues. In 
particular, we lack information about the rate and variation of bacterial 
replication in different tissues and at different stages of the infection, the 
bacterial virulence determinants that specifically contribute to systemic 
replication and the host cell factors that influence bacterial replication in vivo. 
Therefore, the overall objective of this study was to gain a better 
understanding of this, by using fluorescence dilution to examine the 
replication dynamics of S. Typhimurium during systemic disease, in the 
murine model of acute typhoid fever. In the previous two chapters, I described 
the development and validation of an optimised dual fluorescence-encoding 
reporter system, pFCcGi, for use as a tool to measure S. Typhimurium 
replication in mice by fluorescence dilution. Although the experiments showed 
that intrabacterial mCherry is clearly more stable than GFP when exposed to 
external stresses, the arabinose-inducible production of mCherry in S. 
Typhimurium was too low to provide a meaningful measure of bacterial 
replication in vivo. Therefore, GFP had to be used as the dilutable marker to 
measure bacterial replication, as it had a far superior dynamic range of 
measurement. Importantly, information gained from experiments using pFCiGi 
enables the identification of profiles that represent replication-independent 
loss of GFP fluorescence. In this chapter, pFCcGi is used to reveal insights 
into the extent, rate and population variation of S. Typhimurium replication in 
different tissues during systemic disease.  
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5.2. Results 
 
5.2.1. Net growth of S. Typhimurium in mice following oral inoculation 
 
In the murine model of typhoid fever, orally-acquired S. Typhimurium passes 
along the gastrointestinal tract and gains access to systemic tissues, 
predominantly by invasion of M cells that overlie the PP in the small intestine 
(Clark et al., 1994, Jones et al., 1994). Bacteria subsequently colonise the PP, 
MLN and eventually the liver and spleen. Since S. enterica transmission 
naturally occurs via the oral route, I chose to study the replication dynamics of 
S. Typhimurium in mice after oral inoculation. These investigations were 
conducted at early stages in the development of disease, as events occurring 
at this time are crucial to the establishment of a productive infection. The aim 
was to address specific questions, including: whether S. Typhimurium must 
replicate in order to traverse the intestinal wall and seed systemic organs, 
whether the replication kinetics of S. Typhimurium differs in different tissues 
and whether all bacteria within one tissue replicate at the same rate. In these 
experiments, it is important to remember that the colonisation of host tissues 
by S. Typhimurium is a dynamic process governed by several variables, 
including bacterial replication and killing, dissemination from one organ to 
another (entry of bacteria to and exit from an individual tissue) and shedding 
from the host (intestine only). 
 
Mice were inoculated i.g. with 2 x 1010 CFU of pre-induced dual fluorescent 
wild-type S. Typhimurium carrying pFCcGi, where GFP acts as a reporter of 
bacterial replication. Bacterial inocula were prepared as described previously 
for oral inoculations (see Section 4.2.5.2.). At 2 h, 6 h, 12 h, 24 h and 48 h 
p.i., mice were sacrificed and bacteria were recovered from the SI, PP, MLN 
and spleen. Following tissue homogenisation and host cell lysis (except 
samples recovered from the SI), bacteria were either plated onto LB agar for 
CFU enumeration or fixed and analysed by flow cytometry. Bacteria were 
distinguished from autofluorescent host tissue fragments according to size, 
granularity and red fluorescence intensity (see Section 4.2.1.). The green 
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fluorescence intensity of these bacteria was then analysed to determine the 
amount of replication that had taken place.  
 
From 2 h to 48 h after inoculation, the numbers of S. Typhimurium in the SI 
gradually decreased from 5 x 107 CFU to 4 x 103 CFU (Fig. 5.1A), which is 
consistent with peristalsis-mediated shedding from the intestine. In the PP, 
approximately 7 x 105 CFU of bacteria were routinely recovered as early as 2 
h p.i. (Fig. 5.1A), which supports the finding that S. Typhimurium invasion of 
M cells overlying the PP is a rapid process (Clark et al., 1994, Jones et al., 
1994). Following this, the net growth of S. Typhimurium in the PP decreased 
to 4 x 104 CFU at 6 h p.i. and remained relatively static from 2 h to 24 h p.i, 
representing a balance between bacterial influx and/or replication, in 
conjunction with bacterial killing and/or dissemination to another site. An 
increase of bacterial numbers in the PP, to over 2 x 105 CFU, was then 
observed at 48 h p.i. In contrast, there was a constant gradual increase in the 
numbers of S. Typhimurium in the MLN over the same time period, from <10 
CFU at 2 h to 3 x 104 CFU at 48 h p.i. (Fig. 5.1A), suggestive of a low level of 
seeding and/or bacterial replication in this tissue. Additionally, the total CFU 
count of S. Typhimurium was consistently lower in the MLN than in the PP at 
all time-points (Fig. 5.1A). In the spleen, very few bacteria (20 CFU or less) 
were detected from 2 h to 24 h p.i. and only at 48 h p.i. were larger numbers 
(approximately 500 CFU) of bacteria detected (Fig. 5.1A). The net growth of 
S. Typhimurium in this experiment was calculated per mouse and compared 
with other published work, bearing in mind that many variables can affect the 
course of infection, for example: the size of the inoculum and genetics of both 
the host and bacterial strain. The trend of bacterial growth and the numbers of 
bacteria recovered from different tissues obtained in these experiments were 
generally similar to those described in previous reports (Hohmann et al., 
1978, Cirillo et al., 1998, Hopkins et al., 2000, Cheminay et al., 2004, 
McSorley et al., 2002, Salazar-Gonzalez et al., 2006, Voedisch et al., 2009). 
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In separate experiments, the tissues from infected mice were processed for 
flow cytometric analysis. The number of bacteria detected in each tissue in 
these experiments was then compared to the number of bacteria recovered 
by CFU in the previous experiment. However, as acquisition by flow cytometry 
was terminated when 10 000 events were acquired, comparisons can only be 
made for the MLN and spleen samples (in which less than 10 000 events 
were obtained). In the spleen, similar numbers of bacteria were detected by 
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Figure 5.1. Detection of bacteria in different host tissues by CFU and flow cytometry. 
Mice were inoculated orally with 2 x 1010 CFU of pre-induced S. Typhimurium carrying 
pFCcGi. At designated times p.i., mice were sacrificed and bacteria were recovered from the 
SI, PP, MLN and spleen. The numbers of bacteria at each site were determined by growth 
on LB agar (A) and by flow cytometric detection of constitutive red fluorescence (B). Dashed 
line in (B) indicates the maximum number of events acquired (n = 0-10,000 bacteria). 
Groups of 5 mice were used in each experiment. Data represent the mean ± SEM for 2 (A) 
or 3 to 6 (B) independent experiments.  
A. 
B. 
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flow cytometry and CFU, apart from at 24 h p.i., when more bacteria were 
detected by flow cytometry (Fig. 5.1A-B). From 2 h to 12 h p.i. in the MLN, 
more bacteria were also detected by flow cytometry, compared to CFU (Fig 
5.1A-B) and this did not resemble the gradual increase in net growth that was 
observed by CFU. One explanation for the detection of more bacteria by flow 
cytometry compared to CFU, is that the bacteria detected by flow cytometry 
were non-culturable, perhaps because they were damaged by the host or had 
entered a dormant state. Other authors described the development of a 
relapsing infection in mice infected with S. Typhimurium, despite the fact that 
bacteria were no longer culturable by plating from any intestinal or systemic 
tissues (Griffin et al., 2011). In addition, bacteria that had not replicated, but 
remained viable, were observed to persist for several days in splenocytes 
recovered from mice infected with S. Typhimurium (Helaine et al., 2010) and a 
significant proportion of these bacteria were non-culturable (Dr. S. Helaine, 
personal communication). Furthermore, experiments in the current study 
suggested that a large proportion of the bacteria detected in the MLN at early 
time-points had not replicated (see below).  
 
5.2.2. Replication dynamics of S. Typhimurium in the SI, PP, MLN and 
spleen 
 
In experiments where the tissues of infected mice were subjected to flow 
cytometric analysis, the green fluorescence intensity of S. Typhimurium was 
analysed to determine the profile of bacterial replication. Representative 
fluorescence dilution profiles of bacteria recovered from different tissues, at 
different times p.i. and from different experiments are shown in Figure 5.2 and 
5.3. Detailed quantification of the fluorescence dilution data from the 
experiments are shown in Tables 5.1-3.  
 
5.2.2.1. Identification of replication-independent loss of green 
fluorescence  
 
Experiments described in Chapter 4 revealed that environmental stress can 
give rise to replication-independent loss of intrabacterial green fluorescence. 
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Therefore, it was important to identify these events before any conclusions 
could be made about the replication of S. Typhimurium.  
 
The intestinal lumen represents the main site in which S. Typhimurium is likely 
to encounter environmental stress that could cause intrabacterial GFP 
instability. Indeed, earlier experiments revealed that the highest degree of 
replication-independent green fluorescence loss was observed in the SI 
(Table. 4.1). Therefore, no conclusions were made about S. Typhimurium 
replication at this site.  
 
Earlier experiments also demonstrated that a large proportion of bacteria 
recovered from murine PP displayed evidence of a replication-independent 
loss of green fluorescence, at least after 6 h post-i.g. inoculation (Table. 4.1). 
Indeed, close examination of the fluorescence profiles of S. Typhimurium 
recovered from the PP from 2 h to 12 h p.i. revealed populations of bacteria 
that displayed heterogeneous, low levels of green fluorescence intensity 
(‘black circles’ in Fig. 5.2). These profiles are characteristic of the replication-
independent loss of green fluorescence described in experiments conducted 
in Chapter 4, using pFCiGi (Fig. 4.9Aii, Bii). Therefore, these populations were 
not considered to represent S. Typhimurium replication and were not included 
in the analysis in Tables 5.2 and 5.3. On the other hand, the fluorescence 
profiles of S. Typhimurium recovered from the PP also clearly revealed a 
population of bacteria that displayed normally distributed, intermediate levels 
of green fluorescence (blue, Fig. 5.2). Since these profiles are characteristic 
of bacterial replication (Fig. 3.8C), they were included in the replication 
analysis, illustrated in Tables 5.2 and 5.3. 
 
Since earlier experiments revealed no evidence of replication-independent 
intrabacterial GFP fluorescence loss in the MLN at 6 h post-i.g. inoculation 
(Table 4.1) and in the spleen at 1 h post-i.v. inoculation (Fig. 4.10) of mice, all 
low green fluorescent populations of bacteria recovered from these tissues, at 
all time-points, were considered to have undergone replication. The number of 
divisions undergone by these bacteria was quantified and is illustrated in 
Tables 5.2 and 5.3.  
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Bacteria that have not replicated are found in all tissues 
Spleen preferentially seeded by bacteria that have replicated  
Replication is first observed in the PP and is rapid  
MLN preferentially seeded by bacteria that have not replicated  
Replication dynamics in the PP differ from the MLN 
Replication-independent green fluorescence loss 
Figure 5.2. Replication dynamics of S. Typhimurium in different host tissues during a 
systemic infection. Mice were inoculated i.g. with pre-induced wild-type S. Typhimurium carrying 
pFCcGi. At designated time-points, bacteria were recovered from the SI, PP, MLN and spleen and 
green fluorescence was analysed by flow cytometry. The data illustrate representative green 
fluorescence dilution profiles of S. Typhimurium in different tissues, taken from different experiments. 
Although a representative profile for the spleen at 6 h is shown, this represents <20 events and is 
not quantified in Table 5.2. White bars represent the number of bacteria detected in each sample, by 
flow cytometry. Groups of 5 mice were used in each experiment. Data are representative of 3 to 6 
independent experiments. 
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Since exposure to environmental stress resulted in a loss of green 
fluorescence intensity, this suggests that bacteria retaining high levels of 
green fluorescence intensity, comparable to bacteria in the inoculum, had not 
been affected by environmental stress. Retention of high levels of green 
fluorescence intensity also shows that these bacteria have not replicated. 
Therefore, conclusions could be made about these bacteria, regardless of the 
tissue in which they had been recovered from. Quantification of the 
proportions of bacteria that had not replicated (also referred to as non-
replicating bacteria) recovered from the SI, PP, MLN and spleen are 
illustrated in Table 5.1.  
 
5.2.2.2. Analysis of bacterial replication by fluorescence dilution 
 
In contrast to cell culture systems, a large amount of inter-experiment 
variation is expected when using animal models, since more variables exist 
and these cannot all be precisely controlled. However, despite this variation, 
several consistent observations could be made about the replication dynamics 
of S. Typhimurium within the SI, PP, MLN and spleen.  
 
Bacteria that had not replicated were found in all sites at different times 
throughout the infection (Fig. 5.2). These were quantified, shown in Table 5.1. 
These results reveal that replication is not a prerequisite for S. Typhimurium 
to traverse the intestinal wall and enter the PP, or to seed the MLN and the 
spleen.  
 
In the SI, large proportions (ranging from approximately 20% to 90%) of non-
replicating bacteria were detected from 2 h to 24 h p.i. (Table 5.1). Non-
replicating bacteria were still detected at 48 h p.i., however at this time-point 
much smaller proportions (approximately 2%) were found (Table 5.1). This 
suggests that non-replicating bacteria are able to persist within the intestinal 
lumen for at least 48 h.  
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Figure 5.3. Variation of bacterial replication 
in vivo. Representative green fluorescence 
dilution profile of pre-induced wild-type S. 
Typhimurium carrying pFCcGi recovered from 
the PP at 12 hfollowing  i.g. inoculation of mice. 
Gates indicate the number of divisions 
undergone by bacteria.  
PP MLN Spleen
0 7 29 -
0-1 27 50 -
1-2 22 14 -
2-3 23 2 -
3-4 16 0 -
4-5 5 0 -
5-6 0 0 -
0 17 21 0
0-1 15 23 0
1-2 6 11 0
2-3 6 8 0
3-4 8 11 11
4-5 10 9 26
5-6 11 6 6
0 0 0 1
0-1 0 0 2
1-2 0 0 0
2-3 1 1 1
3-4 2 4 3
4-5 15 24 26
5-6 17 20 19
Replication              
(number of generations)
Proportion of bacteria (%)
Time  (h.p.i.)
2
12
48
Table 5.3. Spectrum of bacterial replication within the PP, MLN and spleen. The 
proportion of bacteria, from representative experiments, that have undergone the 
designated number of divisions within the PP, MLN and spleen at different times 
post-i.g. inoculation of mice with pre-induced wild-type S. Typhimurium carrying 
pFCcGi. Groups of 5 mice were used in each experiment. 
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Surprisingly, at 2 h p.i. the MLN were preferentially seeded by bacteria that 
had not replicated, despite the presence of replicating bacteria in the PP (Fig. 
5.2, Tables 5.1 and 5.2). Earlier experiments with pFCiGi strongly suggest 
that these bacteria have avoided or resisted environmental stress in the 
gastrointestinal tract (Table 4.1). Replicating bacteria were subsequently 
found in the MLN at later time-points, from 6 h to 48 h p.i., and this was 
corroborated by the increase in net growth, measured by CFU (Fig. 5.1A).  
 
When non-replicating bacteria were observed in the MLN, replication had 
already begun in the PP (Fig. 5.2). This was relatively rapid, as approximately 
45% of bacteria had already undergone 1 to 3 divisions within 2 h of infection 
(Table 3). It is possible that some of the bacteria recovered in the PP sample 
were located on the luminal side of the PP tissue and therefore, represent 
contaminating bacteria from the SI. However, the replicating population of 
bacteria observed in the PP at 2 h was never observed in the SI, providing 
strong evidence that this replication only took place once S. Typhimurium had 
entered the PP. Bacterial replication in the PP then continued steadily from 2 
h to 48 h p.i. (Fig. 5.2). Interestingly, the replication observed by fluorescence 
dilution in the PP from 2 h to 24 h p.i. was not accompanied by an increase in 
net growth by CFU (Fig. 5.1A). However, many factors are likely to affect the 
numbers of viable bacteria recovered from this site, including: potential host 
cell killing of bacteria and/or dissemination of bacteria to other tissues. 
Eventually this replication did lead to an increase in bacterial net growth, from 
24 h to 48 h p.i. (Fig. 5.1A).  
 
Bacteria that had not replicated were found in both the PP and the MLN at all 
time-points from 2 h to 24 h p.i. (Table 5.1). The overall proportion of these 
bacteria gradually declined in both tissues as the infection progressed and as 
the replicating population increased (Fig. 5.4A-B, Tables 5.1 and 5.2). At 48 h 
p.i., non-replicating bacteria were no longer detected (Fig. 5.4A and Table 
5.1). It is possible that these bacteria eventually begin to replicate or are killed 
by the host. Alternatively, non-replicating bacteria may simply become too 
difficult to detect, since they represent an increasingly small proportion of the 
total population of bacteria within the tissue, given the increasing numbers of 
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replicating bacteria that accumulate over time. Despite this decline, the MLN 
consistently contained a higher average proportion of bacteria that had not 
replicated, compared to the PP (Fig. 5.4A and Table 5.1). At 2 h p.i., 
significantly more (p < 0.01) non-replicating bacteria were found in the MLN 
compared to the PP (Fig. 5.4A). At the same time, the average number of 
divisions undergone by bacteria in the MLN was consistently lower than in the 
PP (Fig. 5.4B). This difference was significant at 2 h (p < 0.001) and 12 h p.i. 
(p < 0.05). The average replication of bacteria in the MLN was also slightly 
lower than in the PP at 24 h and 48 h p.i. (Table 5.2). However, it is likely that 
this represents an underestimation in both cases, as the limit of GFP 
sensitivity is reached after approximately 6 generations of replication. In 
conclusion, there were more non-replicating bacteria and less replication of 
bacteria in the MLN compared to the PP, which suggests that the MLN 
represent a more restrictive site for S. Typhimurium replication compared to 
the PP. 
 
Whereas large proportions of non-replicating bacteria were frequently found in 
the SI, PP and MLN (Table 5.1), in the spleen, only small proportions of non-
replicating bacteria were detected in most experiments at all time-points. 
However, in one experiment, 83% of bacteria recovered from the spleen were 
non-replicating (Table 5.1). Instead, the majority of bacteria first detected in 
Figure 5.4. Bacterial replication dynamics in the PP and MLN. Mice were inoculated 
orally with pre-induced wild-type S. Typhimurium carrying pFCcGi. Bacteria were recovered 
from the PP and MLN at the designated times p.i. and the degree of bacterial replication was 
determined by analysis of green fluorescence dilution using flow cytometry. (A) Proportion of 
non-replicating (NR) bacteria and (B) average replication of bacteria within the PP and MLN. 
Groups of 5 mice were used in each experiment. Data represents the mean ± SEM for 3 to 6 
independent experiments. Data was analysed using a non-paired one-tailed student’s t test 
and values that were significantly different are indicated with asterisks: p < 0.05 (*), p < 0.01 
(**), p < 0.001 (***). 
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the spleen had already replicated (Fig. 5.2 and Table 5.2), for example 43% 
and 48% of bacteria had already undergone 3 to 6 divisions at 12 h and 48 h 
p.i., respectively (Table 5.3). This indicates that S. Typhimurium replicated in 
other tissues, such as the SI, PP or MLN, prior to reaching the spleen.  
 
The fluorescence dilution profiles of S. Typhimurium recovered from different 
murine tissues indicated that there was a great deal of variation in the extent 
of bacterial replication within an individual site. At each time point, the total 
population of bacteria detected in the PP, MLN and spleen consisted of 
different proportions of bacteria that had undergone 0 through to 6 or more 
divisions (Fig. 5.3 and Table 5.3). For example, at 48 h p.i., 3%, 4% and 45% 
of bacteria in the spleen had undergone 0 to 1, 2 to 4 and 4 to 6 divisions, 
respectively. Heterogeneous profiles such as these could be the result of a 
number of variables, including differences in the initiation of replication, 
differences in replication rate and possibly, dissemination of bacteria from one 
organ to another. 
 
5.2.3. Bacterial replication within different host cell types in the PP and 
MLN 
 
It is possible that the replication of S. Typhimurium within the PP and MLN 
might be host cell type dependent, since S. Typhimurium has been found to 
replicate at different rates within different host cell types, such as 
macrophages and DCs (Schwan et al., 2000, Jantsch et al., 2003).   
 
To investigate relationships between host cell type and bacterial replication, 
mice were inoculated orally as above, with pre-induced wild-type S. 
Typhimurium carrying pFCcGi, and at 12 h p.i. mice were sacrificed and the 
PP and MLN were removed. This time-point was chosen, as both replicating 
and non-replicating bacteria were routinely recovered from the PP and MLN at 
this time (Tables 5.1 and 5.2). To increase the sample size, tissues from 10 
mice were pooled together. Cell suspensions of infected tissues were 
generated and these were separated into CD11b+ and CD11c+ cell fractions 
using magnetic bead cell separation. CD11b or integrin alpha M is a subunit 
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of the macrophage-1 antigen, also known as complement receptor (CR)3. It is 
highly expressed on monocytes and macrophages and to a lesser extent on 
granulocytes and certain DCs (Springer et al., 1979, Ho and Springer, 1982, 
Liu and Nussenzweig, 2010). CD11c or integrin alpha X is a subunit of CR4 
and is a widely used marker of DCs, although it can be expressed to a lower 
extent on activated macrophages (Metlay et al., 1990). These cell fractions 
were subsequently lysed, to release intracellular bacteria, and bacterial 
fluorescence was detected by flow cytometry. The unlabelled cell fraction, 
which also included extracellular bacteria, was treated in the same way. In 
this manner, the replication of S. Typhimurium within broadly different host 
cell types in the PP and MLN could be analysed. 
 
In most experiments, bacteria that had not undergone any replication were 
detected in all cell fractions in the PP and MLN (Fig. 5.5A-B and Table 5.4). 
On average, a higher proportion (approximately 62%) of these non-replicating 
bacteria were detected in the MLN, compared to the PP (approximately 46%) 
(Fig. 5.5C), which is in agreement with earlier observations (Fig. 5.4A and 
Table 5.1). However, there was no significant difference in the proportions of 
non-replicating bacteria detected within the different host cell fractions (Fig. 
5.5C and Table 5.4). In addition to bacteria that had not replicated, those that 
had replicated were also detected in all cell fractions in the PP and MLN, in 
most experiments (Fig. 5.5A-B and Table 5.5). The average replication of S. 
Typhimurium in the MLN was lower (approximately 3.6 generations) 
compared to in the PP (approximately 4.6 generations) (Fig. 5.5D), which is in 
agreement with earlier experiments (Fig. 5.4B and Table 5.2). However, this 
was not statistically significant. In addition, there was no significant difference 
between the amount of bacterial replication that took place within certain host 
cell types in the PP compared to the MLN (Fig. 5.5D and Table 5.5).  
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Figure 5.5. Bacterial replication within different host cell types in the PP and MLN. Flow 
cytometric detection of green fluorescence expression in pre-induced wild-type S. 
Typhimurium carrying pFCcGi after oral inoculation of mice. At 12 h.p.i., the PP (A) and MLN 
(B) were removed and homogenised. Cell suspensions were separated into a CD11b+ (Ai, 
Bi), CD11c+ (Aii, Bii) and unlabelled cell fraction that also contained extracellular bacteria (Aiii, 
Biii). These were then lysed to release intracellular bacteria. Bacterial GFP dilution was 
analysed using flow cytometry to determine the extent of bacterial replication. Groups of 10 
mice were used in each experiment. Data is representative of 3 independent experiments. 
(C-D) Proportion of non-replicating (NR) bacteria and average replication of bacteria within all 
samples (total) or designated cell fractions. Data represents the mean ± SEM for 3 
independent experiments. Unlabelled cell fraction and extracellular bacteria (Other + Ex).  
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NR (%) NR (%)
Table 5.4. Proportion of non-replicating bacteria within different host cell types in the PP and 
MLN. The proportion of non-replicating (NR) wild-type S. Typhimurium carrying pFCcGi detected 
within CD11b+ cells, CD11c+ cells and unlabelled cells plus extracellular bacteria (Other + Ex) in the 
PP and MLN at 12 h.p.i. Groups of 10 mice were used in each experiment. 
	   138	  
  
Therefore, these experiments suggest that the differential replication of S. 
Typhimurium within the MLN and PP is not related to the host cell type. 
However, it is difficult to draw firm conclusions from these data, as there was 
a large degree of variation between experiments. Small numbers of bacteria 
(approximately 100 bacteria per cell fraction) were recovered from the PP and 
MLN in these experiments, compared to earlier experiments (Fig 5.1B), which 
was most likely due to the more gentle tissue homogenisation required to 
obtain intact cell suspensions. As a result, these small samples may be less 
representative of the entire intracellular population of bacteria and therefore, 
may have generated more variation. In addition, it is possible that the 
separation of different host cell types was not efficient, since neither CD11b or 
CD11c are exclusive to a particular host cell type. Nevertheless, it is 
interesting to note that in most experiments, bacteria that had undergone 
between 3 and 6 divisions were also found within CD11c+ cells (Table 5.5), 
suggesting that S. Typhimurium could have replicated within DCs. This was 
unexpected, since S. Typhimurium is not thought to replicate efficiently within 
DCs (Niedergang et al., 2000, Jantsch et al., 2003, Bueno et al., 2008). 
However, it is possible that these cells could have phagocytosed bacteria 
after they replicated extracellularly or within another cell type.  
 
5.2.4. Contribution of the SPI-2 T3SS to replication of S. Typhimurium in 
vivo 
 
In addition to investigating the potential influence of host cell type on S. 
Typhimurium replication in vivo, I also wanted to determine the impact of 
bacterial factors on S. Typhimurium replication in the mouse model. The SPI-
CD11b+ CD11c+ Other + Ex CD11b+ CD11c+ Other + Ex
1 3.5 4.2 3.6 3.4 3.2 3.5
2 4.5 4.4 4.3 4.5 5.5 4.7
3 5.7 - 6.4 - - 0.0
Time     
(h.p.i.)
Experiment
PP MLN
Replicaton (number of generations) Replicaton (number of generations)
12
Table 5.5. Replication of bacteria within different host cell types in the PP and MLN. The 
average extent of replication undergone by wild-type S. Typhimurium carrying pFCcGi within CD11b+ 
cells, CD11c+ cells and unlabelled cells plus extracellular bacteria (Other + Ex) in the PP and MLN at 
12 h.p.i. Groups of 10 mice were used in each experiment. 
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2 T3SS has been shown to facilitate the intracellular growth of S. 
Typhimurium within host cells (Ochman et al., 1996, Hensel et al., 1998) and 
to be essential for efficient colonisation of the MLN, liver and spleen of mice 
(Hensel et al., 1995, Cirillo et al., 1998, Shea et al., 1999). Therefore, 
fluorescence dilution was used to further clarify the contribution of the SPI-2 
T3SS to S. Typhimurium replication in vivo.  
 
Mice were inoculated intravenously as described earlier (see Section 4.2.5.3.) 
with a low dose (200-1000 CFU) of pre-induced wild-type or SPI-2 T3SS 
mutant S. Typhimurium carrying pFCcGi. This mutant contains a deletion in 
ssaV (ΔssaV), which encodes a protein required for the assembly of the SPI-2 
T3SS (Beuzon et al., 2000). As a result, no SPI-2 effectors are translocated 
by this strain. An i.v. route of inoculation was chosen to facilitate direct 
seeding of the spleen, as earlier experiments revealed that the majority of 
bacteria first detected in the spleen, after oral inoculation, had already 
undergone several divisions (Fig. 5.2), thereby reducing the measurable 
range of GFP dilution at this site. However, of course the disadvantage of this 
is that it represents an artificial route of inoculation. 
 
Groups of 8 infected mice were sacrificed at 2 h, 6 h and 8 h p.i. and their 
spleens were removed and homogenised together in a cell lysis buffer, to 
release intracellular bacteria. Early time-points were investigated, as 
preliminary experiments revealed that the replication of S. Typhimurium in the 
spleen was very rapid and the limit of GFP dilution was reached well within 24 
h of infection. A fraction of the homogenate was then removed and fixed for 
flow cytometric analysis, while another fraction was plated for CFU 
enumeration. Since fluorescence dilution provides a direct measure of 
bacterial replication and CFU provides a measure of net growth, the 
difference between these two parameters can provide a measure of the 
amount of bacterial killing, termed the ‘killing index’ (Helaine et al., 2010). 
When measuring bacterial growth dynamics within the host, it is important to 
bear in mind that the population of bacteria in a particular tissue is not only 
influenced by replication and killing, but also by spread of bacteria between 
different sites. However, work described in another report indicates that 
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bacterial spreading between different organs at the time-points investigated in 
this study would be very unlikely (Grant et al., 2008).  
 
Fluorescence dilution revealed that the replication of both wild-type and 
ΔssaV strains was relatively homogeneous in the spleen (Fig. 5.6A-B), which 
contrasts with the relatively heterogeneous replication of S. Typhimurium 
observed in different tissues after oral inoculation of mice (Fig. 5.3). Instead, 
the normally distributed profiles of bacterial replication in the spleen were 
reminiscent of the replication profiles of S. Typhimurium in MM in vitro (Fig. 
3.8C). The total population of bacteria recovered at each time-point consisted 
of different proportions of bacteria that had undergone varying numbers of 
divisions (Fig. 5.6A-B). For example, at 8 h p.i., 1%, 19%, 40% and 39% of 
wild-type and 10%, 34%, 44% and 10% of ΔssaV bacteria had undergone 0 to 
2, 2 to 4, 4 to 6 or 6+ divisions, respectively (Table 5.6). Surprisingly, by 8 h 
p.i., all bacteria of both strains had undergone replication (Fig. 5.6A-B and 
Table 5.6), which is in contrast with the identification of non-replicating 
bacteria in different host tissues, including the SI, PP, MLN and spleen 
following oral (Fig. 5.2 and Table 5.1) or i.p. (Helaine et al., 2010) inoculation 
of mice with wild-type S. Typhimurium.  
 
During the first 2 h, wild-type S. Typhimurium replicated at a very rapid rate, 
dividing every 0.7 h (1.2 generations per h) (Fig 5.6C). This was accompanied 
by a slightly higher rate of killing (1.4 generations per h) (Fig. 5.6D). However, 
this most likely represents an over-estimation of the killing rate, since not all 
bacteria in the inoculum will seed the spleen. Over the next 6 h, the rate of 
replication gradually slowed to approximately 2.8 h per division (0.35 
generations per h) and by 8 h p.i. the majority of bacteria had undergone over 
4 divisions (Fig. 5.6C and Table 5.6). This was paralleled by a significant 
decrease in the killing rate to negligible levels by 8 h p.i. (0.1 generations per 
h) (Fig. 5.6D). These results are consistent with the dynamics of bacterial 
growth described in other work, using WITS to provide a proxy measure of 
bacterial replication and killing in the spleen following i.v. infection of mice 
(Grant et al., 2008).  
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Figure 5.6. Contribution of SPI-2 to replication in vivo. Mice were inoculated intravenously 
with 200-1000 CFU of pre-induced wild-type and !ssaV S. Typhimurium carrying pFCcGi. At 2 
h, 6 h, and 8 h p.i., bacteria were recovered from the spleens and analysed by flow cytometry or 
plated for CFU enumeration. (A-B) Representative profiles of green fluorescence expression in 
wild-type (A) and !ssaV (B) bacteria. Gates indicate number of divisions undergone by bacteria, 
as follows: 0, 0-1, 1-2, 2-3, 3-4, 4-5, 5-6 from right to left. (C) Replication (fluorescence dilution, 
FD) and net growth (CFU) of wild-type and !ssaV bacteria. (D) Killing rate of wild-type and 
!ssaV bacteria. Groups of 8 mice were used in each experiment. Data represents the mean ± 
SEM for 3 independent experiments. Data was analysed using a paired, one-tailed student’s t 
test and values that were significantly different (p < 0.05) are indicated with an asterisk (*). 
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Table 5.6. Spectrum of replication undergone by wild-type and !ssaV S. Typhimurium 
in the spleen. Mice were inoculated intravenously with 200-1000 CFU of pre-induced wild-
type or !ssaV S. Typhimurium carrying pFCcGi. The proportion of bacteria in the spleen at 8 
h p.i. that have undergone the designated number of divisions is shown. 
	   142	  
In comparison to wild-type bacteria, the replication of the SPI-2 T3SS-
deficient strain was significantly less at all time-points (p < 0.05) (Fig. 5.6C). 
The reduced replication of the SPI-2 T3SS mutant was the main factor that 
accounted for the large difference in net growth between the two strains (Fig 
5.6C), as no significant difference was detected between the extent of host 
killing undergone by wild-type and SPI-2-deficient bacteria from 0 h to 8 h p.i. 
(Fig 5.6D). The fluorescence dilution profiles of both strains were also similar 
and normally distributed (Fig. 5.6A-B), which provides further evidence that 
the SPI-2 T3SS-deficient strain did not incur more killing. In conclusion, these 
experiments confirm that the SPI-2 T3SS contributes to the replication of S. 
Typhimurium in vivo and that this effect begins to manifest early in infection. 
These results also corroborate work carried out by Shea and colleagues, in 
which the SPI-2 T3SS was shown to contribute preferentially to the replication 
of S. Typhimurium in the spleen, rather than resistance to host killing (Shea et 
al., 1999).  
 
5.2.5. Analysis of the host cell type that S. Typhimurium preferentially 
replicates within during systemic disease 
 
Having characterised the replication of wild-type S. Typhimurium in the 
spleen, experiments were subsequently carried out to determine the host cell 
type that these bacteria preferentially replicate within during systemic disease. 
This is currently a matter of debate, as different studies have found that S. 
Typhimurium is predominantly found within macrophages (Richter-Dahlfors et 
al., 1997, Salcedo et al., 2001) or PMNs (Geddes et al., 2007, Aussel et al., 
2011) at late stages of infection.  
 
Mice were inoculated intravenously with approximately 800 CFU of pre-
induced wild-type S. Typhimurium carrying pFCcGi. Animals showed signs of 
illness (hunched posture, ruffled fur and laboured movements) by day 5 p.i., at 
which time they were sacrificed and the spleens were removed. In each 
experiment, the spleens from 2 infected mice were pooled together. These 
were homogenised in the absence of detergent to avoid cell lysis and CD11b+ 
cells were isolated using magnetic bead cell separation. In accordance with 
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other reports, splenic CD11b+ cells were found to contain the majority of S. 
Typhimurium (Fig. 5.7A) (Matsui et al., 2000). Since CD11b+ is a common 
phagocyte marker found on both tissue macrophages and granulocytes, 
nuclear morphology was used to distinguish between these two host cell 
types. To do this, CD11b+ cells were seeded onto lysine-coated coverslips, 
stained with a nuclear dye, DRAQ5, and examined by microscopy. The nuclei 
of PMNs were classified as lobed and macrophages as non-lobed (Fig. 5.7B) 
(Xu et al., 2005, Geddes et al., 2007, Egorina et al., 2008). CD11b+ 
splenocytes were simultaneously labelled with anti-F4/80 antibodies, followed 
by secondary antibodies conjugated to a green fluorescent dye. F4/80 is 
widely used as a marker of mature macrophages (Austyn and Gordon, 1981), 
therefore this was used as a secondary marker to identify macrophages. Non-
specific background labelling was controlled for by using infected splenic 
CD11b+ cells labelled with a IgG2b isotype control and the same cells labelled 
with secondary antibody alone. In these cases, negligible or very low levels of 
labelling were observed (data not shown), compared to infected splenic 
CD11b+ cells, after labelling with anti-F4/80 (Fig. 5.7D). This demonstrated 
that F4/80 labelling was specific.  
 
Examination of the nuclear morphology of infected CD11b+ splenocytes 
indicated that the majority (approximately 72%) of cells had non-lobed nuclei 
(Fig. 5.7B). Furthermore, approximately 62% of these infected non-lobed, 
CD11b+ splenocytes also expressed F4/80 (Fig. 5.7C-D). Bacteria were 
considered intracellular if they were positioned entirely within the boundary of 
the host cell plasma membrane, which was visualised by using DIC imaging 
alongside fluorescence microscopy. However, as this technique can only 
visualise the cell on the x and y planes, 1 µm-thick Z stacks at 0.4 µm 
increments were acquired on randomly chosen cells, which confirmed that the 
vast majority (18 out of 20) were clearly intracellular (Fig. 5.7E). Therefore, 
these findings suggest that S. Typhimurium preferentially colonises splenic 
macrophages. Next, to determine which host cell type S. Typhimurium 
preferentially replicates within, the numbers of intracellular bacteria within 
each infected CD11b+ cell were calculated. Over 60% of the total population 
of infected CD11b+ splenocytes contained 1 or 2 bacteria per cell (Fig. 5.7F), 
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which is in accordance with other reports that have examined tissue sections 
or cell suspensions from the liver and spleen, after infection of mice with wild-
type S. Typhimurium (Sheppard et al., 2003, Thone et al., 2007). The number 
of intracellular bacteria was subsequently assessed with respect to host cell 
type. To ensure that only PMNs and macrophages were considered, only 
CD11b+, F4/80- cells with lobed nuclei (PMNs) and CD11b+, F4/80+ cells with 
non-lobed nuclei (macrophages) were scored. Over 80% of PMNs contained 
1 or 2 bacteria per cell (Fig. 5.7F). However, enumerating the density of S. 
Typhimurium within macrophages revealed that this cell type contained many 
more bacteria (Fig. 5.7F). Significantly more macrophages contained 3 to 5 (p 
< 0.05), 6 to 10 (p < 0.01) and more than 10 (p < 0.01) bacteria per cell (Fig. 
5.7F). In addition, PMNs were never observed to contain more than 10 
bacteria per cell. This provides strong evidence that S. Typhimurium 
preferentially replicates within macrophages. In addition, all intracellular 
bacteria analysed had very low or undetectable levels of green fluorescence 
(Fig. 5.7D), indicating that these bacteria had been through 6 divisions or 
more. This is consistent with earlier results, which suggested that 
intrabacterial GFP would probably have diluted to undetectable levels shortly 
after 8 h p.i. (Fig. 5.6C). In conclusion, these data demonstrate that S. 
Typhimurium preferentially colonises and replicates within macrophages in 
the spleen during systemic infection of mice. 
 
Experiments were also conducted as above, with ΔssaV S. Typhimurium, to 
investigate the contribution of the SPI-2 T3SS to bacterial growth in different 
cell types in the spleen. In comparison to wild-type S. Typhimurium-infected 
mice, animals that were challenged with the same dose of ΔssaV strain 
appeared perfectly healthy by day 5 p.i. Additionally, dissected spleens of 
these mice were not enlarged and no bacteria were detected by microscopy 
or CFU (data not shown). These findings are in agreement with previous 
publications showing that the SPI-2 T3SS is important for the growth of S. 
Typhimurium in the spleen of mice (Shea et al., 1999). However, because no 
infected cells were detected under these conditions, it was not possible to 
analyse the numbers of intracellular ΔssaV bacteria. Therefore, this requires 
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further study, possibly by using higher doses of inocula and at earlier time-
points. 
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Figure 5.7. Identification of host cell types that S. Typhimurium colonises in the spleen. 
Mice were inoculated intravenously with 800 CFU of pre-induced wild-type S. Typhimurium 
carrying pFCcGi. On day 5 p.i., spleens were removed and CD11b+ cells were isolated. (A) The 
proportion of bacteria contained within CD11b+ splenocytes or CD11b! splenocytes plus 
extracellular bacteria. (B) Proportion of infected CD11b+ splenocytes with lobed or non-lobed 
nuclei. (C) Proportion of infected lobed or non-lobed CD11b+ splenocytes that expressed 
F4/80. (D) Representative microscopic images of a non-lobed and lobed CD11b+ splenocytes 
infected with S. Typhimurium (red) and labelled with DRAQ5 (blue) and anti-F4/80 (green). 
Scale: 10 µm. (E) Representative images showing projections of xy, yz and xz planes taken 
from 1 µm thick Z-stacks of infected CD11b+ splenocytes. Scale: 5 µm. (F) Proportion of total 
(white), F4/80! lobed (PMNs; black) or F4/80+ non-lobed (macrophages; grey) infected CD11b+ 
splenocytes that contain different numbers of intracellular bacteria. Groups of 2 mice were 
used in each experiment. (n=100 infected cells). Data represents the mean ± SEM for 2 
independent experiments. Data were analysed using a non-paired, one-tailed student’s t test. 
Values that were significantly different are indicated with asterisks: p < 0.05 (*), p < 0.01 (**).  
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5.3. Summary 
 
To gain a better understanding of how S. Typhimurium colonises host tissues 
during disease, I applied fluorescence dilution to study the spatiotemporal 
replication dynamics of S. Typhimurium during systemic infection of mice, 
following the natural, oral route of inoculation. These experiments revealed, 
for the first time, that replication is not required for S. Typhimurium to traverse 
the intestinal wall and reach systemic tissues, including the spleen. 
Surprisingly, the MLN were found to be seeded initially by bacteria that have 
not replicated, while replication had already started in the PP. Indeed, the 
replication dynamics of S. Typhimurium appeared to be more restricted in the 
MLN, compared to the PP. In contrast to the MLN, the spleen was 
preferentially seeded by bacteria that had already undergone several 
divisions. Further investigation of the replication dynamics of S. Typhimurium 
in the spleen, using i.v. inoculation, confirmed that the SPI-2 T3SS contributes 
significantly to bacterial replication at this site and that within this organ, wild-
type S. Typhimurium preferentially colonises and replicates within 
macrophages. 
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6. DISCUSSION 
 
An area of increasing interest is the study of growth and dissemination of S. 
Typhimurium in vivo. This is fundamental to understanding disease 
pathogenesis, particularly with respect to the colonisation of host tissues. 
During this study, fluorescence dilution was developed as a tool to measure 
bacterial replication directly at the population and single cell levels. This 
technique was subsequently used to study the spatiotemporal replication 
dynamics of S. Typhimurium during systemic disease in mice. 
 
6.1. Fluorescence dilution as a tool to measure bacterial replication 
 
As a result of experiments carried out in Chapter 3, fluorescence dilution was 
established as a robust and versatile technique. I used several fluorescent 
proteins (DsRed, GFP and mCherry) as reporters of bacterial replication and 
showed that measurements of replication, obtained by fluorescence dilution 
with any of these fluorescent proteins, were comparable to CFU enumeration. 
Furthermore, the simultaneous dilution of two fluorescent proteins in vitro was 
also equivalent. The dynamic range of measurement using a single 
fluorescent protein was limited to 6 generations of replication. However, this 
could be increased to 10 generations, by sequentially diluting a second 
fluorescent protein. Sequential fluorescence dilution can easily be applied to 
tissue culture models and a dynamic range of up to 10 generations (over 1000 
fold) is more than enough to adequately monitor S. Typhimurium replication in 
these systems. However, this might not be as easily applied to in vivo models 
(discussed below).    
 
Fluorescence dilution was first developed in vitro, using pDiGc. However, this 
plasmid was found to impart a significant invasion and replication defect on S. 
Typhimurium, which prevented the use of this plasmid for in vivo studies, 
primarily because invasion of the intestinal epithelium is required for S. 
enterica to efficiently establish a systemic infection in mice (Galan et al., 
1989). Indeed, it has been shown that plasmid carriage and fluorescent 
protein expression can affect bacterial activities, including invasion efficiency 
	   148	  
and survival inside host cells (Wendland et al., 2002, Rang et al., 2003, 
Coulson et al., 1994, Abromaitis et al., 2005, Knodler et al., 2005, Clark et al., 
2009). Therefore, a major element of the work described in Chapter 3 was the 
development of pFCcGi, an optimised reporter system, to overcome these 
limitations. S. Typhimurium carrying pFCcGi invaded non-phagocytic cells 
efficiently in vitro and, despite being recovered from the spleen in moderately 
lower numbers than the wild-type strain on day 3 post-oral inoculation of mice, 
this strain efficiently colonised spleens by day 6. The decreased fittness cost 
of pFCcGi over pDiGc is most likely due to its lower copy number, based on 
the copy number of pFPV25 (10-30 copies per cell) (Valdivia and Falkow 
1996) compared to pBAD18 (50-100 copies per cell) (Guzman et al., 1995). In 
addition, pFCcGi lacks DsRed, which was suggested to attenuate the 
virulence of S. Typhimurium in vivo (Prof. D. Bumann, personal 
communication). This is potentially due to the tetrameric nature of DsRed, 
which could lead to aggregation within bacterial cells and disruption of cellular 
functions. When used in mixed infection experiments with the wild-type strain, 
a mild virulence attenuation of S. Typhimurium carrying pFCcGi was 
apparent. However, this level of attenuation was comparable to strains 
carrying the widely used plasmid, pFPV25.1 (Knodler et al., 2005a). 
Importantly, in experiments where the replication rates of wild-type and 
mutant strains are compared, such as those carried out in Chapter 5 with SPI-
2 T3SS-deficient bacteria, all strains carry the fluorescence-encoding plasmid. 
Therefore, differences due to the mutation(s) in question should still be 
apparent. 
 
Applying fluorescence dilution to bacteria in an in vivo model raised the 
question of how stresses present within this system might affect intrabacterial 
fluorescent protein stability. In particular, it was crucial to assess whether 
there was replication-independent loss of GFP fluorescence, which could lead 
to incorrect interpretation of green fluorescence loss. Within the host, bacteria 
are exposed to gastric acid in the stomach and low oxygen tension within the 
intestinal lumen: conditions well known to affect fluorophore formation (Heim 
et al., 1994, Marteyn et al., 2010, Doherty et al., 2010). Other authors have 
described deficient or partial fluorescence of GFP, when synthesised by 
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bacteria in the intestine, but not in systemic organs (Rollenhagen et al., 2006, 
Marteyn et al., 2010). For example, Rollenhagen and colleagues 
demonstrated that the fluorescence of GFP synthesised by S. Typhimurium in 
the caeca of mice could be enhanced by approximately 33% after a further 
incubation step in aerated medium in the presence of chloramphenicol to 
block de novo synthesis of GFP. However, no further increase was observed 
when bacteria were recovered from the spleen. In contrast to these 
investigations, I was concerned with the stability of pre-formed intrabacterial 
GFP in vivo. However, my findings are consistent with these reports. 
Experiments described in Chapter 4, using pFCiGi, revealed that 40% and 
30% replication-independent loss of intrabacterial GFP fluorescence did occur 
in vivo, in bacteria recovered from the ileal lumen and PP, respectively (Table 
4.1). However, no evidence of GFP instability was observed in bacteria 
recovered from the MLN and spleen, which also support the conclusion that 
the replication-independent loss of green fluorescence observed in S. 
Typhimurium recovered from the SI and PP is due to exposure to some 
environmental stress that bacteria are exposed to in the gut. These results 
conflict with a previous suggestion that the fluorescence of GFP synthesised 
by S. Typhimurium prior to entering the host is not altered when recovered 
from the caecum (Rollenhagen et al., 2006). The reason for this is unclear. In 
experiments described in Chapter 5, I excluded replication-independent loss 
of GFP fluorescence from analysis: replication-independent loss of GFP 
fluorescence produced heterogeneous profiles, each with a low level of green 
fluorescence intensity, whereas bacterial replication produced homogeneous 
profiles, each with a normal-distribution of green fluorescence intensity (Fig. 
5.2).  
 
The identification of replication-independent loss of GFP fluorescence in 
bacteria recovered from the intestinal lumen and PP indicates that a 
proportion of bacteria in these sites has been subjected to environmental 
stresses. Therefore, pFCiGi provides a GFP sensor to detect bacterial stress 
in S. Typhimurium in vivo. Fluorescence biosensors developed to detect 
specific stresses to which S. Typhimurium is exposed, include that of the 
OxyR-dependent ahpC-gfp fusion, which senses oxidative stress (Aussel et 
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al., 2011). Aussel and colleagues used this system to show that S. 
Typhimurium is exposed to oxidative stress within vacuoles in macrophages. 
 
Exposure to low ambient pH and subsequent loss of intracellular pH 
homeostasis, rather than oxygen-limitation, most likely resulted in the 
replication-independent loss of GFP fluorescence in vivo, as in vitro 
experiments indicated that intrabacterial GFP was stable for up to 24 h after 
complete removal of oxygen (Fig. 4.3C). In contrast, GFP lost fluorescence 
within 5 min, when S. Typhimurium was exposed to an ambient pH of 2.0 (Fig. 
4.3A). S. Typhimurium does possess acid tolerance response (ATR) systems 
to protect itself against acid stress and maintain a relatively neutral internal 
pH. ATR systems are controlled by regulatory genes, including the alternative 
sigma factor encoded by rpoS, the iron regulator fur, the phoPQ regulon and 
the ompR response regulator (Foster, 1995, Foster, 1999). These are typically 
activated during growth in a moderately acidic environment and induce the 
synthesis of acid shock proteins, which protect the cell against more extreme 
acid conditions. The ATR enables cells to withstand a pH of approximately 3.3 
(Foster and Hall, 1990). However at increased acidic conditions, loss of 
intracellular pH homeostasis rapidly leads to bacterial cell death (Peterson et 
al., 1989). Since hydrochloric acid in the stomach can generate conditions as 
acidic as pH 1 to 2 (Peterson et al., 1989), bacteria were administered to mice 
in an alkaline buffer. Nevertheless, the results described in Chapter 4 suggest 
that this buffer was insufficient to neutralise stomach acidity. 
 
Following the validation, optimisation and adaptation of fluorescence dilution 
to measure bacterial replication in vitro and in vivo, this technique was used to 
study S. Typhimurium replication both in macrophages and in mice. This 
revealed several important insights into the pathogenesis of S. enterica that I 
will discuss below. However, this work also identified a number of limitations 
of the technique, namely the restricted dynamic range of measurement in vivo 
to 6 generations of replication and the replication-independent loss of GFP 
fluorescence within the gastrointestinal tract. The former limitation did not 
present a significant problem in tissue culture models, as sequential 
fluorescence dilution can be used to increase the dynamic range of 
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measurement to over 10 generations, furthermore the inducer can easily be 
maintained and removed when desired. However, this might not be as 
straight-forward in mice, since an externally administered inducer would have 
to penetrate deep into tissues to reach bacteria and in addition, fluorescent 
protein synthesis would have to be terminated by all bacteria in a reasonably 
synchronous manner. The issue of GFP instability in vivo could potentially be 
overcome by using mCherry, which I showed to be more stable, instead of 
GFP. However, this would require the generation of a mCherry variant, for 
example by using site-directed mutagenesis, that provides a greater 
fluorescence yield. 
 
6.2. Intracellular replication of S. Typhimurium within macrophages in 
vitro 
 
Fluorescence dilution was used initially to characterise the replication 
dynamics of S. Typhimurium within a RAW264.7 macrophages. This 
demonstrated that bacteria can replicate approximately 400 fold (8 
generations) over 16 h inside these cells. From 2 h to 6 h post-uptake, 
bacteria replicate slowly, which could be due to nutrient deprivation 
(Appelberg, 2006) and exposure to oxidative stress (Vazquez-Torres et al., 
2000a). Replication increases to a rate of 1 division per h, from 6 h onwards. 
This corresponds to the time at which SPI-2 T3SS-associated genes are 
maximally expressed (Cirillo et al., 1998) and when certain SPI-2 T3SS-
translocated effectors can be detected within host cells (Kuhle and Hensel, 
2002). These effectors subsequently create a more favourable environment 
for replication, by modifying the SCV (Waterman and Holden, 2003). Indeed, 
the replication defect of SPI-2 T3SS mutants becomes apparent 6 h after 
uptake by RAW264.7 macrophages (Helaine et al., 2010), suggesting that the 
increased replication rate from 6 h onwards is due to the activities of the SPI-2 
T3SS effectors. Interestingly, S. Typhimurium was found to replicate at 
approximately the same rate during exponential growth in MM and within 
RAW264.7 macrophages. This indicates that bacteria are very well adapted to 
life within this host cell type. From 16 h onwards, it is possible that bacteria 
continue to proliferate at high rates until the host cell ruptures. Alternatively, 
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replication may begin to subside as the host cell becomes limiting for 
nutrients. Indeed, mathematical modelling has indicated that the intracellular 
replication of S. Typhimurium decreases as the intracellular bacterial load 
increases (Brown et al., 2006). Since fluorescence dilution provides analysis 
of single host cells, this technique could provide a means to test this 
hypothesis of intracellular growth restriction.  
   
6.3. Spatiotemporal replication dynamics of S. Typhimurium during 
systemic disease in mice 
 
6.3.1. Replication and systemic dissemination 
 
S. Typhimurium uses several routes to traverse the intestinal barrier, mainly at 
the level of the distal ileum, and gain access to systemic sites (Fig. 1.5). SPI-
1-mediated invasion of enterocytes and particularly, M cells that overlie the 
PP, represent the predominant route of intestinal traversal (Galan et al., 1989, 
Jones et al., 1994, Clark et al., 1994). Following this, a subpopulation of S. 
Typhimurium from the PP and/or lamina propria is presumably transported to 
and colonises the draining MLN. Experiments described in Chapter 4 suggest 
that initial colonisation of the MLN is an active process, as only unstressed 
bacteria were found in these tissues soon after oral inoculation of mice (Table 
4.1). It is possible that stressed bacteria are less able to activate a virulence 
mechanism, such as SPI-1 T3SS-mediated invasion of the intestinal wall, 
which facilitates seeding of the MLN. On the other hand, this finding may 
simply indicate that stressed bacteria are unable to reach the MLN, as they 
are killed in the intestine and/or PP.  
 
Large numbers of bacteria can only be detected in the liver and spleen after 
an initial increase in bacterial numbers in the PP and MLN (Carter and Collins, 
1974). Therefore, it seems likely that a subpopulation of replicating bacteria 
from the PP and/or MLN disseminates further via the lymphatics and 
bloodstream, to eventually seed the liver and spleen. In support of this, the 
majority of bacteria found to populate the spleen following oral inoculation had 
already undergone several divisions and at these times, bacterial replication 
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was observed within the PP and MLN (Fig. 5.2). However, extensive 
intracellular replication of bacteria does not appear to be essential for 
systemic dissemination, as mutants that are unable to replicate inside host 
cells can still disseminate from the gut to the liver and spleen (Leung and 
Finlay, 1991, Cheminay et al., 2004). Indeed, findings presented in Chapter 5 
show that bacteria that have not replicated are able to traverse the intestinal 
epithelium and seed the PP, MLN and spleen (Fig. 5.2). Interestingly, this 
suggests that S. Typhimurium is capable of uncoupling virulence gene 
expression from bacterial replication in vivo. Growth-phase has been 
suggested to regulate S. Typhimurium virulence traits. Some genes, for 
example those associated with the SPI-2 T3SS, are upregulated during 
stationary-phase growth (Guiney et al., 1995, Beuzon et al., 1999). Therefore, 
certain virulence genes are preferentially expressed during conditions of low 
bacterial growth. However to my knowledge, the expression of S. 
Typhimurium virulence genes in the absence of bacterial replication, has not 
yet been described. 
 
Despite having a reduced ability to traverse the intestinal epithelium, SPI-1 
mutants are still eventually able to reach the MLN and systemic organs 
following oral inoculation (Galan and Curtiss, 1989, Baumler et al., 1997b, 
Murray and Lee, 2000), suggesting that invasion-independent routes of 
dissemination exist. Consistent with this, studies have identified routes of 
dissemination that do not require prior colonisation of PP. Vazquez-Torres 
and colleagues demonstrated that a SPI-1 mutant strain of S. Typhimurium 
was able to bypass the PP and seed the spleen directly from the intestinal 
lumen, via the bloodstream (Vazquez-Torres et al., 1999). A later study 
showed indirectly that invasive S. Typhimurium also disseminates via this 
route (Worley et al., 2006). The results in Chapter 5 illustrated the possibility 
of a direct route of bacterial dissemination from the gut to the spleen: non-
replicating bacteria were found to reach the spleen following oral inoculation 
of mice and non-replicating bacteria were found to persist predominantly 
within the ileal lumen (Fig. 5.2 and Table 5.1). However, non-replicating 
bacteria were also detected in the PP and MLN, therefore it is equally as likely 
that non-replicating bacteria detected in the spleen were derived from the PP 
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and MLN. Nevertheless, it would be interesting to investigate if the same 
processes mediate the migration of replicating and non-replicating bacteria 
towards the spleen. Indeed, SPI-1-dependent and independent seeding of the 
spleen involves distinct processes, which appear to differ in efficiency and 
timing. 
 
The contribution of different routes of bacterial dissemination to eventual 
colonisation of the spleen by S. Typhimurium is not fully understood. 
Interestingly, a PP-independent route is evident in yersiniosis and this 
represents the main route of dissemination of Yersinia to the spleen and liver 
(Barnes et al., 2006). Barnes and colleagues elegantly demonstrated that a 
lethal infection of mice was dependent on a wave of Yersinia that disseminate 
to the spleen via the bloodstream, from a replicating pool of bacteria in the 
gut. It was suggested that these bacteria might be more appropriately primed 
to colonise the spleen and liver following prior and prolonged replication in the 
intestine (Barnes et al., 2006). In contrast to this, my results suggest that an 
alternative pathway of S. Typhimurium dissemination to the spleen might stem 
from a non-replicating population of bacteria.  
 
6.3.2. Rapid bacterial replication within the PP 
 
Fluorescence dilution revealed that S. Typhimurium began to replicate in the 
PP within 2 h of infection (Fig. 5.2). In addition, this replication was relatively 
rapid (up to 1 division every h). Replication of S. Typhimurium was not 
observed within the intestinal lumen at this time, suggesting that bacteria only 
began to replicate upon invasion of the PP, presumably once they had 
reached a permissive intracellular compartment. However, microscopy would 
be required to establish unequivocally whether this replicating population is 
intracellular. If so, it is interesting to consider which host cell type this early 
replication might be taking place within. M cells often contain several 
intracellular bacteria (Jones et al., 1994), therefore it is likely that S. 
Typhimurium replicated rapidly upon invasion of these host cells. Interestingly, 
despite the identification of replicating bacteria in the PP at 2 h and 6 h p.i., in 
most cases at these time-points, the majority of bacteria had not replicated yet 
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(Table 5.1). Bacterial replication in the PP could be host cell type dependent. 
It has been reported that subepithelial DCs are the first cell type to take up S. 
Typhimurium in the PP (Hopkins et al., 2000) and in addition, S. Typhimurium 
is not thought to replicate efficiently within cultured DCs in vitro (Niedergang 
et al., 2000, Jantsch et al., 2003, Bueno et al., 2008). Therefore, it is possible 
that DCs preferentially contain non-replicating bacteria in the PP and 
replicating bacteria reside within other cell types. Indeed, another study 
reported that PP CD11c+ cells typically contain single bacteria after oral 
inoculation of mice, whereas clusters of replicating bacteria were observed 
within CD11c− cells (Cheminay et al., 2005). However, at 12 h p.i., I found 
bacteria that had replicated within CD11c+ cells in the PP, as well as the 
CD11b+ and unlabelled cell fractions, suggesting that replication might also 
have occurred within DCs. Microscopy could be used to distinguish if bacteria 
had replicated within DCs or if these cells phagocytosed replicating bacteria: 
one replicating bacterium per cell would suggest that replication occurred 
elsewhere. 
 
6.3.3. Restricted bacterial replication within the MLN  
 
Fluorescence dilution revealed that the dynamics of S. Typhimurium 
replication in different murine tissues were not equivalent. Experiments 
described in Chapter 5 indicated that bacterial replication was more restricted 
in the MLN compared to the PP. This is consistent with evidence showing that 
the growth of S. Typhimurium in the MLN is not as marked as in the liver and 
spleen (Voedisch et al., 2009). Furthermore, the MLN seem to represent a 
restrictive site for dissemination of S. Typhimurium, as mesenteric 
lymphadenectomised mice experienced accelerated spleen and liver 
colonisation and increased mortality (Voedisch et al., 2009). Using the same 
technique, a recent study showed that the MLN also restrict the dissemination 
of S. Typhimurium during a relapsing infection (Griffin et al., 2011).  
 
The MLN are important for the generation of systemic immune responses 
(Yamamoto et al., 2000) and these tissues produce significant quantities of 
protective cytokines during infection with S. Typhimurium (Karem et al., 1996). 
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Therefore, it is possible that mice lacking MLN develop an increased 
susceptibility to S. Typhimurium, because of a general impairment in the 
development of an appropriate immune response. However, 
lymphadenectomised Rag2-/- mice that lack mature T and B-cells, do not 
develop enhanced bacterial loads in the spleen and liver infection with S. 
Typhimurium (Voedisch et al., 2009). On the other hand, restricted replication 
and dissemination of S. Typhimurium within the MLN could result from an 
intrinsic property of these lymphoid tissues, for example due to the host cell 
type that bacteria are contained within. Indeed, DCs appear to represent the 
majority of infected cells at this site (Macpherson et al., 2004, Voedisch et al., 
2009) and S. Typhimurium seems to be unable to replicate (Jantsch et al., 
2003, Niedergang et al., 2000) or to replicate poorly (Bueno et al., 2008) 
within this cell type. Furthermore, upon entering the lymph nodes, DCs 
harbouring commensal bacteria do not leave this tissue (Macpherson et al., 
2004). The restrictive capacity of the MLN could therefore be due to DCs that 
harbour the majority of bacteria. I did attempt to determine whether replication 
within the MLN was host cell type dependent, however unfortunately the 
results were inconclusive, as a large amount of error was observed between 
experiments.  
 
The restriction of S. Typhimurium replication in the MLN and their limited 
dissemination from this site could represent a selective pressure favouring the 
exploitation of alternative pathways for bacteria to bypass the MLN and 
directly target more permissive environments, such as within macrophages in 
the liver (Richter-Dahlfors et al., 1997) and spleen (Salcedo et al., 2001). 
Bypassing certain tissues, such as the PP or MLN, might also diminish the 
priming of adaptive immune responses (Vazquez-Torres et al., 1999, Martinoli 
et al., 2007). On the other hand, the reduced replication of S. Typhimurium in 
the MLN may be bacterially directed. Reducing replication may seem 
counterintuitive; however, several S. Typhimurium virulence factors have 
been implicated in the downregulation of bacterial growth, including: the 
PhoPQ two-component regulatory system (Cano et al., 2001), genes involved 
in nitric oxide production (Eriksson et al., 2000) and the D-Ala-D-Ala 
dipeptidase, pcgL (Hilbert et al., 1999), which could stimulate immune 
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signalling (Mouslim et al., 2002). Such ‘antivirulence’ genes are also found in 
other organisms and have been hypothesised to promote host survival 
(Cunningham et al., 2001) or alternatively, to facilitate survival in secondary 
environments during host to host transmission (Giraud et al., 2001). Reduced 
replication of S. Typhimurium within DCs could help to limit antigen 
presentation (Albaghdadi et al., 2009) and therefore, evade immune 
recognition and avoid bacterial killing. Interestingly, Monack and colleagues 
demonstrated that S. Typhimurium is capable of persisting in the MLN of mice 
for up to one year (Monack et al., 2004a). Therefore, it is possible that 
bacteria could also exploit the restrictive capacities of these tissues or 
specifically downregulate replication within this site to form reservoirs of 
persistent bacteria. In light of my findings, it would be interesting to investigate 
whether the restrictive nature of S. Typhimurium replication within the MLN is 
even more pronounced in the murine model of chronic typhoid fever.  
 
3.4. Bacterial growth dynamics in the spleen 
 
Bacterial growth and organ colonisation during murine typhoid is mostly 
studied within the spleen and liver, as these represent the major sites of 
systemic bacterial replication. Inoculation of mice with S. Typhimurium via the 
oral route provided insights into how bacterial replication relates to initial 
seeding of the spleen. However, to investigate the detailed dynamics of 
population growth at this site, the i.v. route of inoculation had to be used, to 
facilitate direct seeding of the spleen and to circumvent the problem of the 
limited range of cell divisions that could be measured by fluorescence dilution 
within this organ after oral inoculation. 
 
Following i.v. inoculation, the replication of S. Typhimurium in the spleen 
proceeded in a relatively homogeneous manner. This contrasted with the 
typically heterogeneous profile of bacterial replication observed within murine 
tissues following oral inoculation. The constant entry and exit of bacteria from 
an individual tissue creates greater heterogeneity within an individual 
population of bacteria (Grant et al., 2008) and this probably explains the 
heterogeneous profiles observed after oral inoculation. In the same way, at 
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the early time-points investigated after i.v. inoculation, spread of bacteria 
between organs is unlikely (Grant et al., 2008).  
 
The precise contribution of bacterial replication and killing to overall net 
growth of S. Typhimurium during initial colonisation of the spleen was 
determined by coupling measurements of bacterial replication obtained from 
fluorescence dilution and net growth from CFU; these were then used to 
generate a killing index (Helaine et al., 2010). These experiments 
demonstrated that high rates of bacterial replication took place soon after 
reaching the spleen, despite the onset of rapid bacterial killing. The dynamics 
of replication and killing, in addition to the actual rates obtained with 
fluorescence dilution, are consistent with results obtained using DNA-tagged, 
isogenic strains of S. Typhimurium (WITS) (Grant et al., 2008). These authors 
also used Phox-deficient mice to demonstrate that this early killing is 
mediated by the oxidative burst. Following this, a second phase occurred, 
characterised by negligible killing and moderate division rates, which is also in 
accordance with experiments using WITS (Grant et al., 2008). In the WITS 
model, this temporal change in growth dynamics was attributed to a shift in 
the role of oxidative stress from bactericidal to bacteriostatic, as the mean 
generation time of S. Typhimurium in Phox-deficient mice was more than half 
that observed in wild-type mice, from 6 h onwards when killing was negligible. 
Transfer of S. Typhimurium from PMNs to macrophages, a more permissive 
cell type, could potentially account for this observation. However, an 
increased replication rate of S. Typhimurium was not observed by 
fluorescence dilution in Phox-deficient bone marrow-derived macrophages, 
compared to their wild-type counterparts (Dr. S. Helaine, personal 
communication).  
 
The replication of S. Typhimurium in the spleen was also measured by using 
a temperature-sensitive plasmid, in previous work by our group (Shea et al., 
1999). In this report, the i.p. route of inoculation was used. After 16 h of 
infection, wild-type S. Typhimurium was found to have undergone 4 
(intracellular) or 5 to 6 (extracellular) generations of replication. Intra- and 
extracellular populations of bacteria were not distinguished in my 
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experiments. However, since the replication profile of the pooled populations 
of bacteria were relatively homogeneous (Fig. 5.6A-B), this does not provide 
evidence of two distinct populations of replicating bacteria. Nonetheless, it is 
possible that a difference in replication between intra- and extracellular 
bacteria becomes more pronounced as the infection progresses. In the WITS 
model, bacteria were found to divide every 1.7 h between 0.5 h to 6 h p.i. and 
every 8 h between 6 h to 24 h p.i. (Grant et al., 2008). Therefore, this 
suggests that at 16 h p.i. bacteria would have undergone approximately 4.5 
divisions. S. Typhimurium replication in the spleen after i.v. inoculation has 
also been measured by Maw and Meynell using the dilution of a 
superinfecting phage (Maw et al., 1968). Bacteria were found to replicate 
through 1 generation by 1.5 h and a further 10 generations by 48 h p.i., 
therefore this suggests that bacteria replicate through approximately 4 
generations over 16 h of infection. Therefore, three independent methods 
(plasmid dilution, WITS and phage dilution) to measure S. Typhimurium 
replication, using different routes of inoculation (i.p. and i.v.), yield similar 
results. These findings demonstrate that S. Typhimurium replicates within the 
spleen at a similar rate, despite having reached this organ via different routes.  
 
3.5. The contribution of the SPI-2 T3SS to bacterial replication in the 
spleen 
 
SPI-2 T3SS-deficient strains of S. Typhimurium are competent for invasion of 
non-phagocytic cells (Ochman et al., 1996) and after oral inoculation, these 
bacteria are able to reach the PP (Cirillo et al., 1998, Cheminay et al., 2004). 
However, without a functional SPI-2 T3SS, S. Typhimurium cannot efficiently 
colonise the PP, MLN, spleen and liver of mice to develop a systemic disease 
(Shea et al., 1996, Cirillo et al., 1998, Shea et al., 1999, Cheminay et al., 
2004). Previous work from our group demonstrated that from 4 h to 8 h post-
i.p. inoculation, ΔssaV and wild-type bacteria undergo a small increase in net 
growth in the liver and spleen (Shea et al., 1999). However, as the net growth 
of wild-type bacteria continued to increase, the numbers of the mutant 
remained constant over the next week, then began to gradually decrease. 
After 4 months, most mice had cleared the SPI-2 T3SS-deficient strain (Shea 
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et al., 1999). Consistent with these results, there was a slight increase in net 
growth of wild-type S. Typhimurium from 2 h to 8 h post-i.v. inoculation in my 
experiments. However, there was a decrease in net growth of the SPI-2 
T3SS-deficient strain over the same period of time (Fig. 5.6C), which 
contrasts with earlier findings. Differences in the experimental conditions used 
in the two studies could explain the discrepancies in cell counts, including the 
dose and route of inoculation. In my experiments, mice were inoculated 
intravenously with 800 CFU, whereas Shea et al. inoculated mice 
intraperitonally with 105 CFU of bacteria.  
 
Reduced net growth in vivo could be due to a defect in replication or an 
increased susceptibility to host killing, or both. However, by using the 
temperature-sensitive plasmid to calculate the rate of bacterial replication and 
killing in the spleen, the reduced growth of SPI-2 T3SS mutants was found to 
be predominantly due to a defect in replication, rather than resistance to host 
killing (Shea et al., 1999). An inability to replicate within macrophages was 
also suggested by other work from our group, which demonstrated that after 3 
days of infection, less than 5% of SPI-2 T3SS mutant-infected splenocytes 
contained more than 5 bacteria per cell, whereas approximately 45% of wild-
type-infected splenocytes contained more than 5 bacteria per cell (Salcedo et 
al., 2001). The findings by Salcedo et al. also suggested that the SPI-2 T3SS-
deficient bacteria were not more susceptible to host killing, as the number of 
splenocytes infected with this strain remained constant over 5 days of 
infection. My results confirm these observations, showing that SPI-2 T3SS 
mutants replicate in the spleen to a significantly lesser extent than wild-type 
bacteria and this was not accompanied by a significant difference in host 
killing sustained by both strains. Results consistent with this were also 
obtained by Dr. S Helaine of our group, who used fluorescence dilution and 
CFU to examine S. Typhimurium replication and killing within bone marrow-
derived macrophages (Helaine et al., 2010).  
 
Other reports have implicated the SPI-2 T3SS in the avoidance of SCV-
lysosome fusion (Uchiya et al., 1999) and Phox- (Vazquez-Torres et al., 
2000b), and iNOS- (Chakravortty et al., 2002) mediated killing. My results and 
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other work from our group (Shea et al., 1999, Salcedo et al., 2001, Helaine et 
al., 2010) contradict these findings, in particular the role of SPI-2 in resistance 
to the respiratory burst, as this accounts for the early host killing experienced 
by S. Typhimurium in the spleen (Grant et al., 2008). In addition, a recent 
study reported that, although the spleens of phox-knockout mice contained 
higher loads of a SPI-2 T3SS mutant than those from wild-type mice, CI tests 
indicated that the mutant was similarly attenuated in both mouse strains, 
compared to wild-type S. Typhimurium (Aussel et al., 2011). In conclusion, my 
results add to an increasing body of evidence that indicates that the SPI-2 
T3SS contributes to replication of S. Typhimurium in vivo and not resistance 
to host killing. 
 
Although the SPI-2 T3SS is required for replication within and eventual 
colonisation of host tissues, it is clear that a SPI-2 T3SS-deficient mutant is 
still capable of limited growth in vivo (Shea et al., 1999, Salcedo et al., 2001). 
This seems most prominent during the early stages of infection in the spleen 
(Fig. 5.6C), which is surprising given that the SPI-2 T3SS is maximally 
expressed 6 h following uptake by cultured cells (Cirillo et al., 1998). 
However, the temporal activation of the SPI-2 T3SS is not known in vivo. In 
addition, S. Typhimurium has been shown to replicate independently of the 
SPI-2 T3SS within some cultured cell-lines for at least the first 6 h post-uptake 
(Brumell et al., 2001, Helaine et al., 2010). 
 
For the experiments discussed in this section, further insights could clearly be 
obtained by extending the dynamic range of measurement of fluorescence 
dilution. This is because SPI-2 T3SS-translocated effectors are only detected 
within host cells after several hours of infection and SPI-2-dependent 
replication only becomes apparent 6 h following uptake by cultured 
macrophages. Therefore, the functions of the SPI-2 T3SS are likely to be 
more pronounced later in infection. Fluorescence dilution could be used in 
future work to investigate the role of other bacterial factors, such as the SPI-1 
T3SS and the PhoPQ regulon, and host factors, such as the Slc11a1, Phox 
and iNOS, on S. Typhimurium growth during systemic disease. How bacterial 
replication (or lack of replication) relates to the expression of specific genes 
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could also potentially be investigated by combining fluorescence dilution with 
additional fluorescent protein reporters that are encoded downstream of target 
gene promoters. It would also be interesting use fluorescence dilution to 
determine how bacterial growth relates to host-specific disease progression 
by different S. enterica serovars (Paulin et al., 2007).  
 
6.4. S. Typhimurium preferentially colonises and replicates within 
splenic macrophages 
 
Despite extensive study of the growth dynamics of S. Typhimurium in the liver 
and spleen, the intracellular localisation of replicating bacteria within these 
organs is still debated. It is generally accepted that S. Typhimurium 
preferentially colonises macrophages in vivo. This is partly because the ability 
of S. Typhimurium to survive and replicate intracellularly within macrophages 
correlates with virulence in mice (Fields et al., 1986) and macrophage-
depleted mice display reduced bacterial loads (Wijburg et al., 2000). In 
addition, several studies, using microscopic or flow cytometric analysis, have 
shown that S. Typhimurium is contained predominantly within cells labelled 
with macrophage markers in the liver (Richter-Dahlfors et al., 1997) and 
spleen (Salcedo et al., 2001), during late stages of systemic disease. Further 
characterisation of infected splenocytes, by our group, revealed that S. 
Typhimurium localises to specific subsets of marginal zone and red pulp 
macrophages (Salcedo et al., 2001). However, these conclusions have been 
challenged recently by two other groups, which instead found that the majority 
of S. Typhimurium is contained within splenocytes labelled with antibodies 
specific for PMNs, at late stages of infection (Geddes et al., 2007, Aussel et 
al., 2011). Furthermore, one such study also used morphologic analysis on a 
portion of these antibody-labelled cells, after fluorescence-activated cell 
sorting (FACS), to confirm their identity (Geddes et al., 2007). This is 
surprising, since PMNs are thought to be relatively short-lived and appear to 
kill S. Typhimurium efficiently (Conlan, 1997).  
 
In experiments described in Chapter 5, S. Typhimurium was found within 
macrophages and PMNs in the spleen, at late stages of infection. However, 
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the majority of infected cells resembled macrophages (distinguished as non-
lobed, F4/80+, CD11b+ splenocytes), suggesting that S. Typhimurium 
preferentially colonises this host cell type in vivo. It is possible that a 
proportion of the infected macrophages identified in my study might represent 
DCs, as F4/80 was found to be expressed by these cells (Leenen et al., 
1998). Indeed, other studies have shown that S. Typhimurium infects splenic 
DCs in mice (Yrlid et al., 2001, Yrlid and Wick, 2002). However, the 
experimental conditions used in these studies differed greatly from my work. 
Yrlid et al., inoculated mice intraperitoneally or intravenously with very large 
numbers of bacteria (108 to 109 CFU) and recovered infected cells after 4 h, 
whereas I inoculated mice intravenously with 800 CFU and sacrificed mice 
after 5 days. To exclude the possibility of including DCs as macrophages in 
future experiments, additional macrophage-specific markers, such as 
scavenger receptors or MOMA-2 could be used (Leenen et al., 1994, Peiser 
et al., 2002). A potential explanation for the contradictory results of my study, 
and work by Richter-Dahlfors et al. and Salcedo et al., to the results of 
Geddes et al. and Aussel et al., who found that the majority of infected cells 
represented PMNs, could be the time of infection in which the respective 
investigations were carried out. Although in all studies, mice were sacrificed 
when the disease had reached an advanced stage, Geddes et al. and Aussel 
et al. inoculated mice with higher doses of bacteria (>105 CFU) and analysed 
infected splenocytes after a shorter period of infection (2 days). Therefore, the 
host cell type that S. Typhimurium colonises in vivo may be very dependent 
on the inoculum dose, stage of disease and time of infection. For example, it 
is possible that S. Typhimurium replicates within different host cell types as 
they become available and PMN influx to infection foci preceeds the influx of 
mononuclear cells (Nakoneczna and Hsu, 1980). Indeed, it has been 
previously reported that the majority of infected splenocytes after 4 h and 24 h 
post-i.v. inoculation represented PMNs (Dunlap et al., 1992). However, it 
should be noted that Dunlap et al., used very high doses (106 CFU) of 
bacteria to inoculate mice and very few infected cells were recovered. Geddes 
et al., also suggested that immune cell-surface expressed proteins might 
change during an infection, which could give rise to misleading results 
(Geddes et al., 2007). They detected F4/80 (Austyn et al., 1981) and CD115 
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or macrophage colony-stimulating factor receptor (Sasmono et al., 2003) on 
both splenic monocytes and PMNs, despite the widespread assumption that 
these are monocyte/macrophage-specific. Therefore, in the future, it may 
prove valuable to clarify the expression pattern of cell-specific markers under 
the appropriate context in which they are to be used. 
 
My results also demonstrated that macrophages contained significantly higher 
numbers of intracellular bacteria, compared to PMNs, providing evidence that 
S. Typhimurium preferentially replicates within macrophages in vivo. In 
addition, all intracellular bacteria had diluted their green fluorescence to 
undetectable levels, indicating that they had divided over 6 times. 
Examination of intracellular bacterial loads has shown that the numerical 
distribution of intracellular bacteria is dependent on the intrinsic bacterial 
growth rate and immune control mechanisms, such as the oxidative burst and 
IFN-γ (Grant et al., 2009). Therefore, lower numbers of intracellular bacteria 
might be observed within PMNs, despite the occurrence of bacterial 
replication, as this cell type is known to be more bacteriocidal than 
macrophages. However, since there were 2.5 times more infected 
macrophages (or non-lobed cells) than PMNs (or lobed cells) (Fig. 5.7B), it is 
more likely that these bacteria replicated elsewhere and upon entering PMNs, 
replication drastically slowed or ceased altogether.  
 
Although macrophages were found to contain higher intracellular bacterial 
loads compared to PMNs, the majority (64%) of all infected CD11b+ 
splenocytes contained an average of one or two bacteria per cell and 
approximately 85% contained less than 5 bacteria per cell (Fig. 5.7F). These 
findings are consistent with other studies that have used microscopy or flow 
cytometric analysis to examine the intracellular loads of S. Typhimurium-
infected cells in the liver and spleens of mice at late stages of infection 
(Sheppard et al., 2003, Thöne et al., 2007, Grant et al., 2008). In contrast, our 
group previously found much higher numbers of intracellular S. Typhimurium 
in infected splenocytes, with approximately 45% of infected cells containing 
more than 5 bacteria (Salcedo et al., 2001). These contradictory findings 
appear to be independent of the challenge dose, as low numbers of 
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intracellular bacteria within infected cells have been reported after inoculating 
mice with a wide range of CFU, from 800 CFU (this study) to greater than 107 
CFU (Sheppard et al., 2003). Importantly, the main difference between the 
experimental conditions used by Salcedo et al., compared to those used in my 
work and other studies, is the route of inoculation. Salcedo et al., inoculated 
mice intraperitonally whereas in my experiments and those of others, mice 
were inoculated by the i.v. route. Therefore, it is possible the progression of 
infection might differ depending on the route of inoculation. With this in mind, 
it might be useful to examine the intracellular loads of infected cells after oral 
inoculation of mice, which represents the natural route of S. enterica 
transmission. 
 
Interestingly, although most infected cells typically harbour only one or two 
bacteria, several studies have found that the vast majority of S. Typhimurium 
in the liver and spleen reside within a few highly infected host cells (Salcedo 
et al., 2001, Sheppard et al., 2003, Thöne et al., 2007). Some infected cells 
have been reported to contain at least 50 bacteria (Salcedo et al., 2001). 
Experiments described in Chapter 5 indicated that high loads of intracellular 
bacteria were exclusively within macrophages and splenocytes containing 
more than 10 bacteria represented only approximately 4% of all infected cells. 
How these two populations of abundant poorly infected or few highly infected 
host cells contribute to disease is still not fully understood. Classic activation 
of macrophages leads to upregulation of microbicidal activities, which could 
result in lower intracellular bacterial densities (Grant et al., 2009). However, 
highly or weakly infected cells apparently expressed similar levels of 
macrophage activation markers, suggesting that there is no difference in the 
activation status of these two populations (Thöne et al., 2007). Interestingly, 
the SPI-2 T3SS of S. Typhimurium has been implicated in the downregulation 
of macrophage activities, by inducing IL-10 (Uchiya et al., 2004), 
cyclooxygenase-2 (Uchiya and Nikai, 2004) and suppressor of cytokine 
signalling-3 (Uchiya and Nikai, 2005), which could promote intracellular 
bacterial replication. Indeed, another intracellular pathogen, Francisella 
tularensis, is also known to induce such responses to facilitate intracellular 
growth (Shirey et al., 2008). Therefore, it would be interesting to determine if 
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the activities of highly infected cells observed in S. Typhimurium infections 
might be similarly suppressed. 
 
5. Significance of non-replicating bacteria  
 
Fluorescence dilution also provided information about the replication diversity 
within a bacterial population. Populations of S. Typhimurium recovered from 
murine tissues were found to contain cells that had undergone different 
numbers of divisions (Tables 5.3 and 5.6). This could have resulted from 
differences in the initiation of replication, the replication rate and possibly, the 
dissemination of bacteria from one tissue to another. Indeed, it has been 
shown that bacterial populations are inherently heterogeneous, for example 
with respect to virulence factor expression (Roe et al., 2003, Roe et al., 2004) 
or resistance to antibiotic treatments (Balaban et al., 2004). Heterogeneous 
profiles of bacterial replication were also observed within bone marrow-
derived macrophages (Helaine et al., 2010). In contrast, we observed that S. 
Typhimurium replicated uniformly within more permissive RAW264.7 
macrophages (Fig. 3.6C), demonstrating that bacteria are less stressed within 
these cells.   
 
Surprisingly, this technique also revealed that, while a population of bacteria 
replicated inside both macrophages and epithelial cells, a sub-population of 
bacteria persisted throughout infection without replicating. Further 
examination of these bacteria in macrophages revealed that they remained 
within vacuoles (Helaine et al., 2010). It is very likely that persistent, non-
replicating bacteria have biological significance. Further experiments by our 
group demonstrated the presence of a large sub-population of intracellular S. 
Typhimurium in splenic macrophages that persisted for several days without 
undergoing a single division (Helaine et al., 2010). Consistent with this, 
experiments reported in Chapter 5 revealed that small populations of bacteria 
that had not replicated were frequently detected within the SI, PP, MLN and 
spleen at different time-points, for up to at least 2 days following oral 
inoculation of mice with S. Typhimurium (Table 5.1). Further characterisation 
of intracellular, non-replicating S. Typhimurium recovered from infected 
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splenocytes demonstrated that the majority of these bacteria were able to 
respond to the presence of an extracellular signal, which was detected by the 
de novo production of DsRed (Helaine et al., 2010). Therefore, intracellular, 
non-replicating bacteria are metabolically active and still viable.  
 
The presence of non-replicating bacteria in vivo is intriguing. It is possible that 
these bacteria might represent reservoirs that persist in chronic infections, 
since long-term persistence is thought to be associated with a shut-down in 
replication and metabolic activity, possibly enabling them to avoid killing by 
immune defences and antibiotics. Indeed, S. enterica is well known to cause 
chronic asymptomatic and relapsing infections (Bhan et al., 2005). Little is 
known about how these organisms persist without being killed or where 
persistent organisms are located. Potential reservoirs of latent bacteria have 
been proposed in other work, including the PP (Griffin et al. 2011), the MLN 
(Monack et al., 2004a, Griffin et al., 2011), the liver (Nath et al., 2010) and the 
gallbladder (Sinnott and Teall, 1987), perhaps by forming biofilms on existing 
gallstones (Crawford et al., 2010). 
 
Using fluorescence dilution to identify non-replicating populations of S. 
Typhimurium after oral infection of Slc11a1-resistant mice, which are used to 
model chronic S. enterica infections (Monack et al., 2004a), may help to 
identify reservoirs of dormant bacteria. Interestingly, Griffin and colleagues 
have recently developed a murine model of typhoid relapse. In this model, 
Slc11a1-susceptible mice appear to resolve a primary infection with S. 
Typhimurium, after prolonged treatment with the fluoroquinolone, ciprofloxacin 
(Griffin et al., 2009, Griffin et al., 2011). However, several days following 
antibiotic withdrawal, mice develop relapsing disease, most likely from growth 
initiated within the MLN (Griffin et al., 2011). It would be very interesting to 
apply fluorescence dilution to study the replication dynamics of S. 
Typhimurium in this system, to determine how non-replicating bacteria 
respond to antibiotic therapy and how replication dynamics compare between 
a primary and relapsing infection.  
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Very recent work by our group has shown that a proportion of non-replicating 
bacteria resume growth after release from bone marrow-derived 
macrophages and inoculation in rich laboratory medium or even after uptake 
in more permissive macrophages (Dr. S. Helaine, personal communication). 
However, it is still not understood what causes bacteria to enter this non-
replicating state. Non-replicating S. Typhimurium are not observed in the 
inoculum, whereas they are detected within host cells and in mice (Helaine et 
al., 2010 and this study). This suggests that a signal from host cells is sensed 
by S. Typhimurium, which causes bacteria to stop replicating. The nature of 
this signal remains elusive, as the occurrence of intracellular non-replicating 
bacteria is independent of the host cell type (Fig. 3.6C and 3.10D) and the 
bacteriocidal activity of the host cell (Helaine et al., 2010). Interestingly, work 
described in Chapter 5 of this study provided some insights into the source of 
the signal sensed by S. Typhimurium that might regulate the formation of non-
replicating bacteria in vivo. In contrast with the presence of non-replicating 
bacteria in mice after oral (this study) or i.p. inoculation (Helaine et al., 2010), 
in animals that were inoculated intravenously, all bacteria detected in the 
spleen had begun to replicate soon after inoculation. These findings suggest 
that a proportion of S. Typhimurium may perceive a signal to repress division 
within the gastrointestinal tract or peritoneal cavity. Alternatively, the signal to 
shut-down replication may be actively repressed by some factor sensed in the 
blood or spleen. Indeed, many reports have shown that bacteria can sense 
and respond to signals present within the host. Through the histidine kinases, 
QseC and QseE, Enterohaemorrhagic E. coli can sense autoinducer (AI)-3, 
produced by gut microbial flora, and the mammalian hormones, adrenaline 
and noradrenaline (Sperandio et al., 2003, Clarke et al., 2006, Reading et al., 
2009). These signals lead to upregulation of virulence genes involved in 
motility, intestinal colonisation and toxin production (Hughes et al., 2009) and 
can also stimulate bacterial growth (Lyte and Ernst, 1992). A qseC homologue 
is present in S. Typhimurium and could also regulate virulence gene 
expression in response to mammalian catecholamines (Rasko et al., 2008, 
Merighi et al., 2009, Moreira et al., 2010). Additionally, in one study that used 
a bovine enteritis model, the administration of noradrenaline was associated 
with increased bacterial replication (Pullinger et al., 2010). However, the role 
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of QseC and catecholamine-induced responses in S. Typhimurium is disputed 
(Pullinger et al., 2010, Merighi et al., 2009). Nevertheless, it would be 
interesting to investigate whether the development of a non-replicating 
phenotype in S. Typhimurium may also be influenced by these hormones or 
bacterial AI-3. Isolating non-replicating bacteria from infected cells or tissues 
by FACS and comparing their transcriptomes with those that have replicated 
could provide additional insights into the signals and genes that regulate this 
phenomenon. Alternatively, screens could be carried out to search for 
mutants that have an altered frequency of non-replicating bacteria. 
 
6. Conclusions 
 
This thesis describes the development of fluorescence dilution as a technique 
to measure bacterial replication directly at both the population and single cell 
level in vivo. This work demonstrated that replication is not a prerequisite for 
S. Typhimurium to cross the intestinal wall and seed systemic sites during 
murine salmonellosis. In fact, the MLN were preferentially seeded by non-
replicating bacteria and in contrast, the spleen was preferentially seeded by 
bacteria that had already replicated. Furthermore, these experiments revealed 
that the replication of S. Typhimurium was more restricted in the MLN 
compared to the PP, which contributes to an increasing body of evidence that 
identifies the MLN as a restrictive niche for S. Typhimurium during systemic 
disease. Fluorescence dilution also revealed heterogeneous replication 
behaviour of S. Typhimurium within different environments in vitro and in vivo. 
Often a spectrum of replication was observed within a bacterial population, 
consisting of those that had not replicated or those that had undergone 
different numbers of divisions. Non-replicating bacteria could represent 
reservoirs that contribute to chronic and/or relapsing infections. Importantly, 
the differential fluorescence signal of non-replicating bacteria provides a 
means to identify and isolate these bacteria from infected cells. Many other 
bacterial pathogens are also associated with chronic infections, including 
Mycobacterium tuberculosis, H pylori, Brucella and uropathogenic E. coli 
(Orme, 2001, Schilling et al., 2002, Monack et al., 2004b, Ehlers, 2009). 
Applying fluorescence dilution to study bacterial replication dynamics in 
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models of these infections could provide further insights into the pathogenesis 
of chronic disease. Lastly, to investigate bacterial organ colonisation in more 
detail, information about bacterial replication during the evolution of individual 
infection foci could be obtained by integrating fluorescence dilution with high-
resolution imaging, such as intravital multiphoton microscopy (Liu et al., 2007, 
Månsson et al., 2007). In conclusion, fluorescence dilution provides a means 
to monitor bacterial replication directly in vivo, and therefore can provide more 
detailed insights into the replication dynamics of bacteria during disease 
pathogenesis.  
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